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Abstract 
 
Eukaryotic chromatin is organised into a hierarchy of topologically constrained loop 
structures. Matrix Attachment Regions (MARs) are genomic sequences that mediate the 
anchoring of chromatin to the insoluble proteinaceous fraction of the nucleus known as 
the nuclear matrix. Since only a few MARs have been characterised so far, their role in 
genomic structure and function is not well understood.  
 
The aim of this thesis is to use the human Major Histocompatibility Complex (MHC) as 
model region to provide novel insights into the relationship between chromatin folding 
mediated by MARs and gene expression. This large locus contains critical genes for 
immunity and is associated with more diseases than any other genomic region. Classical 
MHC  genes  are  expressed  in  a  cell  type  specific  pattern,  and  can  be  induced  by 
cytokines such as IFN-γ.  
 
MARs were identified across the entire MHC in uninduced fibroblasts, IFN-γ induced 
fibroblasts and B lymphoblastoid cells. Expression array analysis showed that these cell 
types  exhibit  different  MHC  expression  profiles.  MARs  were  first  isolated  treating 
nuclei  with  hypertonic  buffers  followed  by  nuclease  digestion  and  then  mapped  by 
hybridizing them onto a novel tiling path array for the MHC. The suitability of this 
array platform to study DNA-protein interactions was verified using hybridisations of 
CIITA-enriched DNA and DNA enriched in H3-K9/K14 acetylation.  
 
The findings reveal that MARs are unevenly distributed across the MHC, and that they 
can be classified into three classes: constitutive, cell type specific and transcription-
dependent. These sequences are mainly positioned in intergenic regions and in close 
proximity to the MHC class boundaries, subdividing the locus into physical domains. 
By  comparing  the  position  of  MARs  in  uninduced  fibroblasts,  IFN-γ  induced 
fibroblasts and B lymphoblastoid cells, transcriptional activation of the MHC was found 
to be associated with a reconfiguration of chromatin architecture resulting from the 
formation  of  additional  genomic  anchors.  These  results  suggest  that  the  dynamic 
tethering of chromatin is linked to transcriptional regulation. 
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1  Introduction 
 
A newly formed international consortium has recently announced the ‘1000 Genomes 
Project’,  an  ambitious  effort  which  involves  the  sequencing  of  at  least  a  thousand 
people from around the world. Although there is no doubt that sequencing projects have 
been and will continue to be critical for our understanding of genome function, the 
linear sequence of nucleotide bases does not provide the complete description of the 
genome as genetic information exists in a dynamic and three-dimensional complex of 
DNA with proteins. A central question in biology is how the genetic information is 
packaged into the nucleus so that it can be accessed by nuclear regulatory machineries 
during  cellular  differentiation  and  responses  to  environmental  stimuli.  Through 
hierarchical levels of folding, DNA molecules are packaged with specific proteins into 
chromosomes, which are compartmentalised into discrete domains called chromosome 
territories. The degree of chromatin condensation and the attachment of DNA to the 
nuclear periphery have been shown to contribute to chromosome architecture. Three-
dimensional  chromosomal  structure  is  also  driven  by  other  properties  including  the 
affinity of chromatin for nuclear components such as nucleoli and splicing speckles. 
However, the determinants of chromatin organisation are still largely unknown. The 
aim of my thesis is to improve our understanding of the relationship between chromatin 
architecture  and  gene  expression  in  a  model  genomic  region,  the  human  Major 
Histocompatibility Complex (MHC). 
 
1.1  The complex architecture of the human genome 
 
A typical nucleus of a human cell is about 5 µm in diameter and contains approximately 
2 metres of DNA. This tight packaging is achieved through a complex series of folding 
levels. 
 
1.1.1  DNA organisation in chromosomes 
 
The DNA of the human genome contains approximately 3.2x10
9 nucleotides distributed 
over 24 chromosomes (Makalowski, 2001). With the exception of germ-line cells and   16 
specialised cell types lacking DNA, such as red blood cells, each human cell contains 
46 chromosomes, of which 22 pairs are autosomes and 1 pair are sex chromosomes. 
 
Each chromosome is characterised by a centromere and two telomeres. The centromere 
divides the chromosome into the short and long arms designated as p-arm and q-arm, 
respectively. By interacting with spindle microtubules, the centromere ensures correct 
segregation during mitosis and meiosis. The telomeres are located at the termini of each 
chromosome and protect chromosomes from progressive shortening after each mitotic 
cycle.  
 
The  chromosomes  of  the  human  genome  differ  significantly  with  respect  to  size. 
Chromosome 1 is the largest of the human chromosomes and is approximately six times 
longer  than  chromosome  21,  22  and  Y,  which  are  the  three  smallest  human 
chromosomes (Gregory et al., 2006). The shape of each chromosome, which depends on 
the position of its centromere, is also variable. 
 
The structure of human chromosomes undergoes major changes during the cell cycle. 
At G1-phase, each chromosome is relatively decondensed and is not visible under the 
light  microscope.  During  S-phase,  the  DNA  molecules  are  replicated.  At  G2-phase, 
each chromosome consists of two sister chromatids attached at the centromere. As the 
cell progresses into M-phase, the DNA molecules become more highly condensed and 
form mitotic chromosomes, which are readily visible under the light microscope. Upon 
completion of mitosis and segregation of the chromatids to each daughter nucleus, each 
chromosome is progressively decondensed. 
 
By  applying  specific  chemical  treatments,  each  metaphase  chromosome  can  be 
characterised  by  a  unique  band  pattern.  One  of  the  most  common  treatments  for 
visualising chromosome bands involves the use of trypsin and the Giemsa dye, which 
stains bands with different regional genomic features. Giemsa-dark bands (G-bands) are 
associated with relatively low GC content and gene density, they replicate late in the 
cell  cycle  and  are  often  highly  condensed  during  both  interphase  and  metaphase 
(Niimura and Gojobori, 2002). In contrast, Giemsa-light bands (R-bands) are associated 
with relative high GC content and gene density, they replicate early in the cell cycle and 
are less condensed than Giemsa-dark bands (Niimura and Gojobori, 2002). This finding   17 
has revolutionised the identification of chromosomes and the detection of abnormalities 
that characterise genetic diseases. 
 
1.1.2  Nucleosomal DNA 
 
Within the nucleus, the DNA double helix does not exist as a naked molecule, but rather 
as a complex with histone (H) and non-histone proteins to form chromatin, which is the 
substrate  of  enzymatic  machineries  involved  in  critical  nuclear  processes  including 
DNA  replication,  transcription  and  repair.  The  basic  unit  of  chromatin  is  the 
nucleosome,  which  is  formed  by  DNA  wrapped  around  a  disc-shaped  structure 
consisting  of  highly  conserved  histone  proteins.  The  individual  nucleosome  core 
particle (NCP) consists of an octameric histone structure comprising two copies each of 
the  core  nucleosomal  histones  H2A,  H2B,  H3  and  H4  and  146  nucleotide  pairs  of 
double-stranded  DNA,  which  forms  1.7  turns  of  a  left-handed  coil  (Ramakrishnan, 
1997).  Nucleosomes  are  separated  by  linker  DNA  of  length  ranging  from  a  few 
nucleotide pairs to up to about 80, and can be visualised under the electron microscope 
as ‘beads on a string’ structures, which are about 11 nm wide (Khorasanizadeh, 2004; 
Luger et al., 1997).  
 
The nucleosomal fibre becomes condensed into a 30 nm wide fibre to further compact 
the DNA. This structure consists of several nucleosomes tightly linked together by the 
non-nucleosomal H1 histone, a polypeptide characterised by a globular domain that 
interacts with linker DNA (Ramakrishnan, 1997). The two major models that have been 
proposed to describe the 30 nm fibre are the solenoid and the zigzag models (Fig 1.1). 
According to the solenoid model, consecutive nucleosomes are arranged into a simple 
one-start  helix  (Finch  and  Klug,  1976).  In  the  alternative  model,  the  packing  of 
nucleosomes  creates  a  double  helical  structure  (a  two-start  helix),  which  twists  to 
produce a zigzag pattern (Bednar et al., 1998). 
 
Higher  organisms  have  genes  encoding  histone  variants  that  contribute  to  distinct 
nucleosomal architectures and confer unique functions to nucleosomes (Brown, 2001). 
For example the centromere protein A (CENPA), an H3 histone variant, is required for 
the assembly of centromeric nucleosomes and might function as a centromere mark for 
kinetochore  assembly  (Brown,  2001;  Howman  et  al.,  2000).  While  expression  of   18 
histone  proteins  takes  place  predominantly  during  S-phase,  the  synthesis  of  histone 
variants  occurs  throughout  the  different  phases  of  the  cell  cycle  (Khorasanizadeh, 
2004). 
 
Histones  and  histone  variants  are  characterised  by  N-terminal  and  C-terminal  tails 
which extend out from the DNA histone core (Khorasanizadeh, 2004; Ramakrishnan, 
1997).  These  tails  are  subject  to  covalent  modifications  (discussed  below),  which 
regulate different aspects of genomic structure and function. 
 
 
 
 
 
Figure 1.1 Models of the 30 nm chromatin fibre.  
(Left) In the solenoid model, the consecutive arrangement of nucleosomes forms an 
interdigitated one-start helix. Alternative helical gyres are coloured blue and magenta. 
The linker DNA has not been modelled. (Right) In the zigzag model, the alternating 
pattern  of  adjacent  nucleosomes  generates  a  two-start  helix.  Alternative  gyres  are 
coloured blue and orange (Tremethick, 2007). 
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1.1.3  Histone modifications 
 
Histone  residues  are  subject  to  different  covalent  modifications.  So  far,  8  types  of 
modifications  have  been  identified  on  over  60  histone  residues,  acetylation, 
methylation,  phosphorylation,  ubiquitylation,  sumoylation,  ADP  ribosylation, 
deimination  and  proline  isomerisation  (Kouzarides,  2007).  Individual  histone 
modifications and their combinations can change the structure of each nucleosome in 
many different ways and have the potential to fine-tune mechanisms regulating genomic 
function.  
 
Histone modifications are catalysed by chromatin remodelling enzymes and can both 
alter  chromatin  architecture  and  recruit  specific  proteins  (Kurdistani  and  Grunstein, 
2003). Genome-wide studies have suggested that these modifications are not evenly 
distributed across the genome (Kurdistani et al., 2004; Quina et al., 2006). Furthermore, 
they  can  dynamically  appear  and  disappear  on  the  nucleosomes  depending  on  the 
presence or absence of environmental stimuli at the cell surface (Li et al., 2007; Quina 
et al., 2006). The role of the different modifications is being unveiled by examining 
their  associations  with  different  nuclear  processes  (Kouzarides,  2007).  The  most 
common  histone  modifications,  acetylation,  methylation  and  phosphorylation,  which 
are also the most well characterised, are discussed below. The target residues of each 
modification type and their relative functions are summarised in Table 1.1. 
 
Histone acetylation is believed to facilitate transcription since it is frequently associated 
with promoters and coding regions of transcriptionally active genes (Grunstein, 1997; 
Kurdistani et al., 2004). Acetylation of specific residues on newly synthesised histones 
at S-phase persists throughout G2-phase if the DNA is damaged, but disappears if the 
DNA is undamaged, suggesting that this modification could be involved in DNA repair 
(Celic et al., 2006; Maas et al., 2006). There is also evidence showing that histone 
acetylation is required for S-phase initiation and chromatin decondensation (Aggarwal 
and Calvi, 2004; Iizuka et al., 2006; Shogren-Knaak et al., 2006). 
 
Histone methylation can either activate or repress transcription depending on which 
histone residue is modified. Specific methylated residues at the 5’ end and 3’ ends of 
active genes recruit the initiating and the elongating form of RNA polymerase (Pol) II, 
respectively,  and  correlate  with  transcriptional  activation  (Kouzarides,  2007).   20 
Conversely,  other  methylated  residues  are  associated  with  the  formation  of  silent 
heterochromatin and the repression of euchromatic genes (Kouzarides, 2007). Recent 
evidence suggests that histone methylation may recruit the cell cycle protein Crb2 to 
sites of DNA damage and trigger the arrest of the cell cycle at G2-/M-phase to allow 
DNA repair (Botuyan et al., 2006). 
 
Histone phosphorylation has been linked to transcriptional activation of specific genes, 
including FOS and JUN (Clayton et al., 2000; Zippo et al., 2007). In addition, histone 
phosphorylation contributes to the recognition of sites where DNA repair needs to take 
place,  by  marking  long  stretches  of  nucleotides  around  sites  of  DNA  damage 
(Fillingham et al., 2006). Phosphorylation of specific histone residues facilitates the 
removal of H1, indicating that this histone modification might also play a role in the 
accessibility of chromatin (Fischle et al., 2005). 
 
 
 
Chromatin Modification  Residue(s) Modified  Functions Regulated 
Acetylation  Lysine  Transcription, Repair, 
Replication, Condensation 
Methylation  Lysine, Arginine  Transcription, Repair 
Phosphorylation  Serine, Threonine  Transcription, Repair, 
Condensation 
Ubiquitylation  Lysine  Transcription, Repair 
Sumoylation  Lysine  Transcription 
ADP ribosylation  Glutamic acid  Transcription 
Deimination  Arginine  Transcription 
Proline Isomerisation  Proline  Transcription 
 
Table 1.1 Different types of histone modifications. 
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1.1.4  Histone-modifying enzymes 
 
Histone acetylation is catalysed by histone acetyltransferases (HATs), which transfer an 
acetyl group from Acetyl CoA to histone lysine residues. HATs are grouped into three 
main  families:  GNATs,  p300/CBP  and  MYST  depending  on  their  histone  lysine 
specificities  (Lee  and  Workman,  2007).  HATs  frequently  exist  in  multiprotein 
complexes and are able to regulate other histone modifications (Baker and Grant, 2007; 
Lee  and  Workman,  2007).  This  can  be  seen  from  acetylation  of  lysine  residues, 
preventing  their  modification  by  other  histone  modifying  enzymes  and  vice  versa 
(Yamada et al., 2005; Yang and Seto, 2007). HATs can also affect modifications of 
neighboring residues (Ahn et al., 2006; Li et al., 2006). 
 
Histone methyltransferases (HMTs) catalyse histone methylation by transferring one to 
three  methyl  groups  from  the  cofactor  S-adenosyl  methionine  to  lysine  or  arginine 
residues.  They  are  divided  into  histone  arginine  methyltransferases  (HRMTs)  and 
histone  lysine  methyltransferases  (HKMTs)  (Berger  and  Gaudin,  2003;  Kouzarides, 
2007). Specific HMTs can interact with HATs to synergistically augment transcription 
as  well  as  recruit  DNA  methyltransferase  (DNMT)  to  promote  DNA  methylation 
(Zhang  and  Reinberg,  2001).  One  of  the  best-characterised  HMTs  is  arginine 
methyltransferase 1 (PRMT1), which is associated with transcriptional activation (Lin 
et al., 1996; Tang et al., 2000; Wang et al., 2001). 
 
Studies  with  specific  MAP  kinase  inhibitors  show  that  histone  phosphorylation  is 
mediated by distinct signalling pathways such as the ERK or p38 MAP kinase pathways 
(Kouzarides, 2007; Soloaga et al., 2003). Downstream kinases, including the mitogen-
stress-induced  kinases  (MSKs),  but  not  the  MAP  kinases  themselves,  catalyse  the 
addition of a phosphate group to histone residues (Soloaga et al., 2003). By modifying 
histones, MSKs promote transcription and regulate spindle function during mitosis and 
meiosis.  The  mechanism  with  which  histone  modifying  kinases  catalyse  other 
modifications remains to be established (Nowak and Corces, 2004). 
 
The paucity of isolated and characterised enzymes catalysing histone modifications has 
limited  our  understanding  of  how  they  regulate  chromatin  function  and  structure. 
(Kouzarides, 2007). While there is evidence linking these enzymes with transcription,   22 
replication  and  DNA  repair  processes,  the  molecular  mechanisms  underlying  such 
associations remain unclear. 
 
Most covalent modifications of histone tails are reversible and a number of enzymes 
removing those modifications have been identified (Cheung et al., 2000; Kouzarides, 
2007). Histone deacetylases (HDACs), which can catalyse the cleavage of acetyl groups 
from  histone  residues,  are  the  best-characterised  (Yang  and  Seto,  2007).  Histone 
modifications  are  thus  governed  by  the  interaction  between  enzymes  adding  and 
removing functional groups from histone residues, enabling cells to alter the structural 
and functional properties of the genome in response to changing environmental signals. 
 
1.1.5  Heterochromatin and euchromatin 
 
Early microscopic observations revealed two types of chromatin, heterochromatin and 
euchromatin. Heterochromatin was defined as chromatin remaining highly condensed as 
the  cell  makes  the  transition  from  metaphase  to  interphase,  and  euchromatin  as 
chromatin  with  a  more  ‘open’  conformation.  Each  of  these  two  chromatin  states  is 
characterised  by  distinctive  biochemical  features,  most  importantly  histone 
modifications,  which  alter  the  level  of  chromatin  packaging  and  convert 
heterochromatin into euchromatin and vice versa (Jacobs et al., 2001; Meneghini et al., 
2003; Richards and Elgin, 2002; Schneider and Grosschedl, 2007). 
 
Heterochromatin  contains  transcriptionally  silent  DNA  and  euchromatin  contains 
actively  transcribing  DNA  sequences  (Schneider  and  Grosschedl,  2007).  While 
heterochromatin  is  associated  with  the  NCPs,  euchromatin  is  characterised  by 
nucleosome-free DNase hypersensitive sites (HSs) (Grewal and Elgin, 2002; Sun et al., 
2001).  Typically,  if  an  active  gene  from  a  euchromatic  region  is  relocated  to  a 
heterochromatic domain via chromosome rearrangement or transposition, it is usually 
silenced (Richards and Elgin, 2002). These observations gave rise to the hypothesis that 
highly packaged chromatin would prevent access of DNA to regulatory factors and 
would  thus  function  as  a  physical  barrier  for  transcriptional  activation  (Dillon  and 
Festenstein, 2002; Misteli, 2007). 
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The view of chromatin folding as a regulator of accessibility has been challenged by 
Gilbert et al. (2004) on the basis that chromatin fibres with a more ‘open’ structure were 
associated  with  gene-rich  regions  while  more  decondensed  chromatin  fibres  were 
associated with gene-poor regions (Gilbert et al., 2004). Surprisingly, their analysis also 
indicated that an ‘open’ chromatin conformation did not correlate with high levels of 
gene expression and that a ‘closed’ conformation could contain active genes. Taken 
together, these findings suggest a relationship between chromatin architecture and gene 
density  rather  than  between  chromatin  architecture  and  gene  activity.  Furthermore, 
Gilbert’s findings were in agreement with studies showing that dextrans and proteins 
with  molecular  weights  of  several  hundred  kilodaltons  were  able  to  freely  diffuse 
throughout heterochromatic as well as euchromatic domains within the nucleus (Cremer 
and  Cremer,  2001;  Lukacs  et  al.,  2000;  Verschure  et  al.,  2003).  From  these 
observations, it can be concluded that chromatin condensation does not constitute an 
insurmountable barrier for transcriptional activation (Misteli, 2007). 
 
1.1.6  Models of higher-order chromatin structure 
 
The higher-order three-dimensional architecture of chromatin structure, which includes 
the  different  levels  of  DNA  organisation  beyond  the  30  nm  chromatin  fibre  up  to 
metaphase  chromosomes,  is  still  poorly  described.  Although  numerous  models 
describing higher-order chromatin architecture in both interphase and metaphase nuclei 
have been put forward, there is still no conclusive evidence for any of them. 
 
Two  key  models  of  interphase  higher-order  chromatin  structure  are  the  random-
walk/giant-loop (RW/GL) and the multi-loop sub-compartment (MLS) models (Fig 1.2) 
(Munkel et al., 1999; Sachs et al., 1995). Both of these models interpreted data obtained 
by employing fluorescence in vitro hybridisation (FISH) to visualise distinct chromatin 
sites  and  analyse  their  physical  distance  as  a  function  of  genomic  distance.  In  the 
RW/GL model, chromatin loops averaging about 3 Mb are associated at their bases to a 
protein scaffold that extends throughout the nuclear interior. According to this model, 
the giant loops and the protein scaffold are described as random walks. In the MLS 
model, the 30 nm chromatin fibre is folded into loop domains of approximately 100 kb. 
About ten of these loops are spatially arranged in a rosette-like structure forming a sub-
compartment of approximately 1 Mb. At the centre of each rosette, the bases of the   24 
loops are held together by a ‘loop base spring’, which simulates the anchoring function 
of the nuclear scaffold postulated by the RW/GL model. Multiple consecutive rosettes 
are interconnected by stretches of 30 nm chromatin fibre and are backfolded to form 
interphase  chromosomes.  The  MLS  model  is  compatible  with  studies  on  DNA 
replication showing that 1 Mb chromatin domains are visible throughout subsequent 
cell cycles. 
 
A  third  model,  the  chromonema  model,  was  proposed  by  Belmont  et  al.  (1994) 
following a study using both light and electron microscopy (EM). Here, the 30 nm 
chromatin fibre is folded onto itself to form supercoiled, highly condensed structures 
called chromonema fibres (Fig 1.2) (Belmont and Bruce, 1994). The observed diameters 
of chromonema fibres are predominantly 60-80 nm in late G1- and early S-phase and 
100-130 nm in early G1-phase. Interphase nuclei also have local segments of more 
highly compacted chromatin measuring 200-400 nm in diameter, as well as more local 
decondensed chromatin corresponding to more loosely folded chromonema fibres and 
extended 30 nm chromatin fibres. The folding of the 30 nm chromatin fibre is proposed 
to  be  mediated  by  proteins  of  a  nuclear  scaffolding  or  non-specific  inter-fibre 
interactions at multiple sites and not necessarily at the bases of the loops. 
 
An  earlier  model,  the  radial  loop  model  was  proposed  for  mitotic  chromosome 
architecture based on the visualisation of EM micrographs of thin sections containing 
swollen metaphase chromosomes isolated using different ionic conditions (Marsden and 
Laemmli, 1979; Paulson and Laemmli, 1977). Here, highly condensed chromatin loops 
are arranged in a radial fashion with their bases anchored to a central axis extending 
along  most  of  the  length  of  the  chromatid.  Recent  studies  have  indicated  that  the 
metaphase chromosome axis is constituted of structural proteins which are physically 
disconnected from one another to form a discontinuous network (Kireeva et al., 2004; 
Marko, 2008). However, the validity of the radial loop model has been questioned by 
concerns that the structure of mitotic chromosomes visualised using non-physiological 
ionic conditions might not reflect their true structure in vivo. 
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Figure 1.2 Models of higher-order chromatin architecture in interphase cells.  
A) The random-walk/giant-loop model proposes that 3 Mb loops are attached to a non-
DNA  scaffold.  B)  The  multiloop  sub-compartment  model  proposes  a  structure  of 
multiple rosettes containing loops of approximately 100 kb each. C) The chromonema 
model proposes hierarchical levels of chromatin folding back on itself to form fibres 
with diameters of 60-80 and 100-130 nm, depending on the compaction.   26 
1.1.7  Organisation of chromosomes in the nucleus 
 
It was long assumed that, when cells are not dividing, chromatin exists as long thin 
tangled threads randomly arranged within the nucleus. Now there is solid evidence that 
interphase  chromosomes  display  a  high  degree of  organisation  (Bolzer  et  al.,  2005; 
Branco and Pombo, 2007; Cremer and Cremer, 2006; Cremer et al., 2004; Spector, 
2003). Groundbreaking experiments by Cremer et al. (1982) using UV microirradiation 
on defined areas of interphase nuclei in living cells revealed that only a small number of 
chromosomes  were  damaged.  This  indicated  that  the  genome  is  compartmentalised 
during interphase (Cremer et al., 1982). The subsequent development of FISH using 
probes  specific  for  entire  chromosomes  allowed  the  visualisation  of  interphase 
chromosomes  in  situ  and  demonstrated  that  each  chromosome  occupies  a  distinct 
physical  domain  within  the  nucleus  called  a  chromosome  territory  (CT)  (Fig  1.3) 
(Bolzer et al., 2005; Cremer and Cremer, 2006). 
 
Microscopic analysis has provided evidence that CTs are not solid structures but rather 
are porous entities with invaginations of non-chromatin spaces extending from their 
peripheries  throughout  their  interiors  (Cremer  and  Cremer,  2001;  Misteli,  2005; 
Verschure et al., 1999; Visser et al., 2000). These  spaces might facilitate access of 
regulatory protein complexes to DNA sequences located within the interior of the CT. 
Visualisation of chromatin with H2B tagged with green fluorescent protein (GFP) has 
enabled  the  identification  of  interchromatin  channels,  now  called  the  interchromatin 
compartment  (IC)  or  interchromatin  domain  (ICD),  starting  from  nuclear  pores, 
expanding between CTs and into their interior (Cremer and Cremer, 2001; Kanda et al., 
1998). 
 
The  positioning  of  CTs  is  cell  type  specific.  In  several  human  cell  types  including 
lymphocytes and lymphoblastoid cell lines, gene-rich chromosomes are situated in the 
nuclear interior and gene-poor chromosomes in the periphery of the nucleus (Boyle et 
al., 2001; Cremer et al., 2001; Croft et al., 1999). Gene-dense regions are typically 
transcriptionally active and replicate early. However, it is still not clear whether in these 
cell  types  CT  position  is  shaped  by  either  gene  density  per  se,  replication  timing, 
transcriptional activity or different combinations of these related parameters (Cremer 
and Cremer, 2006). In contrast, chromosome size appears to be the major determinant 
of  CT  positioning  in  human  fibroblasts  since,  independent  of  gene  density,  larger   27 
chromosomes  are  preferentially  located  towards  the  nuclear  periphery  and  smaller 
chromosomes towards the nuclear interior (Bolzer et al., 2005). 
 
Branco  and  Pombo  (2006)  developed  a  novel  FISH  procedure  (cryo-FISH),  which 
provides  high-resolution  images  of  chromosomes  while  preserving  chromosomal 
architecture (Branco and Pombo, 2006). The findings revealed that CTs are not entirely 
physically separated by the IC as they show extensive levels of intermingling mostly at 
their  boundaries.  From  these  data,  it  was  estimated  that  approximately  20%  of  the 
nuclear volume is occupied by intermingling chromosomes. Furthermore, it was shown 
that in human lymphocytes, the degree of intermingling between specific chromosome 
pairs is positively correlated with the frequency of chromosomal translocations in the 
same cell type (Branco and Pombo, 2006; Branco and Pombo, 2007). CT intermingling 
might  thus  facilitate  interchromosomal  interactions  and  have  a  direct  impact  on  the 
formation of chromosomal aberrations. 
 
 
 
 
 
Figure  1.3  Organisation  of  chromosomes  in  a  human  fibroblast  nucleus  at 
interphase. 
The chromosomes occupy discrete domains called chromosomal territories, which are 
represented here by different colours (Bolzer et al., 2005). 
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1.1.8  The nuclear position of genes  
 
The architecture of the nucleus is highly complex since it comprises a nuclear envelope, 
distinct higher-order chromatin domains such as heterochromatin and euchromatin, and 
various proteinaceous structures including the nucleolus and small nuclear bodies. As 
the position of genes relative to these different nuclear landmarks as well as to each 
other is non-random, it is essential to understand how the spatial organisation of genes 
affects their function (Misteli, 2005; Parada et al., 2004; Wang et al., 2004).  
 
One of the difficulties in designing experiments to understand nuclear organisation is 
that there are currently few options for defining a nuclear address. One approach is to 
determine the radial distance of the gene from the geometrical centre of the nucleus 
(Lukasova et al., 1997). Another method is to determine the position of the gene within 
one of the concentric ‘shells’ of the nucleus of equal radius or volume (Murmann et al., 
2005).  A  novel  approach  was  taken  by  Wang  et  al.  (2004)  who  determined  the 
proximity of genes to promyelocytic leukaemia (PML) nuclear bodies (Wang et al., 
2004). 
 
The nuclear periphery contains significant amounts of heterochromatin, and therefore it 
is traditionally regarded as a transcriptionally repressive environment (Misteli, 2004). 
The repositioning of the murine IgH and Igκ loci from the nuclear periphery to the 
nuclear interior following their activation during lymphocyte development supports this 
view (Kosak et al., 2002). However, recent observations suggest that the role of the 
nuclear periphery is more complex than originally thought. Experimental positioning of 
human chromosomes to the nuclear periphery by tethering them to a protein of the inner 
nuclear membrane was shown to have a silencing effect on many, but not all active 
genes  (Finlan  et  al.,  2008).  Furthermore,  in  budding  yeast  boundary  activities  that 
protect  the  expression  status  of  active  genes,  are  achieved  by  binding  of  active 
chromatin  to  nuclear  pore  complexes  (NPCs)  (Ishii  et  al.,  2002). Thus,  the  nuclear 
periphery is not simply a transcriptionally repressive zone but a heterogeneous nuclear 
microenvironment regulating gene activation and repression. 
 
The proximity of loci to particular nuclear structures is also of functional significance. 
Actively  transcribed  genes  frequently  colocalise  with  nuclear  structures  called 
interchromatin  granule  clusters  (IGCs),  which  contain  splicing  components  such  as   29 
small  nuclear  ribonucleoprotein  particle  (snRNP)  and  SR  proteins  (Lamond  and 
Spector, 2003). This has led to the idea that the localisation of active genes near ICGs 
facilitates  transcription  by  providing  relatively  high  concentrations  of  splicing 
components (Kosak and Groudine, 2004). Similarly, the frequent association of a subset 
of  active  genes  with  Cajal  bodies,  which  contain  snRNPs,  has  suggested  that  this 
colocalisation is linked to mRNA processing (Gall, 2000; Ogg and Lamond, 2002).  
 
The formation of spatial gene clusters indicates that certain gene loci are non-randomly 
positioned relative to each other. In a typical mammalian nucleus, 50-100 ribosomal 
genes located on 2-4 different chromosomes coalesce in the nucleolus where they are 
brought  into  physical  proximity  (Olson  et  al.,  2000).  A  similar  phenomenon  was 
observed for tRNA genes in Saccharomyces cerevisiae where over 50 genes from 16 
chromosomes  are  clustered  near  the  nucleolus  (Thompson  et  al.,  2003).  Studies  in 
erythroid cells showed that certain co-ordinately regulated genes are relocated at shared 
sites of ongoing transcription upon activation (Osborne et al., 2004). Although these 
associations could have a regulatory function, it remains to be established whether they 
are a general feature for other co-regulated genes. The extent to which the physical 
proximity  of  particular  genes  facilitates  co-ordinate  regulation  remains  to  be 
established. 
 
In addition to playing a role in gene expression, non-random gene positioning may be 
involved  in  the  formation  of  chromosomal  abnormalities  such  as  chromosomal 
translocations (Misteli, 2005). There are strong indications that the positions of genes 
relative to each other determine their probability of undergoing translocations. The loci 
involved  in  translocations  in  promyelocytic  leukaemia,  acute  myelocytic  leukaemia, 
Burkitt’s lymphoma and thyroid lymphoma are observed in closer spatial proximities 
than non-translocating regions in the corresponding normal cells (Misteli, 2004; Neves 
et al., 1999; Parada et al., 2004; Roix et al., 2003). These findings are also supported by 
studies in human lymphocytes showing that the degree of chromosomal intermingling 
between  certain  chromosomes  correlates  with  the  frequencies  of  chromosomal 
translocations (Branco and Pombo, 2006).  
 
Studies carried out so far have investigated the nuclear positions of relatively small 
genomic regions in a limited number of cell types. The use of high-throughput imaging 
methods and pattern recognition tools are likely to overcome this limitation and extend   30 
our understanding of the relationship between gene positioning and function (Misteli, 
2004). 
 
1.1.9  Chromatin loop structures 
 
Higher-order chromatin architecture is derived from hierarchical loop configurations, 
which  are  thought  to  be  of  fundamental  importance  for  the  regulation  of  gene 
expression. Within a eukaryotic cell, the size of these chromatin loops is reported to 
vary extensively. Local chromatin loops arise from short-range chromatin interactions 
and  can  be  analysed  using  biochemical  approaches,  such  as  the  chromosome 
conformation capture (3C). Giant chromatin loops can be identified by FISH. 
 
In order to understand the function of chromatin loop domains, it is critical to know 
how they are formed and determine whether they are either static or dynamic. The 
development of the 3C technique has provided significant insights into the role of local 
chromatin  loops.  This  assay  involves  formaldehyde  fixation  of  cells  followed  by 
restriction enzyme digestion, ligation and polymerase chain reaction (PCR) analysis to 
quantify the frequency of ligated DNA products (Cullen et al., 1993; Dekker et al., 
2002).  As  two  restriction  fragments  in  close  physical  proximity  will  have  a  higher 
ligation frequency than two other restriction fragments located further apart from one 
another, the in vivo 3-D organisation of chromatin can be examined. 
 
These studies have identified interactions of locus control regions (LCRs) or enhancers 
with  their  relative  promoters  and  genes  to  promote  gene  expression.  A  classical 
example is found at the murine β-globin locus where the promoter and the LCR, which 
is  located  several  kb  upstream,  are  brought  into  physical  proximity  by  a  local 
rearrangement of the chromatin at the onset of transcriptional activation (Apostolou and 
Thanos, 2008; Vakoc et al., 2005). The tethering of the loop at its base requires the 
recruitment  of  haematopoietic  transcription  factor  GATA1  and  its  co-factor  FOG1, 
indicating that expression of the locus is associated with loop formation (Vakoc et al., 
2005). 
 
Local  loops  are  also  formed  by  the  transcription-dependent  interaction  between 
promoter  and  terminator  regions  of  individual  genes.  Activation  of  several  loci  in   31 
Saccharomyces cerevisiae and in humans, is dependent on the folding back of genes 
onto themselves to juxtapose their 5’ and 3’ end sequences (Ansari and Hampsey, 2005; 
O'Sullivan et al., 2004). Physical interactions have also been observed between the 3’ 
end processing complexes and transcription initiation factors (Bentley, 2005; Misteli, 
2007). These loops facilitate a single RNA Pol II molecule re-initiating transcription, 
which would not be possible with a linear configuration since de novo recruitment of 
RNA  Pol  II  molecules  would  be  required  for  consecutive  rounds  of  transcription 
(Ansari and Hampsey, 2005). 
 
The physical interaction between insulator DNA sequences which shield genes from 
stimulatory and repressive effects arising from flanking regions, can also produce local 
loop structures. In Drosophila melanogaster, for instance, the insulators scs and scs’ 
which are located about 15 kb apart from each other are brought into close proximity by 
the interaction between scs and scs’ insulator proteins, Zw5 and BEAF, respectively 
(Blanton et al., 2003). The topological constraints of the loops are thought to establish 
chromatin domains characterised by unique properties. In Schizosaccharomyces pombe, 
the tethering of insulators with the transcription factor TFIIC at the nuclear periphery 
mediates the formation of loops containing active sequences which protrude into the 
nuclear interior (Noma et al., 2006). Here, the loops appear to function as physical 
barriers  separating  active  euchromatic  domains  from  repressive  heterochromatic 
regions. 
 
Giant chromatin loops have been observed at certain genomic regions with high gene 
density. This phenomenon was first discovered for the 4 Mb major histocompatibility 
complex (MHC), which was shown to escape from the borders of the FISH-painted 
chromosome 6 domain by forming a giant chromatin loop extruding typically about 1 or 
2 µm into the surrounding nucleoplasm (Volpi et al., 2000). Upon transcriptional up-
regulation of the MHC, the frequency with which the MHC was located on a giant loop 
increased (Christova et al., 2007; Volpi et al., 2000). Similar higher-order chromatin 
configurations were subsequently observed in co-ordinately regulated and other gene-
rich regions of the genome, such as the human epidermal differentiation complex and 
the mouse Hox gene clusters (Chambeyron and Bickmore, 2004; Sproul et al., 2005; 
Williams et al., 2002). Although the molecular basis underlying the formation of these 
loops and their functional significance are still not clear, it was recently found that the 
MHC  loops  represent  regions  of  decondensed  chromatin  conformation  which  might   32 
facilitate  the  binding  of  transcription  factors  and  promote  up-regulation  of  gene 
expression (Christova et al., 2007). 
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1.2  Matrix attachment regions 
 
It has long been hypothesised that the major determinants of chromosomal architecture 
are found in the fraction of the nucleus termed the nuclear matrix. These determinants 
are  thought  to  interact  with  genomic  sequences  called  matrix  attachment  regions 
(MARs), located at the bases of chromatin loops, thus organising the genome into loop 
domains. Although the nuclear matrix is almost certainly not a discrete entity, there is 
increasing evidence showing that its components are required to establish the three-
dimensional structure of chromosomes, organise the nucleus into different functional 
compartments and regulate fundamental nuclear processes including transcription and 
DNA replication. 
 
1.2.1  The nuclear matrix 
 
The nuclear matrix is the insoluble fraction that remains after the nucleus is treated with 
high-strength ionic buffers and nucleases to remove soluble proteins and chromatin. It 
was first observed approximately 40 years ago where it was described as a residual 
nuclear  protein  fraction  (Wang,  1966).  Although  the  terms  ‘nuclear  scaffold’  and 
‘nucleoskeleton’ are sometimes employed to describe this fraction, the term that is most 
widely  used  is  nuclear  matrix,  which  was  coined  by  Berezney  and  Coffey  in  1974 
(Berezney and Coffey, 1974). 
 
Electron  micrographs  of  the  nuclear  matrix  indicate  that  it  has  a  fibrogranular 
organisation extending from the nuclear envelope throughout the nuclear volume (Fig 
1.4) (Jackson, 2003; Nickerson, 2001). This structure has been identified in different 
eukaryotes ranging from yeasts to mammals. It is composed of hundreds of different 
proteins and RNA and can be divided into two main regions: the nuclear lamina and the 
internal nuclear matrix that is connected to the  lamina and fills the nuclear interior  
(Berezney  and  Coffey,  1977).    The  internal  nuclear  matrix  consists  of  an  intricate 
ribonucleoprotein  (RNP)  network  of  highly  branched  10  nm  filaments,  which  are 
preserved through the matrix isolation procedure (Jackson, 2003). Structural remnants 
of nucleoli can be observed in this network. 
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The most common experimental procedures for isolating nuclear matrices are extraction 
with buffers containing 25 mM lithium di-iodosalicylic acid (LIS), 2 M NaCl or 0.65 M 
(NH2)2SO4 (Donev et al., 2002). The LIS and ammonium sulphate extraction conditions 
are  relatively  mild  and  more  physiological  compared  to  the  2  M  NaCl  procedure 
(Donev,  2000).  However,  these  and  other  similar  procedures  generate  underlying 
networks of core filaments with remarkably similar ultrastructural features (Nickerson, 
2001). 
 
Upon treatment with high-salt buffers, soluble proteins including histones are released 
from the nucleus causing the DNA to unfold and loop out far beyond the nuclear lamina 
(Vogelstein et al., 1980). These preparations can be observed under fluorescent light 
microscopy by staining with 4’,6-diamidino-2-phenylindole (DAPI), which fluoresces 
brightly  when  it  forms  complexes  with  the  minor  groove  of  double-stranded  DNA. 
Multiple DNA loops, which can be seen as circular ‘halos’ around the nuclei, remain 
attached to the insoluble intranuclear structure suggesting that the core filaments of the 
nuclear matrix are bound to chromatin (Heng et al., 2004; Jackson, 2003). 
 
Whether the nuclear matrix is a continuous network of fibres is still under debate. GFP 
tagging of Drosophila nuclear matrix proteins CP60 and CP190 shows that they form 
filaments throughout the nucleus in vivo (Oegema et al., 1997). In mammalian cells, 
immunostaining of proteins that resist high-salt extraction has allowed the visualisation 
of  networks  of  filaments  at  the  nuclear  periphery  as  well  as  ‘cage-like’  structures 
throughout the nucleus (Cai et al., 2003; Dechat et al., 2008). However, most of the 
characterised nuclear matrix proteins have not been demonstrated to form core filaments 
in living cells (Jackson et al., 2003; Pederson, 2000). 
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Figure 1.4 The nuclear matrix in a mammalian cell. 
This electron micrograph of a HeLa cell shows the nucleus demarcated by a dense 
nuclear lamina (L) and a heavily stained nucleolus (No).  Prior to this micrograph being 
taken, the cell was treated with nucleases to remove approximately 90% of its DNA.  
The  nuclear  matrix  is  seen  here  as  an  intricate  network  of  filaments  extending 
throughout the nucleus (Jackson et al., 2003). 
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1.2.2  Proteins of the nuclear matrix 
 
The  composition  of  the  nuclear  matrix  can  vary  depending  on  the  cell  type  and 
organism.  In  matrices  prepared  from  different  human  cell  lines  and  tissues, 
approximately 200-300 proteins are seen on two-dimensional gels (Fey and Penman, 
1988; Gerner et al., 1998). Many matrix proteins are common to different cell types, 
including lamins, scaffold attachment factor A (SAFA), scaffold attachment factor B1 
(SAFB1), and topoisomerase II (Fey and Penman, 1988; Mattern et al., 1997; Stuurman 
et al., 1990). 
 
Lamins provide shape and stability to the nucleus and contribute to a wide range of 
nuclear functions. They are composed of a long α-helical rod flanked by globular N-
terminal and C-terminal domains, and have the capacity to self-assemble into higher-
order structures (Herrmann and Foisner, 2003; Stuurman et al., 1998). Lamins form 
type V intermediate filaments, which are the main constituents of the nuclear lamina, 
but they are also found in a diffused form throughout the nuclear interior (Dechat et al., 
2008;  Goldman  et  al.,  2002).  Most  insights  into  the  function  of  lamins  have  been 
obtained by studying cells and organisms with mutated lamin genes. While there is firm 
evidence that lamins are important in the regulation of transcription, DNA replication 
and repair, their precise roles in these processes remain to be elucidated (Kennedy et al., 
2000; Liu et al., 2005; Moir et al., 1994; Spann et al., 2002). Cells with mutated lamins 
usually have irregularly shaped nuclei and abnormal positions of CTs. Furthermore, 
heterochromatin appears to be displaced from the nuclear periphery. Therefore, lamins 
are likely to maintain the integrity of nuclear architecture (Meaburn et al., 2007; Muchir 
et al., 2003; Nikolova et al., 2004; Sullivan et al., 1999). In humans, mutations in lamin 
genes cause a group of disorders called laminopathies, which include severe diseases 
such as Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy, premature aging 
and progeroid syndromes (Bonne et al., 1999; Dechat et al., 2008; Worman and Bonne, 
2007). 
 
The nuclear matrix proteins SAFA and SAFB1 are associated with transcription. Both 
proteins contain the highly conserved SAF-box, a homodomain-like motif, which can 
interact  with  DNA  sequences  (Kipp  et  al.,  2000;  Oesterreich,  2003).  Chromatin 
immunoprecitation  experiments  indicate  that  SAFA  binds  to  DNA  and  recruits  the 
transcriptional  co-activator,  p300  (Martens  et  al.,  2002).  This  interaction  is   37 
accompanied by local histone acetylation, suggesting that SAFA might poise genes for 
transcription. By binding to DNA as well as the C-terminal of RNA Pol II and RNA 
processing  factors,  SAFB1  is  thought  to  co-ordinate  transcription  by  bringing  these 
complexes into physical proximity (Nayler et al., 1998; Oesterreich, 2003; Weighardt et 
al., 1999). SAFB1 knockout mice show high pre-neonatal and neonatal lethality while 
their  embryonic  fibroblasts  fail  to  undergo  senescence  and  exhibit  spontaneous 
immortalisation, highlighting the importance of this protein in development and cellular 
growth (Dobrzycka et al., 2006; Ivanova et al., 2005).  
 
Topoisomerases alter the topological status of DNA to ensure correct progression of 
transcription, DNA replication, recombination and condensation. Topoisomerase II is 
one  of  the  abundant  components  of  the  nuclear  matrix  (Berrios  et  al.,  1985).  In 
metaphase  cells,  it  is  mainly  concentrated  along  the  longitudinal  axis  spanning  the 
chromatid, while at interphase it is diffused throughout the nuclear interior (Earnshaw et 
al., 1985). By catalysing the decatenation of DNA by an ATP-dependent mechanism, 
which cleaves and rejoins single- or double-stranded DNA, topoisomerase II relieves 
the torsional stress due to DNA supercoiling (Martins and Krawetz, 2007; Wang, 2002). 
Althought  the  role  of  topoisomerase  II  in  nuclear  structure  is  still  uncertain,  its 
interaction with chromatin at the bases of chromatin loops may play an important role in 
maintaining the integrity of chromosome architecture (Adachi et al., 1989; Earnshaw et 
al., 1985).  
 
Other  molecules  identified  in  the  nuclear  matrix  include  components  of  the 
transcriptional  machinery  such  as  the  phosphorylated  form  of  RNA  Pol  II,  HATs, 
HDACs,  chromatin  remodelling  factors  and  numerous  general  transcription  factors 
(Boulikas, 1995; Davie and Hendzel, 1994; Nayler et al., 1998; Patturajan et al., 1998; 
Reyes et al., 1997). The nuclear matrix also harbours molecules involved in mRNA 
processing  including  splicing  factors  and  the  ubiquitous  heterogeneous  nuclear 
ribonucleoproteins (hnRNPs), which are important in RNA biogenesis (Blencowe et al., 
1994; Gerner et al., 1998; Mattern et al., 1996; Nayler et al., 1998). Furthermore, active 
DNA polymerase, primer recognition proteins (PRPs) and a number of other critical 
proteins involved in DNA replication are retained in the nuclear matrix (Collins and 
Chu, 1987; Jackson and Cook, 1986; Vishwanatha et al., 1992). The nuclear matrix is 
thus associated with fundamental nuclear processes. 
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1.2.3  The function of the nuclear matrix 
 
The  nuclear  matrix  has  been  hypothesised  to  determine  the  spatial  arrangement  of 
transcription  and  DNA  replication  by  providing  the  structural  framework  for  these 
processes (Berezney, 2002). Transcription and replication are highly compartmentalised 
in the nucleus (Fig 1.5). By incorporating bromo-UTPs to newly transcribed mRNA, 
Jackson et al. (1993) showed that RNA synthesis occurs at a few hundred foci termed 
transcription  factories  (Jackson  et  al.,  1993).  Subsequent  studies  showed  that  each 
factory was a transcription ‘hot spot’ containing transcription factors and several active 
forms of RNA Pol which are involved in transcription initiation and elongation (Cook, 
1999;  Grande  et  al.,  1997;  Iborra  et  al.,  1996;  Pombo  et  al.,  1999).  Distinct 
transcriptional  microenvironments  are  created  in  transcription  factories  that  contain 
different sets of transcription factors and transcribe certain sets of genes (Xu and Cook, 
2008). This organisation is likely to ensure effective interactions between components 
of  the  transcription  machinery  (Misteli,  2007).  Furthermore,  sharing  a  transcription 
factory could facilitate the co-ordinate transcription of commonly regulated genes. 
 
There are several lines of evidence suggesting that transcription factories are attached to 
the nuclear matrix. Treatments of nuclei with hypertonic solutions show that as well as 
the  main  components  of  the  transcriptional  machinery,  the  nuclear  matrix  retains 
nascent RNA transcripts (Cook, 1999). As transcription factories are formed prior to 
transcription,  they  are  likely  to  exist  as  independent  sub-nuclear  compartments 
(Osborne  et  al.,  2007).  Furthermore,  the  movement  of  molecules  visualised  during 
transcription  reveals  that  upon  activation,  genes  migrate  to  pre-existing  relatively 
immobile transcription factories (Mitchell and Fraser, 2008). 
 
As  found  for  transcription,  DNA  replication  is  clustered  at  discrete  sites  known  as 
replication  factories,  which  can  be  visualised  by  incorporation  of  dUTP  into  newly 
replicating DNA (Cook, 2002). These foci contain the entire replication machinery, 
multiple replication origins as well as factors involved in chromatin assembly (Cook, 
1999). 
 
The binding of replication factories to the nuclear matrix is more controversial than for 
transcription factories. The nuclear matrix contains nascent DNA fragments, DNA Pol 
and other factors involved in replication (Cook, 1999). Furthermore, replication sites   39 
coincide  with  intranuclear  lamin  structures,  and  initiation  of  replication  is  impaired 
when lamins are disrupted (Kennedy et al., 2000). However, replication factories are not 
formed prior to replication and appear to be maintained by the process of active DNA 
replication,  suggesting  that  they  are  not  independent  sub-nuclear  compartments 
(Kitamura et al., 2006). 
 
A different view is that the global organisation of nuclear architecture, and therefore 
also of these essential nuclear processes, is not determined by the nuclear matrix but 
rather by the self-organising properties of the nuclear components (Misteli, 2005). In 
this model, the ongoing nuclear processes and the various affinities of chromatin for 
nuclear regulatory components are the major factors responsible for shaping the nuclear 
compartments  (Cook,  2002;  Misteli,  2001;  Pombo  and  Branco,  2007).  The  global 
changes  observed  in  nuclear  architecture  upon  interference  with  transcription  and 
replication  support  the  self-organising  nature  of  the  nucleus  (Lamond  and  Spector, 
2003). 
 
The  major  impediment  in  experimental  testing  of  self-organising  systems  is  the 
difficulty in separating structure from function. Computer simulations, which are based 
on a combination of data including the movement and the affinities of different nuclear 
components,  are  being  developed  to  construct  detailed  models  and  make  testable 
predictions (Misteli, 2007). The self-organising model does not exclude the existence of 
an underlying nuclear structure such as the nuclear matrix, as nuclear machineries can 
still  be  formed  on  a  stable  scaffold  functioning  as  a  landing  platform  (Gorski  and 
Misteli, 2005; Misteli, 2007). 
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Figure 1.5 Distribution of transcription and replication factories throughout the 
nuclear interior.  
A) Transcription sites were visualised by extending nascent transcripts in the presence 
of  bromo-UTPs.  Newly  made  RNA  (red)  is  concentrated  in  discrete  foci,  called 
transcription  factories.  B)  Replication  sites  were  visualised  by  growing  cells  in  the 
presence of bromo-dUTPs. Newly synthesised DNA (green) is clustered at sites known 
as replication factories (Misteli, 2007). 
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1.2.4  The controversy of the nuclear matrix 
 
Despite evidence of an association between the nuclear matrix, nuclear architecture and 
different nuclear processes, the existence of a nuclear matrix as a separate nuclear entity 
remains controversial (Jackson, 2003; Pederson, 2000). Opponents of the nuclear matrix 
consider it to be an aggregation phenomenon generated by the preparative procedures, 
which can alter the structure of chromatin as well as the global nuclear environment. 
The removal of nucleic acids from the nucleus could disrupt DNA-protein interactions 
and allow the cationic sites of proteins previously bound to DNA to interact with other 
proteins (Pederson, 1998). Furthermore, different ionic conditions affect van der Waals’ 
forces  which  in  turn  influence  interactions  between  proteins,  and  could  lead  to  the 
formation of artifactual protein complexes (Pederson, 1998). 
 
On the other hand, the existence of a nuclear matrix is supported by the preservation of 
the functional domains of the nucleus such as splicing sites, PML bodies, CTs as well as 
replication and transcription factories within the nuclear matrix (Berezney, 2002). Since 
it is difficult to predict the changes caused by hypertonic buffers, methodologies have 
been developed to isolate the nuclear matrix in more physiological conditions (Jackson 
and Cook, 1986; Jackson et al., 1990; Mirkovitch et al., 1984). For example, cells can 
be  encapsulated  in  agarose  spheres  and,  after  treating  them  with  detergents  and 
restriction enzymes, the chromatin and the soluble products is electro-eluted rather than 
removed  with  high-salt  buffers  (Jackson  and  Cook,  1986).  Subsequent  observations 
revealed that the ultrastructural features of these matrix preparations were similar to 
those obtained from extraction with high-salt buffers (Capco et al., 1982; Jackson and 
Cook, 1988). However a comprehensive analysis of the proteins constituting nuclear 
matrices isolated using different extraction methods is still lacking. 
 
Based on the findings that nuclear matrix proteins such as special AT-rich sequence 
binding protein 1 (SATB1) are able to form intranuclear networks in vivo, there is now 
a  growing  recognition  of  the  nuclear  matrix  as  a  fraction  containing  functional 
components  of  the  eukaryotic  nucleus  that  are  necessary  for  the  organisation  of 
chromatin domains and the maintenance of sub-nuclear compartments (Cai et al., 2003; 
Oegema et al., 1997). 
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1.2.5  Features of matrix attachment regions 
 
MARs, also described as genomic anchors, are short DNA sequences of approximately 
100-2000 bp that tether chromatin loops to the nuclear matrix (Bode et al., 2003; Frisch 
et al., 2002; Ottaviani et al., 2008b; Singh et al., 1997). The strong interaction of MARs 
with the insoluble proteins of the nuclear matrix protects these sequences from nuclease 
digestion  and  treatments  with  high-strength  ionic  buffers  (Heng  et  al.,  2004). 
Subsequent  digestion  with  proteases  and  RNase  A  followed  by  DNA  extraction 
protocols allows MARs to be isolated and characterised. 
 
MARs  are  ubiquitous  features  of  eukaryotes  since  they  organise  the  genome  into 
hierarchical series of loop domains (Farache et al., 1990). The human genome has been 
estimated to contain between 30,000 and 80,000 MARs (Linnemann et al., 2007). So 
far, only a few hundred MAR sequences have been described. The best-characterised 
are those at the chicken lysozyme and α-globin, and the human β-globin and protamine 
loci (Farache et al., 1990; Girod et al., 2005; Martins and Krawetz, 2007; Ostermeier et 
al., 2003; Phi-van et al., 1998). 
 
Although a consensus sequence has not yet been identified, MARs are rich in AT and 
repetitive  sequences,  and  map  to  regions  where  the  DNA  is  intrinsically  curved  or 
kinked and has a propensity for base unpairing (Bode et al., 1992; Fiorini et al., 2006; 
Kohwi-Shigematsu and Kohwi, 1990; von Kries et al., 1990). They are associated with 
topoisomerase  I  and  II  binding  and  cleavage  sites,  replication  origins,  transcription 
factor binding sites, nucleosome-free stretches, and DNase I cleavage sites, one of the 
hallmarks of ‘open’ chromatin (Boulikas, 1993; Glazko et al., 2003; Singh et al., 1997). 
 
MARs are bound to the nuclear matrix either constitutively or transiently (Jackson et 
al., 1996; Kieffer et al., 2002; Liebich et al., 2002). Constitutive MARs are likely to 
maintain  the  higher-order  chromatin  structure  of  interphase  and  metaphase 
chromosomes (Glazko et al., 2003; Rollini et al., 1999). The transient, more dynamic 
associations are instead dependent on the transcription/replication status of the genomic 
domain, indicating a regulatory role (Heng et al., 2004). 
 
MARs are often referred to as a distinct class of cis-acting elements as there is strong 
evidence linking them with the spatial and temporal regulation of gene expression and   43 
DNA  replication  as  discussed  below.  Furthermore,  by  dynamically  organising 
chromatin in three-dimensional space, these genomic anchors play a prominent role in 
cellular development and disease (Cai et al., 2006; Iarovaia et al., 2004; Petrov et al., 
2006). 
 
1.2.6  Matrix attachment regions and transcription 
 
The tethering of DNA to the nuclear matrix plays a vital role in transcription (Eivazova 
et al., 2007; Geyer, 1997; Heng et al., 2004). Using T cell differentiation as an example, 
the facilitation of transcription by MARs and their shaping of chromatin architecture to 
insulate chromatin domains from the effects of flanking chromatin will be described. 
 
Upon stimulation by antigen, naive CD4+ helper T cells differentiate into effector Th1 
and Th2 cells. In mice, Ifng (the gene for the cytokine IFN-γ) is silenced in naive T cells 
but  transcribed  in  activated  Th1  cells.  The  architecture  of  the  Ifng  locus  has  been 
analysed  in  these  two  cell  types  by  a  combination  of  3C  (see  Section  1.1.9)  and 
microarray technology (Eivazova et al., 2007). In naive T cells, Ifng was found to exist 
in a linear conformation, but in Th1 cells it is  present in a chromatin loop, due to 
tethering of DNA to the nuclear matrix by MARs 7 kb upstream and 14 kb downstream 
of the locus. The absence of this selective DNA attachment to the nuclear matrix in 
naive T cells suggests that dynamic DNA anchors mediate the formation of the looped 
structure and the expression of the Ifng locus (Eivazova et al., 2007). 
 
The  molecular  mechanisms  by  which  MARs  reorganise  higher-order  chromatin 
structure  have  been  investigated  in  detail  at  the  mouse  Th2  cytokine  locus,  which 
contains a cluster of co-ordinately regulated genes, Il4, Il13 and Il5, in a region of about 
120 kb (Loots et al., 2000). These genes are silent in naive T cells but expressed in Th2 
cells.  Following  activation  of  Th2  cells,  expression  of  the  nuclear  matrix  protein 
SATB1 is rapidly induced, and MARs within the locus mediate the formation of small 
loops by anchoring the loops onto a common protein core associated with SATB1 (Cai 
et al., 2006). Down-regulation of SATB1 expression by RNA interference prevents both 
the formation of this looped structure and transcriptional activation of the locus (Cai et 
al., 2006). In SATB1-null thymocytes the expression of many genes is spatially and 
temporally  misregulated,  and  T  cell  development  in  SATB1-deficient  mice  is   44 
prematurely  blocked.  These  findings  indicate  that  the  binding  of  SATB1  at  MARs 
regulates the expression of T cell differentiation genes by reorganising higher-order 
chromatin architecture (Alvarez et al., 2000; Cai et al., 2003). A similar MAR-mediated 
loop-formation  mechanism  regulates  expression  of  the  human  β-globin  gene  cluster 
(Ostermeier et al., 2003; Wen et al., 2005). 
 
Cai  et  al.  (2003)  reported  that,  at  MARs,  SATB1  recruits  chromatin  remodelling 
enzymes,  which  are  able  to  either  activate  or  repress  the  expression  of  adjacent 
sequences (Cai et al., 2003). Other studies have shown that MARs interact dynamically 
with basal components of the transcription machinery and with splicing factors (Donev 
et al., 2002; Rajaiya et al., 2006). As MARs associate with components of transcription 
factories as well as the nuclear matrix, it is tempting to speculate that their dynamic 
interactions  with  the  matrix  bring  together  proximal  and  distal  regulatory  DNA 
sequences and localise them close to transcription factories, thus promoting efficient 
regulation of gene expression (Fig 1.6). 
 
Many genes are shielded by so-called 'insulator' elements from stimulatory or repressive 
transcriptional  effects  attributable  to  the  chromatin  state  and  regulatory  elements  in 
flanking regions. MARs commonly map to sequences flanking genes, and co-localise 
with some of the most  extensively analysed insulator elements, including the gypsy 
retrotransposon in Drosophila melanogaster, suggesting that MARs have an insulator 
function (Nabirochkin et al., 1998). In Drosophila melanogaster, the nuclear matrix 
protein  Su(Hw)  binds  to  gypsy,  creating  chromatin  loops  (Byrd  and  Corces,  2003). 
Certain mutations in Su(Hw) that disrupt the loop structures render the insulator non-
functional (Byrd and Corces, 2003; Valenzuela and Kamakaka, 2006). This suggests 
that the tethering of MARs to the nuclear matrix topologically constrains the DNA into 
looped structures, protecting the intervening DNA from the influence of cis-regulatory 
elements outside the loop. In vertebrates, CTCF, a ubiquitous nuclear matrix protein 
that binds to insulators, has also been shown to interact with MARs (Yusufzai and 
Felsenfeld, 2004). Experiments in a wide variety of higher eukaryotes have shown that 
in stably transfected cells, MAR-containing transgenes were expressed at higher levels 
compared  with  transgenes  lacking  MARs,  indicating  that  the  MARs  shield  the 
transgenes from the effects of the neighbouring chromatin regions (Girod et al., 2007; 
Halweg et al., 2005). 
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Figure 1.6 A simplified model depicting the function of matrix attachment regions 
(MARs) in gene regulation. 
Activation of transcription is accompanied by the anchoring of MARs to the nuclear 
matrix. This results in the formation of an anchored chromatin loop that is insulated 
from the stimulatory or repressive effects of the flanking chromatin. The transcription 
machinery is assembled at the site of the MAR-nuclear matrix attachments. Interaction 
of MARs with the nuclear matrix brings together gene coding sequences, regulatory 
DNA elements and the transcription machinery, thus enabling specific genes to be co-
ordinately regulated. 
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1.2.7  Matrix attachment regions and replication 
 
To ensure that the genome is copied accurately, and only once per cell cycle, eukaryotes 
have  evolved  intricate  mechanisms  to  regulate  DNA  replication.  Some  of  the  best-
characterised  origins  of  replication  (ORIs)  have  been  mapped  to  AT-rich  genomic 
regions with base-unpairing elements. Futhermore, sequences at or near the ORIs for 
the human lamin B2 gene, the chinese hamster dihydrofolate reductase-β and -β' genes, 
the human β-globin gene, the chicken α-globin and lysozyme genes, and the Xenopus 
and mouse c-myc genes, function as dynamic MARs during the cell cycle (Djeliova et 
al., 2001a; Djeliova et al., 2001b; Girard-Reydet et al., 2004; Lagarkova et al., 1998; 
Mesner et al., 2003; Phi-van et al., 1998; Razin et al., 1991). 
 
DNA replication is temporally and spatially ordered in the nucleus so that series of 
replicons  are  co-ordinately  replicated  at  foci  in  the  S-phase  nucleus  (Jackson  and 
Pombo, 1998; Ma et al., 1998). Evidence that replication foci are associated with the 
nuclear matrix came first from EM (Hozak et al., 1993). Further support came from a 
study of nuclear matrix structures where DNA synthesis occurred at replication sites 
that were indistinguishable from those found in intact cells (Nakayasu and Berezney, 
1989).  In  another  study,  DNA  replication  was  found  to  be  initiated  at  discrete 
chromosomal sites attached to the nuclear matrix (Radichev et al., 2005). 
 
At replication foci, the nuclear matrix houses factors necessary for DNA replication, 
such as DNA Pol, the sliding clamp (PCNA) and single-strand binding protein (RPA), 
and  provides  structural  support  throughout  the  replication  process.  Wu  and  Gilbert 
(1996) proposed that origins are selected and replicon size determined in early G1-
phase  of  the  cell  cycle  (Wu  and  Gilbert,  1996).  Using  an  in  vitro  system,  it  was 
subsequently shown that MCM2, a component of the pre-replicative complex, is loaded 
onto  chromatin  gradually  and  cumulatively  throughout  G1-phase,  but  is  rapidly 
excluded from active replication foci in S-phase (Dimitrova et al., 1999). Tatsumi et al. 
(2003) reported a similar cycle of events for ORC1, a component of the replication 
initiation complex at ORIs (Tatsumi et al., 2003). This coincides with the recruitment of 
the chromatin-bound ORC2-5 complex to a structure likely to be the nuclear matrix, 
suggesting  a  link  between  the  accumulation  of  ORC1  and  the  assembly  of  the 
replication complex in human nuclei (Ohta et al., 2003). 
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These observations fit a model in which MARs stably anchor the replicon ends and, 
during G1-phase, small-scale sub-chromosomal chromatin refolding recruits ORIs to 
the nuclear matrix, where factors accumulate to form the pre-replicative complexes (Fig 
1.7).  Subsequently,  as  ORIs  begin  to  replicate  in  S-phase,  certain  protein  factors 
dissociate from the chromatin and undergo proteolysis as part of a control mechanism to 
prevent  re-replication,  thus  releasing  the  ORIs  from  the  nuclear  matrix.  In  the 
meantime, replication continues at the initial location as DNA is reeled through the 
replication  machinery  or  replication  factory  (Hozak  et  al.,  1993).  At  the  ends  of 
replicons, stable MARs could act as barriers to prevent the accumulation of supercoiled 
DNA  structures,  while  providing  binding  sites  for  topoisomerase  II  to  resolve 
replication intermediates. 
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Figure 1.7 DNA replication is organised at the nuclear matrix.  
(a) Replicons are defined in early G1-phase of the cell cycle by attachment of MARs to 
the nuclear matrix. (b) In late G1-phase, origins of replication (ORIs) are recruited to 
the  nuclear  matrix  and  replication  factors  assemble  at  these  sites,  licensing  the 
chromatin  for  replication.  (c)  Once  the  appropriate  mitogenic  stimuli  have  been 
received, cells enter S-phase, at which ORIs become activated. Following initiation of 
replication  at  a  particular  locus,  the  two  identical  newly  replicated  ORIs  probably 
dissociate from the nuclear matrix. Two loops of replicated DNA gradually emerge 
(shown in blue), while the yet-to-be replicated DNA of the replicon moves through the 
replication factory. (d) At the end of S-phase, the replication machinery is dismantled. 
Adapted from (Anachkova et al., 2005), (Ottaviani et al., 2008b). 
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1.2.8  Matrix attachment regions and disease 
 
Integration of retroviral DNA into the host genome is essential for viral replication. 
Although retroviral integration sites lack a consensus sequence, they are often AT-rich 
and have base unpairing and DNA-bending and unwinding elements (Rampalli et al., 
2003; Shera et al., 2001). DNA sequence  analysis indicates that both DNA tumuor 
viruses and retroviruses integrate within or close to MARs (Fig 1.8) (Johnson and Levy, 
2005;  Kulkarni  et  al.,  2004).  Furthermore,  the  efficiency  of  transcription  of  the 
retrovirus HIV-1 is determined by the proximity of its integration to MARs (Rampalli et 
al., 2003). As SATB1 binds to MARs flanking HIV-1 integration sites and silencing of 
SATB1 gene expression alters the pattern of integration sites, it has been suggested that 
retroviruses use MARs to form viral pre-integration complexes (Kumar et al., 2007b). 
 
MARs also appear to play a role in the development of some cancers. Chromosome 
rearrangements are hallmarks of certain malignancies and inherited genetic disorders. 
The breakpoints of recurrent translocations in leukaemia as well as deletions involving 
the breast-cancer susceptibility genes BRCA1 and BRCA2 occur at MARs, indicating 
that  the  bringing  together  of  these  sequences  at  the  nuclear  matrix  facilitates  their 
illegitimate recombination (Iarovaia et al., 2004; Welcsh and King, 2001). Patients who 
develop  leukaemia  following  treatment  of  a  primary  tumour  with  inhibitors  of 
topoisomerase II often have specific chromosome translocations in their cancer cells 
whose  breakpoints  contain  MARs,  emphasising  the  importance  of  the  chromatin 
environment in the generation of chromosome aberrations (Strick et al., 2006). 
 
Fragile sites  are hypervariable regions that generate genomic instability in tumours. 
Certain  fragile  sites  contain  long  AT-rich  minisatellites,  called  AT-islands,  which 
function as MARs (Jackson et al., 2003). AT-islands are susceptible to considerable 
repeat expansion, which, in the fragile site FRA16B associated with leukaemia, appears 
to strengthen their attachment to the nuclear matrix (Jackson et al., 2003). The presence 
of abnormal transcripts of the tumour suppressor gene WWOX (which spans FRA16B) 
in the absence of detectable mutations or deletions may be caused by aberrant chromatin 
architecture due to enhanced MAR anchoring by expanded AT-islands (Woynarowski, 
2004). 
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The identification of AT-islands has led to the emergence of a new class of drugs that 
specifically alkylate them (Woynarowski, 2004). These drugs exhibit an extraordinary 
cytotoxicity, which is likely to be due to their disruption of replication and transcription, 
the two essential nuclear processes organised at MARs (Fig 1.9). One of these drugs, 
bizelesin,  binds  specifically  to  the  minor  groove  of  DNA  at  AT-rich  regions  and 
generates interstrand cross-links. It has high cytotoxic activity in vitro towards a broad 
spectrum of human cancer cell lines and, more importantly, high activity against various 
tumours engrafted in mice (Alley et al., 2004; Carter et al., 1996). While extensive 
development  will  be  needed  to  make  these  compounds  safe  anti-cancer  drugs  for 
clinical use, their DNA sequence-specificity might offer a novel approach for targeting 
tumour cells containing expanded AT-repeat sequences. 
 
 
 
 
 
Figure 1.8 Schematic representation of viral genome integration.  
Tumour viruses and HIV-1 integrate near MARs attached to the nuclear matrix, where 
the transcription and DNA replication machinery is assembled. The viral genome is thus 
integrated near the machinery required for its transcription and replication. Adapted 
from (Shera et al., 2001), (Ottaviani et al., 2008b). 
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Figure 1.9 Proposed mechanism for the cytotoxic action of AT-specific drugs.  
The drugs bind to AT-rich MARs in chromatin, cross-linking the two strands of the 
DNA.  This  leads  to  the  disruption  of  processes  such  as  transcription  and  DNA 
replication that are initiated at or in the vicinity of MARs (Ottaviani et al., 2008b). 
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1.3  The major histocompatibility complex 
 
The  human  major  histocompatibility  complex  (MHC)  is  one  of  the  most  important 
regions  of  the  genome  with  respect  to  immunity  to  pathogens,  autoimmunity  and 
transplantation. It contains clusters of genes that are critical for innate and adaptive 
immune  function,  including  antigen  processing  and  presentation  as  well  as  the 
complement system. MHC genes are under tight regulatory control and mis-regulation 
of their expression gives rise to a range of diseases. 
 
1.3.1  Overview 
 
The human major histocompatibility complex (MHC) is one of the most extensively 
studied regions of the genome. In humans, it extends over approximately 4 Mb on the 
short  arm  of  chromosome  6.  The  mouse  MHC,  called  H2,  was  first  identified  and 
associated with immunity about 60 years ago by George Snell (Fernando et al., 2008). 
The locus was recognised in humans a few years afterwards where it was termed the 
MHC or human leukocyte antigen (HLA) region since MHC molecules were found to 
be present on the surface of leukocytes cells (Dausset, 1958; Payne et al., 1964). 
 
The classical MHC is divided into 3 sub-regions, class II (centromeric), class III, and 
class  I  (telomeric)  (Fig  1.10).  Relative  to  other  parts  of  the  genome,  the  MHC  is 
extremely gene-rich and highly polymorphic. The identification of MHC related genes 
beyond the boundaries of the classically defined MHC locus, has led to the description 
of  the  extended  MHC,  (xMHC).  The  xMHC  spans  about  7.6  Mb  and  includes  the 
extended class I sub-region, located upstream of the MHC class I and the extended class 
II sub-region, located downstream of the MHC class II (Horton et al., 2004). 
 
The genes contained in each class of the MHC have related functions and are subject to 
co-ordinate  regulation. The  products  of  the  classical  MHC  class  I  and  II  genes  are 
involved in antigen processing and presentation to T cells, while genes in the class III 
region  encode  complement  components  which  are  involved  in  the  induction  of 
inflammatory  responses  and  damages  to  pathogens  via  proteolytic  cleavages  of 
glycoproteins. 
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Approximately  40%  of  the  224  loci  identified  within  the  MHC  play  a  role  in  the 
immune system. HLA genes, which encode cell-surface antigen-presenting molecules, 
are the most polymorphic in the entire genome, some having over 200 alleles. HLA 
genes are closely linked and the entire MHC is inherited as a haplotype from each 
parent. Combinations of different HLA alleles give rise to an extremely large number of 
haplotypes, but in a population certain haplotypes occur more frequently than expected 
by chance (Choo, 2007). This phenomenon, which defines the non-random association 
between alleles at adjacent loci is known as linkage disequilibrium (LD). The high LD 
characterising the MHC could favour the persistence of favourable haplotypes in the 
population.  Each  person  is  heterozygous  for  HLA  genes  as  the  genome  contains  a 
paternal and maternal haplotype, which are co-dominantly expressed. This generates an 
extremely  high  level  of  genetic  variation,  which  is  required  to  mount  an  effective 
immune response against a wide range of evolving pathogens. 
 
The MHC is associated with more diseases than any other region of the human genome 
(Price et al., 1999). These include autoimmune diseases such as multiple sclerosis, type 
1 diabetes, systemic lupus, ulcerative colitis and rheumatoid arthritis (Fernando et al., 
2008; Rubio et al., 2004; Thorsby, 1997). Although the exact mechanisms underlying 
the role of the MHC in these diseases are still unclear, association studies indicate that 
specific HLA haplotypes are related to autoimmune disease susceptibility (Fernando et 
al., 2008). As the MHC is critical in combating pathogens, MHC variants can confer 
susceptibility to infectious diseases such as malaria and HIV (Carrington et al., 1999; 
Hill et al., 1991). Furthermore, HLA molecules are important in transplantation, since 
they are recognised on the organ graft by host T cells causing graft rejection. 
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Figure 1.10 Gene map of the human MHC.  
The human MHC spans approximately 4 Mb on the short arm of chromosome 6. Gene 
annotation  is  according  to  the  RefSeq  database  (http://genome.ucsc.edu,  May  2004 
Assembly).  The  different  classes  of  the  MHC  are  highlighted  in  different  colours: 
classical class I – red; classical class III – blue; classical class II – yellow; and extended 
class II – green. 
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1.3.2  MHC class I genes 
 
The MHC class I region contains the classical HLA-A, HLA-B and HLA-C genes, which 
encode  the  α-chain  (also  called  heavy  chain)  of  the  class  I  molecule.  The  β2-
microglobulin protein, encoded by a gene on chromosome 15, is non-covalently bound 
to the α-chain to form the complete heterodimeric structure of the class I molecule (Fig 
1.11) (Bjorkman and Parham, 1990). The α-chain contains three extracellular domains 
(α-1,  α-2  and  α-3),  a  hydrophobic  transmembrane  domain  and  a  cytoplasmic  tail 
(Bjorkman et al., 1987). The α-1 and α-2 domains, constituted by variable amino acid 
sequences, form a unique groove accommodating the processed peptide antigen, which 
is typically 8-10 residues long (Choo, 2007). 
 
The classical class I genes are expressed on all nucleated cells of the body and bind to 
fragments of peptides derived from intracellular parasites such as viruses or proteins 
normally synthesised by the cell (self-molecules). These peptides are degraded by the 
proteasome complex in the cytosol and then are actively translocated into the lumen of 
the  endoplasmic  reticulum  (ER)  by  the  membrane  transporter  TAP,  a  heterodimer 
constituted  by  the  TAP1  and  TAP2  subunits  (Gromme  et  al.,  1999;  Kloetzel  and 
Ossendorp, 2004; Powis et al., 1992; Powis et al., 1993; Shepherd et al., 1993). Once in 
the ER, these peptides are loaded onto the fully folded classical class I molecules and 
then transported via the secretory pathway to the cell surface where they interact with 
CD8+ cytotoxic T lymphocytes (CTLs) (Kloetzel and Ossendorp, 2004). 
 
The MHC also contains the non-classical class I molecules, encoded by the HLA-E, 
HLA-F  and  HLA-G  genes,  which  are  evolutionary  and  structurally  related  to  the 
classical  class  I  molecules.  The  non-classical  class  I  molecules  also  play  a  role  in 
antigen presentation but are less polymorphic and exhibit a more restricted expression 
pattern than the classical class I molecules (Gobin and van den Elsen, 2000). While 
expression of HLA-E is ubiquitous, expression of HLA-F and HLA-G is mainly confined 
to B lymphocytes and extravillous cytotrophoblast cells, respectively (Gobin and van 
den Elsen, 2000). In addition to presenting peptides derived from the signal sequence of 
classical class I molecules to natural killer (NK) cells, it is emerging that HLA-E might 
also mediate CTL responses (Hoare et al., 2006). HLA-F has been undetected at the cell 
surface,  however,  structural  predictions  in  combination  with  biochemical  studies 
suggest it might be able to reach the cell surface by binding cell type specific peptides   56 
and interact with immunoglobulin-like receptors ILT2 and ILT4 (Lepin et al., 2000). 
Although the function of HLA-G is unknown, there is evidence suggesting it can inhibit 
NK  and  T  cell  mediated  cell-lysis  and  contribute  to  the  normal  progression  of 
pregnancy and growth of the developing foetus (Hviid, 2006). 
 
Additional genes with immune-related functions contained in the MHC class I region 
are MICA and MICB which encode membrane bound polypeptides different from the 
HLA class I proteins (Stephens, 2001). The MIC molecules do not associate with the β2-
microglobulin and the reduced sized of their groove cannot accommodate peptides for 
presentation to T cells (Stastny, 2006). Several studies indicate that MICA and MICB 
function as ligands for the receptor NKG2D, which is found on NK cells as well as 
different types of T cells. This interaction seems to calibrate the cytotoxic activity of 
these cells and may play a role in eliminating infected and tumour cells (Schrambach et 
al., 2007). 
 
 
 
 
 
Figure 1.11 Diagram of the HLA-A, HLA-B or HLA-C molecule.  
The  α-chain  has  three  extracellular  domains,  α1,  α2  and  α3.  It  is  non-covalently 
associated  with  the  smaller  polypeptide,  β2-microglobulin.  The  α3-domain  and  β2-
microglobulin are Ig-like. While β2-microglobulin is invariant, the α-chain is extremely 
polymorphic, mainly in the α1-and α2-domains, which form the peptide-binding site 
(Alberts et al., 1994).   57 
1.3.3  MHC class II genes 
 
The MHC class II region contains the classical HLA-DP, HLA-DR and HLA-DQ loci, 
which encode transmembrane proteins, each constituted by two non-covalently bound 
polypeptide chains: the α-chain and the β-chain (Fig 1.12). Each polypeptide chain has 
two  extracellular  domains  (α-1,  α-2;  β-1,  β-2),  a  single  transmembrane  and  an 
intracytoplasmic domain (Jones et al., 2006). The N-terminal α-1 and β-1 domains form 
a  groove,  the  peptide-binding  domain,  which  binds  to  fragments  of  processed 
polypeptides. The α-2 and β-2 domains form an immunoglobulin-like domain (Stern et 
al., 1994). 
 
The classical class II molecules are expressed by antigen presenting cells (APCs) such 
as dentritic cells, macrophages and B cells, but their expression can be induced in many 
cell types by cytokines including interferon-γ (IFN-γ). The antigens presented by the 
classical class II molecules are derived from peptides that are translocated from the 
extracellular  space  into  the  cytosol  via  micropinocytosis,  phagocytosis  or  receptor-
mediated uptake (Kumanovics et al., 2003). 
 
Synthesis of the classical class II molecules takes place in the ER where they bind to the 
invariant  chain  (Ii)  molecule  at  the  peptide-binding  domain.  Ii  molecules  act  as 
chaperones  directing  the  classical  class  II  molecules  to  the  endocytic  pathway  and 
prevent the peptide grooves from binding with self-molecules (Cresswell, 1996). In the 
endocytic  pathway,  increasingly  acidic  endosome  compartments  degrade  the 
internalised  peptides  to  about  13-18  amino  acids  and  the  Ii  molecule  is  gradually 
degraded  to  a  small  fragment  known  as  class  II  associated  invariant  chain  peptide 
(CLIP),  which  serve  to  stabilise  the  folded  classical  class  II  molecule  (Bakke  and 
Dobberstein,  1990).  The  non-classical  class  II  molecules  HLA-DM  and  HLA-DO 
mediate the removal of CLIP and the loading of the antigens onto the groove of the 
classical class II molecule, which is then transferred to the cell surface where it interacts 
with  CD4+  T  cells  to  regulate  the  adaptive  immune  responses  against  invading 
pathogens (Kumanovics et al., 2003). 
 
Other genes in the MHC class II region encode molecules which participate in the class 
I antigen presentation pathway (Kumanovics et al., 2003). These include the transporter 
genes TAP1 and TAP2 (see Section 1.3.2) as well as the proteasome genes PSMB9 and   58 
PSMB8, which collectively form a gene cluster. Within the MHC, there are genes that 
are not related to antigen processing and presentation but seem to be involved in other 
aspects  of  the  immune  response.  An  example  is  DAXX,  which  encodes  a  molecule 
involved in growth arrest and/or apoptosis of auto-reactive lymphocytes (Kiriakidou et 
al., 1997; Muromoto et al., 2004). 
 
 
 
 
 
Figure 1.12 Diagram of the HLA-DP, HLA-DR or HLA-DQ molecule.  
The α-chains and β-chains are polymorphic, mainly in the α1- and β1-domains, which 
interact to form a groove that binds peptide fragments. The α2- and β2-domains are Ig-
like (Alberts et al., 1994).  
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1.3.4  MHC class III genes 
 
Compared to the class I and II regions, which are characterised by numerous genes 
involved in antigen processing and presentation pathways, the class III region harbours 
a more heterogeneous collection of genes. These genes encode proteins that are crucial 
for  various  aspects  of  immunity  including  activation  of  the  complement  system, 
hormone synthesis, inflammation and cell stress, synthesis of lymphotoxins and heat 
shock proteins (Hauptmann and Bahram, 2004). 
 
The complement system is a major effector of innate immunity and also interacts with 
the  cells  of  the  adaptive  immune  system  to  influence  adaptive  immune  responses 
(Morgan and Harris, 2003). The molecules constituting the complement system include 
approximately  25  soluble  proteins  existing  in  the  serum  as  inactive  pro-enzymes 
(zymogens), which can be activated to augment antibody responses, lyse foreign cells 
and  promote  the  clearing  of  immune  complexes  and  apoptotic  cells  (Sim  and 
Tsiftsoglou,  2004).  The  complement  system  can  be  activated  by  three  different 
pathways known as the classical, lectin and alternative pathways. 
 
The MHC class III region contains genes encoding two critical pro-enzymes, C4 and 
C2. The trigger of the ‘classical pathway’ is the binding of antibodies with their antigen 
(Sim and Tsiftsoglou, 2004). This interaction activates a component of the complement 
system C1, which cleaves C4 into the sub-components C4a and C4b, and C2 into the 
sub-components C2a and C2b (Sim and Tsiftsoglou, 2004). The binding of C4b to C2a 
forms the C3 convertase complex, a protease that initiates a cascade culminating in the 
formation of the membrane attack complex (MAC), which creates a transmembrane 
pore on the target cell leading to its lysis (Law and Dodds, 1997). 
 
The C4 and C2 molecules are also involved in the ‘lectin’ pathway, which is activated 
by  the  binding  of  mannose-binding  lectin  to  mannose  residues  on  the  surface  of 
pathogens. This interaction activates the serine proteases MASP-1 and MASP-2, which 
in turn induces the cleavage of C4 and C2 into their active sub-components leading to 
pathogen elimination via the same steps described for the classical pathway (Holmskov 
et al., 2003). 
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The MHC class III region encodes an additional important pro-enzyme, the B-factor 
that activates the complement system through the ‘alternative’ pathway. This cascade is 
initiated by the spontaneous hydrolysis of C3, which then forms a complex with the B-
factor. This process leads to the cleavage of the B-factor by the D protease and the 
formation  of  the  C3bBb  complex,  which  is  analogous  to  the  C3  convertase  of  the 
classical and lectin pathways (Sim and Tsiftsoglou, 2004). Once formed, the alternative 
pathway  C3  convertase  interacts  with  other  proteins,  including  factor  I  and  H,  to 
regulate opsonisation. 
 
The  MHC  class  III  region  contains  immune-related  loci  that  are  not  part  of  the 
complement system. These include the tumour necrosis factor (TNF), lymphotoxin-α 
(LTA) and lymphotoxin-β (LTB) genes, which encode cytokine precursors involved in 
the signalling networks mediating innate and adaptive immune responses (Deakin et al., 
2006).  Disruption  of  these  signalling  pathways  reduces  inflammation  as  well  as 
resistance to selected pathogens (Ware, 2005). Additional class III genes with important 
functions  in  immunity  are  AIF1,  LST1  and  NCR3  that  play  a role  in  inflammation, 
lymphocyte development and NK activation, respectively (Deininger et al., 2002; Pende 
et al., 1999; Rollinger-Holzinger et al., 2000). 
 
1.3.5  Transcriptional co-regulation of MHC genes 
 
The expression of classical MHC genes, as well as those involved in antigen processing 
and  presentation,  is  subject  to  co-ordinate  regulation.  This  provides  cells  with  an 
effective system to orchestrate the interaction of functionally linked MHC molecules at 
the  appropriate  time  and  place.  The  co-regulation  of  MHC  genes  is  complex  and 
involves the activity of conserved genomic regulatory elements as well as epigenetic 
mechanisms. 
 
The classical and non-classical MHC class I genes, with the exception of HLA-G, share 
three major regulatory elements: enhancer A, IFN-stimulated response element (ISRE) 
and the SXY module (Fig 1.13)(van den Elsen et al., 1998; van den Elsen et al., 2004). 
These  sequences  are  localised  within  about  200  nucleotides  upstream  of  the 
transcription start site and are part of the 5’ promoter region (van den Elsen et al., 
2004). Enhancer A contains binding sites for the nuclear transcription factor kB (NF-  61 
kB),  while ISRE  interacts  with  the  IFN  regulatory  factors  1 (IRF-1)  and  2  (IRF-2) 
(Gobin  et  al.,  1998;  Gobin  et  al.,  1999).  The  synthesis  of  these  molecules,  which 
modulate the induction and suppression of these class I genes, is regulated by cytokines 
including TNF and IFNs (van den Elsen et al., 2004). The SXY module, which contain 
the S, X (comprising X1 and X2  sequences) and Y motifs, binds to a multiprotein 
complex  constituted  by  regulatory  factor  X  (RFX),  activating  transcription  factor 
(ATF),  cAMP  response  element  binding  protein  (CREB)  and  the  nuclear  factor  Y 
(NFY) (van den Elsen et al., 2004). This complex forms a landing platform for the 
crucial  transcription  factor,  class  II  Transactivator  (CIITA),  to  up-regulate  the 
transcription of classical and non-classical MHC class I genes (Krawczyk et al., 2008). 
 
The SXY module is also part of the promoter region of the classical and non-classical 
MHC class II genes (Fig 1.14). In contrast to the class I genes, the class II genes do not 
have the enhancer A and ISRE sequences in their promoter regions. The absence of 
these cis-regulatory sequences could contribute to the differences in expression between 
class I and II genes observed in different cell types. Studies on cell lines with mutated 
forms of CIITA and RFX show that they are essential for the expression of class II 
genes and also contribute, albeit to a lesser extent, to transcription of class I genes 
(Krawczyk et al., 2008). Mutations in the CIITA or RFX genes are responsible for a 
severe  hereditary  immunodeficiency  disease,  the  bare  lymphocyte  syndrome  (BLS), 
which is characterised by lack of expression of the class II genes and down-regulation 
of class I genes (Reith and Mach, 2001). The residual expression of class I genes is due 
to their additional upstream regulatory elements which can partially compensate for the 
absence of functional RFX or CIITA. The expression of classical class II genes is also 
modulated by conserved S’-Y’ modules, which function as transcriptional enhancers 
(Krawczyk et al., 2004). These motifs contain the binding sites for CIITA and RFX and 
are localised several hundred base pairs upstream of the CIITA transcription initiation 
sites (Krawczyk et al., 2004). 
 
CIITA activates and regulates gene expression, not only by interacting with several 
transcription factors at the SXY and S’-Y’ modules, but also by binding to chromatin 
remodelling enzymes (Zika and Ting, 2005). Several studies have shown that CIITA is 
responsible  for  recruiting  HATs,  HMTs,  and  the  ATP-dependent  remodelling  factor 
Brahma-related gene 1 (BRG1) at selected promoter regions (Mudhasani and Fontes, 
2002; Wright and Ting, 2006; Zika and Ting, 2005).   62 
 
Expression of MHC class II genes in APCs is due to their constitutive expression of 
CIITA. The expression of class II can be activated in many other cell types by inducing 
the synthesis of CIITA with IFN-γ via the JAK-STAT signalling pathway (Darnell et 
al., 1994). The pathway starts with the binding of IFN-γ to specific receptors on the cell 
surface, which are associated with protein kinases belonging to the Janus kinase (JAK) 
family  (Darnell  et  al.,  1994;  Hibino  et  al.,  1992).    Ligand  attachment  leads  to  the 
phosphorylation of JAKs, which can than activate latent cytoplasmic signal transducers 
and  activators  of  transcription  (STAT)  proteins  through  phosphorylation  (Lee  and 
Benveniste, 1996).  Subsequently, the activated STATs dimerise and rapidly translocate 
into the nucleus where they binding the IFN-γ  activation sequence (GAS) elements 
present in the promoters of IFN-γ inducible genes, including CIITA (Fig 1.15) (Darnell 
et al., 1994). 
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Figure 1.13 The conserved regulatory elements of the classical and non-classical 
class I HLA genes.  
The SXY module is bound by RFX, ATF/CREB and NFY. CIITA exerts its activity 
primarily through the SXY module and its binding proteins. The enhancer (enhA) and 
ISRE are bound by NF-kB and IRF-1/2 factors, respectively. The protein binding the S 
module has not been identified. 
 
 
 
 
 
 
Figure 1.14 The conserved regulatory elements of the classical and non-classical 
class II HLA genes.  
The SXY module is bound by RFX, ATF/CREB and NFY. CIITA exerts its activity 
through the SXY and S’-Y’ modules.    64 
 
 
Figure 1.15 The JAK/STAT signalling pathway.  
(1) Binding of IFN-γ to specific receptors on the cell surface activate protein kinases 
belonging to the JAK family. (2) The activated JAKs interact with latent cytoplasmic 
proteins termed STATs and activate them through phosphorylation. (3) Subsequently, 
the activated STATs dimerise and (4) translocate into the nucleus where they induce 
transcription of certain genes by binding to specific sequences. 
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1.4  Aims of this thesis 
 
Matrix Attachment Regions (MARs) are genomic sequences that mediate the anchoring 
of  chromatin  into  loop  domains.  Although  there  is  evidence  implicating  MARs  in 
different aspects of genomic function, comprehensive knowledge of their function is 
still  lacking  since  small-scale  methods  have  limited  their  identification  to  very  few 
regions of the genome. Are MARs characterised by a unique sequence consensus motif? 
How are they distributed across the genome? Are they static or dynamic elements of the 
genome? What role do they play in transcriptional regulation? 
 
I  have  approached  these  questions  by  examining  the  tethering  of  a  large  locus,  the 
human  Major  Histocompatibility  Complex  (MHC)  in  cell  types  exhibiting  different 
patterns of MHC expression. Thus, the overall aim of this thesis is to improve our 
understanding  of  the  relationship  between  chromatin  anchors,  or  MARs  and  gene 
expression in the MHC. To this end: 
 
1.  The utility of a novel MHC tiling path array for mapping MARs was determined 
– Chapter 3. 
 
2.  MARs  were  mapped  and  characterised  across  the  MHC  locus  in  human 
fibroblasts – Chapter 4. 
 
3.  MARs were mapped and characterised across the MHC locus in IFN-γ treated 
human fibroblasts and B lymphoblastoid cells – Chapter 5. 
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2  Materials and Methods 
 
2.1   Cell culture 
 
Cells  were  grown  on  75  cm
2  plastic  culture  flasks  in  incubators  maintaining  a 
temperature of 37
 °C and a humidified atmosphere supplemented with 5% CO2. Cell 
lines, growth media and other cell culture reagents were supplied by Cancer Research 
UK Cell Services (Clare Hall). 
 
MRC5  cells  are  human  lung  fibroblasts  derived  from  a  male  embryo  (ECACC 
97112601). They were cultured as monolayers in RPMI-1640 media supplemented with 
10% foetal calf serum (FCS), 2mM L-glutamine, 100 units/ml penicillin V and 0.1 
mg/ml  streptomycin.    MRC5  cells  were  passaged  when  they  reached  confluence, 
usually every 3-4 days. They were washed with phosphate-buffered saline (PBS) and 
detached  by  incubating  them  for  5  min  with  3 ml  of  a  solution  containing  porcine 
trypsin and EDTA per culture flask. The trypsin digestion was then blocked by the 
addition of an excess culture medium containing FCS. Cells were reseeded in two or 
three flasks at 30-50% confluence. Cell-surface expression of HLA molecules in MRC5 
cells was induced by adding 200 IU/ml of human IFN-γ (recombinant Human IFN-γ 
R&D Systems) to the culture medium for 24 h (Darley et al., 1993). 
 
HT1080 is a human fibrosarcoma cell line derived from a female (ECACC 85111505). 
HT1080 cells were cultured as monolayers in Dulbecco’s Modified Eagle’s Medium 
(DMEM) and supplemented with 5% FCS, 2mM L-glutamine, 100 units/ml penicillin V 
and 0.1 mg/ml streptomycin. They were usually passaged every 2-3 days as described 
for MRC5 cells. 
 
PGF  is  a  human  EBV-transformed  B  lymphoblastoid  cell  line  derived  from  a 
consanguineous male and is homozygous for the MHC (ECACC 9405342). PGF cells 
were grown in suspension in RPMI-1640 supplemented as described for MRC5 cells, 
and maintained at exponential growth by addition of fresh media every 2-3 days so that 
their concentration would not exceed 10
6 cells/ml. 
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Raji is a B lymphoblastoid cell line established from a Burkitt’s lymphoma of a human 
male (ECACC 85011429). RJ2.2.5 is a CIITA-deficient mutant derived from the human 
Raji cell line (ICLC HTL02002). Both cell lines were grown in suspension using the 
same  conditions  described  for  PGF  cells  by  the  Immunopathology  Laboratory  at 
Geneva University. 
 
2.2  Isolation of matrix attachment region and halo DNA fractions 
 
The optimal time for nuclear protein extraction was resolved as described previously 
(Krawetz  et  al.,  2005).  PGF  and  MRC5  cells  +/-  IFN-γ  were  washed  in  PBS 
supplemented  with  1  mg/ml  bovine  serum  albumin  (BSA)  and  Complete  Protease 
Inhibitor (CPI) (Roche). The cells were re-suspended in PBS supplemented with CPI 
and lysed on ice for 15 min following addition of Nuclear Buffer (10mM Tris, pH 7.7, 
100mM  NaCl,  300mM  sucrose,  3mM  MgCl2,  0.5%  Triton-X  100  and  CPI).  The 
concentration of nuclei was adjusted to 1.5 x 10
5 /ml with PBS supplemented with CPI 
and 1.25 x 10
4 nuclei were attached to slides using a Shandon Cytospin 2 cytofuge 
(Thermo Shandon).  
 
Halo Buffer (10mM Tris, pH 7.7, 10mM EDTA, 2M NaCl, 1mM dithiothreitol and 
CPI) was placed on the nuclei and incubated for varying times ranging from 0 to 15 
min. The reaction was stopped by washing the slide for 1 min in a graded series of PBS 
washing solutions, and then the cells were dehydrated using a series of graded ice-cold 
ethanol washes. Each slide was then baked for 2 h at 72 °C. The nuclei were stained 
with DAPI and viewed using  a Zeiss  Axiophot microscope, equipped with a  CCD-
camera (Photometrics), which was used to obtain images.  
 
For each cell type, the size of the halo structures at each time point was determined by 
measuring the average distance between the perimeter of the halo and the edge of the 
nuclear matrix of 30 cells in 3 biologically independent experiments. The minimum 
time  required  to reach  maximum  average  distance  between  the  edge  of  the  nuclear 
matrix and the perimeter of the extracted DNA was considered optimal. 
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The isolation of MAR and halo DNA fractions was repeated five times for each cell line 
to obtain a total of five biological replicates. Two of these replicates were used for array 
hybridisations, and the other three for real-time PCR.  
 
PGF and MRC5 cells +/- IFN-γ  were washed in PBS supplemented with 1 mg/ml BSA 
and CPI. The cells were then re-suspended in 125 µl of PBS and 125 µl of 2x Nuclear 
Buffer and lysed on ice for 15 min. The nuclei were collected by centrifugation and 
incubated in 250 µl of 2x Halo Buffer on ice. The incubation time with 2x Halo Buffer 
was 12 min for nuclei from MRC5 cells +/- IFN-γ, while it was 9 min for nuclei from 
PGF. The reaction was then stopped with the addition of 9.5 ml Restriction Buffer (50 
mM Tris, pH 8.0 and 10 mM MgCl2) supplemented with 100 U of EcoRI and HindIII 
(Sigma). The DNA was digested at 37
 °C for 4 h.  
 
Following centrifugation at 16,000 g, the supernatant containing the halo fraction and 
the pellet containing the MAR-enriched fraction were placed in separate tubes. The 
MAR-enriched sample was washed three times with Restriction Buffer. Both samples 
were digested with 120 µg of proteinase K (Roche) in Protease K Buffer (50 mM Tris, 
pH 8.0, 50 mM NaCl, 25 mM EDTA and 0.5% w/v SDS) overnight at 55 °C.  
 
The DNA of both fractions was purified using a commercial purification kit (QIAmp 
DNA blood kit) and their concentration determined by using a NanoDrop ND-1000 
which  can  quantify  DNA  in  1  ul  samples  without  performing  dilutions  or  washing 
cuvettes. 
 
2.3   Chromatin immunoprecipitation 
 
Chromatin immunoprecipitation (ChIP) was carried out using HT1080 cells following 
the method described in (Christova and Oelgeschlager, 2002) with minor amendments. 
Approximately  5  x  10
6  cells  were  cross-linked  with  1%  v/v  formaldehyde  at  room 
temperature for 15 min under constant agitation. To stop the cross-linking reaction, 
glycine was added to a final concentration of 125 mM. 
 
Cells were washed twice in ice-cold PBS and re-suspended in Lysis Buffer (50 mM 
HEPES, pH 7.9, 10 mM EDTA, pH 8.0 and 1% w/v SDS) supplemented with CPI.   69 
They were then sonicated on ice using a sonicator mounted with a 2 mm diameter probe 
(Sonics) until cross-linked chromatin was sheared to an average DNA fragment length 
of  1−2  kb.  The  length  of  the  DNA  fragments  was  monitored  by  agarose  gel 
electrophoresis. 
 
After removing cell debris by centrifugation, the soluble cross-linked chromatin was 
diluted 1:10 in Immunoprecipitation (IP) Buffer (10 mM HEPES, pH 7.9, 1% Triton X-
100 and 150 mM NaCl) supplemented with CPI, divided into aliquots and stored at -80 
°C. Protein A−Sepharose CL4B (Pharmacia) was blocked with 1 mg ml
-1 BSA (Roche) 
and 1 mg ml
-1 herring-sperm DNA (Sigma) in IP Buffer for 4−6 h at 4 °C and washed 
three times with IP Buffer before use. 
 
In order to pre-clear chromatin, blocked Protein A−Sepharose (50 µl of 50% slurry per 
ml of chromatin) was added to the soluble chromatin preparations for 2 h at 4 °C. The 
Protein A−Sepharose was then removed by centrifugation and the pre-cleared chromatin 
was incubated with antibodies against acetyl-histone H3-K9/K14 (Upstate, catalogue 
number 06-599) for 12−14 h at 4 °C. The immunoprecipitates were incubated with fresh 
blocked Protein A-Sepharose for 2 h at 4 °C and recovered by centrifugation. 
 
The pellets were washed three times with IP Buffer, three times with Washing Buffer 
(10 mM Tris, pH 8.0, 0.25 mM LiCl, 0.5% NP-40, 0.5% sodium deoxycholate and 1 
mM EDTA, pH 8.0) and three times with Tris-EDTA (TE), pH 8.0. The pellets were re-
suspended in TE, pH 8.0 and digested with 50 µg ml
-1 RNAse A (Roche) for 30 min at 
37  °C.  The  immunoprecipitated  DNA  was  mixed  with  250  µg  ml
-1  proteinase  K 
(Roche), SDS to 0.25% w/v and incubated for 12 h at 37 °C. The formaldehyde cross-
links were then reversed by incubating the chromatin preparations for 6 h at 65 °C. The 
chromatin was purified using a commercial purification kit (QIAmp DNA blood kit) 
and the DNA concentration determined by using a NanoDrop ND-1000. 
 
2.4   Construction of a MHC tiling path array 
 
The tiling path array of the MHC was constructed and optimised in collaboration with 
the Immunogenomics Group at the Wellcome Trust Sanger Institute (Tomazou et al., 
2008). A total of 1747 overlapping plasmid clones covering the MHC region were used   70 
to generate the array. Of those, 1662 clones (average insert size of 2 kb) were picked 
from the HapMap chromosome 6 library at the Wellcome Trust Sanger Institute. The 
remaining 85 clones were generated by cloning gap-spanning PCR amplicons (average 
insert size 332 bp). Across the MHC, about 12 kb of repeat-rich regions were refractory 
to PCR amplification and could not be included in the array. Therefore, the overlapping 
plasmid clones cover 99.67% of the entire MHC region. 
 
Vector-specific  PCR  was  performed  using  each  clone  to  produce  amino-linked 
amplicons. The PCR reactions were carried out in 50 mM KCl, 5 mM Tris, pH 8.5 and  
2.5 mM MgCl2 (10 min at 95 °C followed by 35 cycles of 95 °C for 1 min, 60 °C for 
1.5 min, 72 °C for 7 min and a final extension of 72 °C for 10 min) using the forward 
primer  5'-CCCAGTCACGACGTTGTAAAACG-3'  and  the  reverse  primer  5' 
AGCGGATAACAATTTCACACAGG-3'.  In  order  to  generate  strand-specific  array 
probes, two separate PCR reactions were performed for each clone, in one case using a 
5'-amino-linked primer for the forward strand, and in the other case, for the reverse 
strand. 
 
After assessing the products by agarose gel electrophoresis, they were re-suspended in 
Spotting Buffer (250 mM sodium phosphate, pH 8.5, 0.00025% w/v sarkosyl and 0.1% 
sodium azide) and filtered (Multiscreen-GV filter plates, Millipore). The products were 
spotted onto amine binding slides (CodeLink, GE Healthcare) at 20–25 °C, 40–50% 
relative humidity. After incubating the slides overnight in a humid chamber, they were 
treated with 1% ammonium hydroxide for 5 min and then 0.1% SDS w/v for 5 min. 
They were then denatured with 95 °C ddH2O for 2 min, rinsed in ddH2O and dried by 
centrifugation. 
 
Each clone was printed four times across the array to minimize spatial effects.  Test 
sequencing was carried out on 15% of the amplified PCR products.  The results show 
that the sequences of ~97% of the selected PCR products matched the expected regions 
of the MHC.  From this partial analysis, it is possible to extrapolate that ~3% of the 
spots of the MHC tiling path array do not represent the expected MHC sequences. 
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2.5   Random labelling of DNA samples 
 
DNA  samples  were  labelled  with  Cy3-  and  Cy5-labelled  dCTPs  (Amersham 
Biosciences) using a random prime labelling system (Bioprime DNA Labelling System; 
Invitrogen) as described previously (Mulholland et al., 2006).  
 
A pre-mixture was prepared containing between 0.3 and 0.5 µg of DNA, 60 µl of 2.5x 
Random Primer Mix. The volume was made up to 126 µl with distilled water.  After 
denaturing the DNA template for 10 min at 100 °C, the pre-mixture was snap-cooled on 
ice. A solution containing 15 µl of 10x dCTP mix, 6 µl of Cy3- or Cy5-labelled dCTP 
(Perkin Elmer) and 3 µl of Klenow fragment was added to the pre-mixture while on ice 
and the sample was incubated at 37 °C overnight. The reaction was stopped by adding 
15 µl of 0.5 M EDTA.   
 
The labelled samples were purified on Micro-spin G50 columns (Amersham) to remove 
unincorporated  nucleotides.  Fluorescent  dye  incorporation  was  monitored  using  the 
Nanodrop ND-1000 spectrophotometer. 
 
2.6   Array hybridisation and washes 
 
The Cy3- and Cy5-labelled DNA samples were hybridised onto the MHC tiling path 
array using a procedure previously described in (Fiegler et al., 2003). In one tube, equal 
amounts of Cy3- and Cy5-labelled probe were combined with 100 µg human Cot-1 
DNA (Roche) and precipitated with absolute ethanol precipitation using the standard 
methodology. In a second tube, 300 µg of herring sperm DNA (Sigma) was added to 50 
µg of human Cot-1 DNA and precipitated in a similar manner. 
 
The  pellets  of  the  first  and  second  tubes  were  re-suspended  in  60  and  200  µl, 
respectively, of Hybridisation Buffer (50% v/v deionised formamide, 10% w/v dextran 
sulphate, 0.1% v/v Tween 20, 2x SSC, and 10 mM Tris, pH 7.5). In order to re-suspend 
the pellets uniformly, after applying the buffer to each tube, the samples were kept at 80 
oC on a heat block for 10 min with vortexing every 2 min. 
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The content of the second tube was applied to the MHC tiling path array, which was 
placed  in  a  humid  chamber  saturated  with  20%  v/v  formamide  and  2x  SSC.  The 
chamber was sealed air-tight and placed in a hybridisation oven with gentle rocking for 
1 h at 37 °C. Meanwhile, 40 ng of yeast tRNA (Sigma) was added to the first tube, 
which  was  then  incubated  at  37  °C  for  pre-annealing.  Subsequent  to  array  pre-
hybridisation the contents of the first tube was applied to the array and placed in the 
same  humid  chamber  and  allowed  to  hybridise  for  48  h  at  the  same  conditions  as 
described above. 
 
The MHC tiling path array was removed from the chamber and placed in a Coplin jar 
containing 2x SSC and 0.03% w/v SDS to wash off any excess hybridisation solution.  
The slide was then transferred to another Coplin jar and washed in 2x SSC and 0.03% 
w/v SDS for 5 min at 65 °C, three times in 0.2x SSC for 20 min at room temperature 
and in PBS and 0.05% v/v Tween 20 for 10 min at room temperature.  After rinsing in 
distilled water, the slide was spin dried at 1000 rpm for 5 min using a swinging rotor 
and then placed in a dark chamber at room temperature. 
 
2.7   Array scanning and data analysis 
 
Arrays were scanned at 532 nm (Cy3) and 635 nm (Cy5) using the confocal scanner 
ScanArray 4000 (GSI Lumonics).  For each clone, a ratio of Cy5 to Cy3 fluorescent 
intensity  was  calculated  by  processing  the  array  images  in  TIGR  Spotfinder 
(http://www.tm4.org/spotfinder.html). The median spot intensities were subtracted from 
the median intensities of each spot for each Cy5 and Cy3 images.  
 
Analysis of the data was carried out with the contribution of Richard Mitter, at the 
Bioinformatics  and  Biostatistics  group,  London  Research  Institute  Cancer  Research 
UK, using the open-source software Bioconductor (Smyth, 2004).  
 
The Cy5 to Cy3 log2 ratios were normalized by subtracting the weighted median for 
each array. Intensities were normalised between arrays using the “quantile” method of 
“NormaliseBetweenArrays” function from the Bioconductor package limma to ensure 
that  the  intensities  have  the  same  empirical  distribution  across  arrays  and  across 
channels. For each clone, a mean log2 was calculated using the four replicates within   73 
each array. Pearson Correlation Coefficients were calculated between all arrays and 
found to be strongest between duplicates. Summarised log2 ratios were calculated by 
taking a mean across duplicate arrays. 
 
Data  points  derived  from  clones  constituted  entirely  of  repetitive  sequences  were 
excluded from the analysis (Appendix I). Repetitive sequences were defined as in the 
‘all  repeats’  track  in  the  Ensembl  browser  (Hubbard  et  al.,  2007).  Dye  swap 
hybridisation for each pair of arrays was performed to normalise for any dye bias. The 
genomic  position  of  the  BACs  used  to  generate  the  MHC  tiling  path  arrays  was 
determined using the NCBI build 34 assembly of the human genome. 
2.8   Real-Time PCR 
 
SYBR Green real-time PCR was used to analyse the process of DNA amplification 
quantitatively throughout the PCR reaction. SYBR is a cyanine dye that binds to the 
minor groove of double-stranded DNA and is fluorescent when bound. 
 
PCR  primers  were  designed  using  Primer  3  software  (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi).  Real-time  PCR  was  performed  using  SYBR  Green 
Jumpstart Taq Ready Mix kit (Sigma Aldrich, Missouri, USA). PCR reactions were 
prepared in 50 µl reaction volume and consisted of 25 µl of SYBR Green Jumpstart Taq 
Ready  Mix, 100 ng of DNA template  and forward and reverse primer mix at final 
concentration of 500 nM.  
 
The PCR cycling conditions consist of an initial denaturation for 5 min at 95 °C, 40 
cycles of denaturation at 95 °C for 40 sec, annealing at 55 °C for 30 sec and extension 
at 72 °C for 30 sec, followed by a final 5 min extension step at 72 °C. After completion 
of  the  amplification,  a  melting  curve  of  each  product  was  obtained  by  heating  the 
samples  from  72  °C  to  95  °C  and  monitoring  fluorescence  every  1  °C  increase  in 
temperature  to  determine  the  specificity  of  the  PCR  reaction.  These  reactions  were 
performed using the Opticon2 (MJ Research) thermal cycler.  
 
In  order  to  quantify  the  target  regions  in  the  DNA  samples,  standard  curves  were 
produced for each primer pair from PCR reactions with known amounts of genomic   74 
DNA.  Data  analysis  was  performed  using  different  versions  of  the  Opticon  (MJ 
Research) amplification detection software. 
 
2.9  Threshold  of  array  enrichment  identifying  matrix  attachment 
regions 
 
In order to identify MARs based on the array data, a threshold of array enrichment was 
determined by comparing the array enrichment values with the quantitative real-time 
PCR enrichment of selected MHC clones using MAR and halo DNA fractions. 
 
The selected MHC clones were characterised by MAR/halo array enrichments ranging 
from  approximately  -1 to  1 (log2). Each  real-time  PCR  reaction  was  carried  out  as 
described in section 2.9. The experiments were performed three times using MAR and 
halo  DNA  fractions  from  three  independent  populations  of  untreated  MRC5  cells 
(samples 3, 4 and 5). 
 
The data show that the clones having array enrichment values greater than 0.4 (log2), 
are consistently confirmed to be MARs (Table 2.1). Therefore, genomic regions with 
array enrichment greater than 0.4 were thus designated as MARs. 
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MHC region  MAR/Halo predicted 
by array enrichment 
Array enrichment 
value MAR/halo (log2) 
RT-PCR enrichment 
MAR/halo (log2) 
30455483-30457800  MAR  0.999  3.234 
31955316-31957399  MAR  0.803  2.526 
32591170-32594283  MAR  0.597  3.624 
29933548-29935949  MAR  0.406  1.902 
29739385-29741249  MAR  0.201  -0.919 
30118308-30120829  MAR  0.008  -1.485 
33051852-33053947  Halo  -0.202  -0.823 
32127610-32130779  Halo  -0.400  -2.724 
33190199-33192634  Halo  -0.602  -1.251 
31236895-31239353  Halo  -0.811  -1.923 
31649837-31652271  Halo  -1.005  -2.014 
 
Table  2.1  Comparison  between  real-time  PCR  (RT-PCR)  data  and  array 
enrichment values. 
 
2.10 Expression Array 
 
The  gene  expression  of  PGF  and  MRC5  cells  +/-  IFN-γ  was  determined  using 
Affymetrix U133 plus 2.0 GeneChips  (Affymetrix, Santa Clara, CA). Total RNA was 
extracted using the Qiagen  RNeasy Mini Kit following the manufacturer’s protocol. 
Briefly,  5  x  10
6  cells  were  lysed  and  homogenised  in  the  presence  of  a  highly 
denaturing  guanidine-thiocyanate–containing  buffer,  which  inactivates  RNases  to 
ensure purification of intact RNA. 70% ethanol was then added to the lysate to promote 
selective binding of RNA to the membranes of the RNeasy Mini spin columns. A series 
of washes with RNeasy washing buffers was then performed to remove contaminants 
before eluting the total RNA from the RNeasy mini columns with 60 µl of RNase-free 
water. The bind, wash and elution steps were performed by centrifugation. The amount 
of RNA was measured using the Nanodrop ND-1000 spectrophotometer and the RNA 
quality assessed using the Agilent 2100 Bioanalyser.   
 
The  samples  were  prepared  and  hybridised  to  the  microarrays  according  to  the 
Affymetrix  Technical  Manual  (www.affymetrix.com/support/technical/manual/   76 
expression_manual.affx).  Briefly,  total  RNA  (10  µg)  was  converted  into  double-
stranded cDNA using the reverse transcriptase and oligo-dT primers of the One-Cycle 
cDNA Synthesis Kit. In vitro transcription of biotin-labelled antisense RNA (cRNA) 
was carried out using the cDNA as a template. Prior to hybridisation, the cRNA was 
fragmented in Affymetrix Fragmentation Buffer at 94 °C for 35 min to produce 25-200 
bp  fragments.  Approximately  15  µg  of  labelled,  fragmented  cRNA  was  added  to  a 
hybridisation cocktail, which was then hybridised to U133 Plus 2.0 GeneChips for 16 h 
at 45 °C with gentle rocking. GeneChips were
 washed with a series of non-stringent and 
stringent  solutions  containing  variable  amounts  of  morpholino  ethane  sulfonic  acid, 
Tween
 20, sodium chloride, sodium phosphate and EDTA. The microarrays
 were then 
stained with streptavidin phycoerythrin, and the fluorescent
 signal was amplified using a 
biotinylated  antibody  solution.
  Fluorescent  images  were  detected  using  a  GeneChip 
Scanner 3000,
 and expression data extracted using the GeneChip Operating
 System v 
1.1 (Affymetrix). 
 
Statistical  analysis  was  performed  using  the  open  source  statistical   environment  R 
(www.r-project.org) and Bioconductor packages (Smyth, 2004). Probe set expression 
measures  were  calculated  using  the  “Affy”  package's  Robust  Multi-chip  Average 
(RMA)  default  method.  Probe  sets  exhibiting  a   >2  fold  change  were  called 
differentially expressed. Where multiple probe sets mapped to the same gene, a mean 
fold  change  was  taken.  All  expression  data  were  deposited  in  NCBI  Gene 
Expression Omnibus  (GEO,  http://www.ncbi.nlm.nih.gov/geo/)  and  are  accessible 
through  GEO Series accession number GSE10880. 
 
2.11 FISH and image analysis 
 
FISH was performed on PGF and MRC5 cells +/- IFN-γ to examine the higher-order 
chromatin architecture of the MHC. The PAC RP1-172K2 probe was selected for the 
MHC class II gene HLA-DRA and obtained from the Wellcome Trust Sanger Institute, 
UK. Probe DNA was labelled with digoxigenin-11-dUTP (Roche) by nick-translation 
using the enzyme mix from BioNick kit (Invitrogen) and a digoxigenin labeling mixture 
replacing  biotin  14-dATP  (Roche  Diagnostics).  A  solution  containing  5  µl  of 
digoxigenin labelling mixture, 5 µl of 10x enzyme mixture, 1 µg of probe DNA and 
made up to 40 µl with water was incubated  at  16 °C for approximately 85 min to   77 
produce 500 bp fragments. The size of the fragments was examined by agarose gel 
electrophoresis. In order to inactivate the enzymes, 5 µl of EDTA was then added and 
the mixture heated to 60 °C for 5 min. 
 
PGF and MRC5 cells +/- IFN-γ were fixed in a methanol acetic acid (3:1) solution and 
placed on glass microscope slides. Prior to hybridisation, the chromosomes on each 
slide  were  aged  with  microwave  irradiation  for  2.5  min  using  a  microwave  (Sharp 
Carousel  II)  set  at  medium/high  power.  To  denature  the  chromosomes,  90  µl  of 
denaturation mixture (70% v/v formamide, 2x SSC) was placed on the slide under a 22 
x 50 mm coverslip and the slide heated on a hot plate at 73 °C for 3 min. The slide was 
then washed with 2x SSC and dehydrated in alcohol. 
 
Labelled DNA (300 ng) was precipitated with human Cot-1 DNA, salmon sperm DNA, 
NaAc  and  absolute  alcohol  and  then  re-suspended  in  hybridisation  mixture  (50% 
formamide, 2x SSC and 10% w/v dextrane sulphate). The probe was denatured on a 
heating block at 85 °C for 5 min and incubated at 37 °C for 30 min. The slide was then 
pre-warmed on a heating block at 37 °C, the denatured probe applied to the slide with 
FITC-labelled chromosome 6 paint (Cambio) and the slide placed in a moist chamber at 
37 °C overnight. 
 
The slide was washed three times in 50% v/v formamide, 2x SSC at 42 °C and then 
three times in 1x SSC at 60 °C. The hybridisation area was then blocked in 90 µl of 
blocking solution (4x SSC, 0.1% v/v Tween 20 and 5% w/v skimmed milk powder 
(Marvel)) and incubated at 37 °C for 25 min. The blocking solution was drained from 
the slide and the detection antibody applied and covered with a coverslip (22 x 50 mm).  
 
Anti-avidin-FITC 1:300 and anti-digoxigenin-rhodamine 1:100 antibodies were used for 
detection by incubation at 37 °C for 45 min followed by three washes with 4x SSC and 
0.1% v/v Tween 20 at 42 °C. The chromosomes were then counterstained with DAPI 
(200 ng/ml) in Citifluor antifade solution and stored at 4 °C in the dark. Slides were 
examined with a Zeiss Axiophot epifluorescence microscope. 
 
Separate grey-scale images were recorded with a cooled CCD-camera (Hamamatsu). 
They were then pseudocoloured and merged using SmartCapture X software (Digital 
Scientific, Cambridge). The position of signal from the HLA-DRA probe was analysed   78 
in  relation  to  the  domain  defined  by  the  chromosome  6-specific  paint.  Each 
chromosome homologue was counted separately and a score derived for the percentage 
of loci that were located on an external chromatin loop. Experiments were repeated 
twice on cells from independent cultures. 
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3  Validation of a tiling path array for the MHC 
 
3.1   Introduction 
 
The MHC is one of the most important genomic regions for protection of the organism 
against diseases. While much effort has been made to understand the genetics of this 
locus, contributing greatly to our knowledge on the regulation of MHC genes, further 
studies  are  necessary  to  elucidate  the  relationship  between  the  three-dimensional 
properties  of  the  MHC  and  its  function.  This  region  constitutes  an  ideal  model  to 
investigate chromatin organisation as it contains genes that are constitutively expressed, 
tissue-specific or inducible (Boehm et al., 1997; Rohn et al., 1996). Furthermore the 
MHC  has  distinct  structural  configurations  dependent  on  its  transcriptional  status 
(Christova et al., 2007; Volpi et al., 2000). 
 
The development of assays using DNA microarrays and high-throughput sequencing 
and their application in combination with other techniques, including ChIP, has allowed 
the  study  of  chromatin  structure  on  a  genome-wide  scale.  These  technologies  are 
applicable  to  properties  of  chromatin  such  as  nucleosome  positioning,  DNA 
methylation, chromatin-modifying enzymes, histone and non-histone structural proteins 
(Schones  and  Zhao,  2008).  In  addition,  high-throughput  approaches  can  be  used  to 
study higher-order chromatin architecture. For instance, the chromosome conformation 
capture  approach  allows  the  identification  of  multiple  long-range  DNA  interactions 
(Simonis  et  al.,  2006;  Zhao  et  al.,  2006).  Analysis  of  cells  at  different  stages  of 
differentiation or exhibiting different transcription and replication profiles enables the 
role of chromosome architecture in genomic function to be determined.  
 
In order to facilitate the comprehensive study of MHC architecture, I generated a novel 
tiling path array covering the locus, in collaboration with the Immunogenomics Group 
at  the  Sanger  Institute.  The  array  was  constructed  to  determine  the  DNA-protein 
interactions  that  contribute  to  the  organisation  of  the  MHC  and  how  the  structural 
properties of the MHC affect its function. It was also designed to be compatible with   80 
various  assays  including  ChIP,  methylated  DNA  immunoprecipitation  (MeDIP)  and 
array comparative genomic hybridisation (aCGH). 
The  array  platform  was  constructed  utilising  a  public  clone  resource 
(http://www.hapmap.org)  at  a  fraction  of  the  costs  associated  with  commercially 
available arrays. A study by Tomazou et al. (2008) showed that the MHC array can be 
successfully  used  for  the  identification  of  tissue-specific  differentially  methylated 
regions (Tomazou et al., 2008). Here, the identification of the Class II Transactivator 
(CIITA) binding sites and the analysis of histone H3-K9/K14 acetylation across the 
MHC were used to validate the array since they are both well described (Krawczyk et 
al., 2004; Krawczyk et al., 2008; Liang et al., 2004; Roh et al., 2005). 
 
CIITA  induces  transcription  of  the  classical  and  non-classical  class  II  genes  by 
interacting with transcription factors at the conserved proximal-promoter SXY motif 
and  the  distal  enhancer-module  S’-Y’(Gobin  et  al.,  1997;  Harton  and  Ting,  2000; 
Krawczyk et al., 2004; Martin et al., 1997). Acetylation of the amino terminal lysines of 
histones  H3  is  associated  with  induction  of  transcription  and  is  thought  to  disrupt 
condensed  chromatin  to  allow  accessibility  of  transcription  factors  and  RNA 
polymerase  (Beresford  and  Boss,  2001;  Grunstein,  1997;  Utley  et  al.,  1998).  The 
histone H3-K9/K14 acetylation profile of the MHC was tested as it is a feature of 5’ 
regions of transcriptionally active human genes (Liang et al., 2004; Roh et al., 2005). 
 
The  validation  experiments  were  performed  using  the  MHC  tiling  path  array  in 
combination with ChIP. The data show that the arrays identify previously described 
CIITA-binding sites with high reliability as well as novel putative CIITA-binding sites, 
which are mostly located in the promoter and regulatory region of MHC genes. The 
histone  study  confirms  that  the  highest  levels  of  H3-K9/K14  acetylation  are  at  the 
promoter regions of constitutively expressed genes. Taken together these experiments 
demonstrate the utility of the arrays for the profiling of DNA-protein interactions and 
the epigenetic status of the region. 
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3.2   Results 
 
3.2.1  MHC tiling path arrays 
 
A  tiling  array,  encompassing  almost  the  entire  4  Mb  MHC  region  (99.67%)  at  a 
resolution of 2 kb, was constructed. The array contains 7832 probes consisting of two 
replicates  of  both  forward  and  reverse  strands  of  MHC  sequences  and  appropriate 
controls. Approximately 97% of these probes were estimated to be informative based on 
the quality controls described in Chapter 2. 
 
3.2.2  Analysis of technical variation 
 
Regardless of the experiment performed, the identification of MHC regions that are 
truly enriched for the factor of interest is of critical importance. To distinguish between 
the real enrichment and the background enrichment, which occurs as consequence of 
technical noise, the experimental variation was  calculated using  a series of self-self 
hybridisations. 
 
The DNA samples used consisted of genomic DNA from human MRC5 fibroblast cells 
sonicated to an average size of 1 kb. These samples were differentially labelled with 
dCTP-Cy3 and dCTP-Cy5 fluorophores and hybridised to the MHC tiling path array. 
The slides were then washed and scanned and acquired images were analysed with an 
imaging  software  (Spotfinder).  This  experiment  was  carried  out  three  times.  The 
Cy3/Cy5 ratio of each probe on the array was used as an indication of the representation 
of region covered by the probe in the two samples. The ratios of the fluorescent dyes of 
each locus were log2 transformed, and the combined means calculated and subsequently 
plotted  on  the  UCSC  human  genome  database  (http://genome.ucsc.edu,  May  2004 
Assembly) (Fig 3.1). Array probes consisting entirely of repetitive sequences, as listed 
in the previous chapter, were excluded from the analyses. 
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Findings are shown as log2 ratios, with a ratio of zero representing no enrichment of 
either sample.  As samples from the same genomic DNA were co-hybridised to the 
MHC tiling path array, the log2 ratios were expected to remain close to 0 and  any 
deviations to be attributable to experimental errors. The average log2 ratio was 0.01. 
The  graphical  representation  of  the  results  shows  that  there  are  no  significant 
enrichments  across  the  MHC  locus.  The  experimental  variation  was  determined  by 
calculating  the  standard  deviation  of  the  log2  ratios  of  the  array  probes  for  each 
experiment. The average standard deviation was as low as 0.11.  
 
In order to validate the array results, eight regions across the MHC were randomly 
selected  and  subjected  to  independent  real-time  PCR  analysis.  The  log2  array 
enrichment of the selected MHC regions varied from –0.04 to. 0.10. For all 8 regions, 
the amount of DNA was found to be almost equivalent in both genomic samples. This is 
consistent with the array data suggesting that the MHC tiling path array is suitable for 
the identification of differential DNA enrichment (Fig 3.2). 
 
 
 
 
 
Figure 3.1 MHC plot of self-self experiments. 
The plot was obtained by co-hybridising the two samples of genomic DNA from MRC5 
cells labelled with  Cy3 and  Cy5 fluorophores onto the MHC tiling path  array. The 
experiment was carried out three times. Each bar represents a clone from the MHC 
locus. The height of each bar shows the average log2 enrichment level of each sample at 
a given MHC region. Positive ratios represent enrichments of a given MHC region in 
the Cy5-labelled samples while negative regions represent enrichments of a given MHC 
region in the Cy3-labelled samples. 
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Figure 3.2 Quantitative real-time PCR analysis of eight regions across the MHC 
locus. 
Real-time PCR was performed using two samples of genomic DNA from MRC5 cells 
and  primers  spanning  eight  MHC  regions  exhibiting  no  significant  difference  in 
enrichment of Cy5- and Cy3-labelled genomic DNA in the array experiments. Real-
time PCR indicated that the quantity of those amplicons is almost equivalent in both 
Cy5-  and  Cy3-labelled  genomic  DNA  samples,  thus  validating  the  array  data.  Bars 
represent the mean of two experiments and show the standard deviation.   84 
3.2.3  CIITA-binding sites across the MHC 
 
ChIP was performed using polyclonal anti-CIITA in the human Burkitts’ lymphoma 
cell-line Raji and a CIITA-deficient cell-line generated in vitro from Raji, RJ2.2.5.  Raji 
cells express CIITA constitutively and the ChIP samples from these cells were enriched 
in CIITA target sequences. Conversely RJ2.2.5 cells do not synthesise CIITA and the 
resulting  ChIP  DNA  sample  was  enriched  only  in  non-specific  immunoprecipitated 
DNA  sequences.  The  ChIP  DNA  products  from  both  cell  lines  were  competitively 
hybridised  to  the  MHC  tiling  path  arrays.  ChIP  assays  were  carried  out  by  the 
Immunopathology Laboratory at the Geneva University using the method described by 
Masternak et al. (2003) (Masternak et al., 2003).  
 
Due to the small amounts of DNA obtained from this procedure, two rounds of ligation 
mediated PCR were carried out prior to competitive hybridisation.  The ChIP samples 
from  Raji  and  RJ2.2.5  cells  were  then  labelled  with  Cy3  and  Cy5  fluorophores, 
respectively, and co-hybridised to the MHC tiling path array.  A dye swap experiment 
was  carried  out  to  control  for  the  efficiency  of  the  labelling.  The  ratios  of  the 
fluorescent dyes of each locus were log2 transformed, and the combined mean values 
calculated and plotted on the UCSC human genome database (http://genome.ucsc.edu, 
May 2004 Assembly). The graphical representation of the results shows that, although 
each class of the MHC contains CIITA-binding sites, the highest peaks representing 
CIITA enrichments are present across the MHC class II (Fig 3.3). The DNA regions 
enriched in the ChIP samples from RJ2.2.5 cells are expected to represent enrichment in 
immunoprecipitated  DNA  sequences  derived  from  the  nonspecific  binding  of  the 
antibody and subsequent DNA amplification. 
 
The best-documented targets of CIITA are the regions proximal to the classical and 
non-classical MHC class II genes, which contain the SXY and S’-Y’ modules. These 
sequences were used as positive controls to validate the MHC tiling path arrays. A 
threshold  of  four  standard  deviations  was  used  to  select  CIITA-enriched  clones  for 
further analysis. The application of this threshold identified 27 CIITA-enriched loci, of 
which 14 overlapped with the SXY and S’-Y’ modules of the MHC  class II genes 
(Table 3.1). No data were available for the S’-Y’ module of HLA-DRA since it is a 
region refractory to PCR amplification due to repeats, thus, it could not be included in   85 
the  tiling  path  array.  The  S’-Y’  module  of  HLA-DQA1  is  the  only  positive  control 
represented in the MHC tiling path array, which is not confirmed to be highly enriched 
in CIITA.  
 
Additional positive controls include the SXY and S’-Y’ modules of MHC class I genes. 
The array results revealed that these modules are among the 27 highest CIITA-enriched 
sites across the MHC locus (Table 3.2). This list also includes sequences that were not 
candidate CIITA-binding sites. These regions were designated as novel putative CIITA-
enriched sites (Table 3.3). As these sequences were more CIITA-enriched than positive 
controls, their enrichment is unlikely to be attributable to stochastic differences in the 
competitive hybridisation of targets to the probes on the arrays and technical variation. 
Of these novel putative  CIITA-binding sites, four overlapped transcription initiation 
sites and two were located in the intergenic region downstream of the start site. Several 
of the novel putative CIITA-binding sites are either within or proximal to genes that 
contribute to a range of clinical conditions (Aquino-Galvez et al., 2008; Heinzelmann-
Schwarz et al., 2004; Matsuzaka et al., 2002). 
 
 
 
 
 
Figure 3.3 CIITA-binding sites across the MHC. 
The plot was obtained co-hybridising Cy3- and Cy5-labelled ChIP DNA from Raji and 
RJ 2.2.5 to the MHC tiling path array.  The values above 0 represent enrichment in 
ChIP DNA from Raji.  The values below 0 represent enrichment in ChIP DNA from RJ 
2.2.5. The experiment was carried out twice. The height of each bar shows the average 
log2 enrichment. 
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Table 3.1 Positive controls within the MHC class II region identified by the MHC 
tiling path arrays. 
 
 
 
 
 
Table 3.2 Additional positive controls identified by MHC tiling path arrays.  
 
 
 
 
 
Table 3.3 Novel putative CIITA-binding sites identified by ChIP-MHC tiling path 
arrays. 
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3.2.4  Quantitative real-time PCR of ChIP DNA from Raji and RJ2.2.5 cells 
 
In order to confirm the array results, six DNA regions enriched in the ChIP sample from 
Raji cells and six DNA regions enriched in the ChIP sample from RJ2.2.5 cells were 
subjected  to  independent  quantitative  real-time  PCR  analysis.  This  validation  was 
performed using the ChIP DNA samples used for the microarray experiments.  
 
Each  amplicon  designed  across  the  selected  regions  was  quantified  using  standard 
curves  produced  for  each  primer  pair  from  real-time  PCR  reactions  with  known 
amounts of genomic DNA. PCR reactions were performed at the same time using the 
same cycling conditions and with equal amounts of template and master mix in order to 
compare the quantity of each amplicon between the Raji and RJ2.2.5 ChIP samples. 
 
The DNA regions enriched in the ChIP samples from Raji cells, representing sequences 
bound to CIITA, overlapped the SXY module of HLA-DRA, HLA-DMA, HLA-F, HLA-
C and the transcription start site of TAP1 and HLA-G. The DNA regions enriched in the 
ChIP  samples  from  RJ2.2.5  cells,  which  instead  represented  enrichment  in  non-
specifically immunoprecipitated DNA sequences, overlapped the intragenic regions of 
MSH5, CFB, C4B, TNXB, COL11A2 and CSNK2A1. The real-time PCR results were 
consistent with the array data indicating that the MHC tiling path array is suitable for 
the study of DNA-protein interactions (Fig 3.4-3.5). 
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Figure 3.4 Quantitative real-time PCR analysis at CIITA-enriched loci in Raji and 
the derivative CIITA negative cell line RJ2.2.5.  
Real-time PCR was carried out using two samples each of ChIP DNA from Raji and RJ 
2.2.5 cells and primer pairs spanning regions of high CIITA enrichment according to the 
array data. The DNA regions overlapping the SXY modules of HLA-DRA, HLA-DMA, 
HLA-F, HLA-C and the transcription start sites of TAP1 and HLA-G were found to be 
highly enriched in the Raji ChIP samples and thus in CIITA target sequences. Bars 
represent the mean of two experiments and show the standard deviation. 
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Figure 3.5 Quantitative real-time PCR analysis at loci enriched in non-specifically 
immunoprecipitated DNA sequences.  
Real-time PCR was carried out using two samples each of ChIP DNA from Raji and RJ 
2.2.5 cells and primer pairs within regions of no CIITA enrichment according to the 
array data. DNA sequences located in the intragenic region of MSH5, CFB, C4B, TNXB, 
COL11A2  and  CSNK2A1  were  found  to  be  highly  enriched  in  the  RJ2.2.5  ChIP 
samples,  which  contain  non-specifically  immunoprecipitated  DNA  sequences.  Bars 
represent the mean of two experiments and show the standard deviation. 
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3.2.5  Histone H3-K9/K14 acetylation across the MHC 
 
In  order  to  profile  histone  H3-K9/K14  acetylation  across  the  MHC,  DNA  samples 
enriched in H3-K9/K14 acetylation were obtained by ChIP and then hybridised to the 
MHC  tiling  path  arrays.  HT1080  fibroblasts  were  treated  with  formaldehyde  and 
subjected  to  standard  ChIP  with  antibodies  directed  against  H3-K9/K14  acetylation. 
ChIP  was  also  performed  using  non-specific  mouse  IgG  antibodies  as  a  negative 
control.  Acetylation  of  H3-K9/K14  has  been  previously  found  at  the  5’  regions  of 
transcriptionally active human genes (Liang et al., 2004; Roh et al., 2005). To assess the 
quality of the ChIP, H3-K9/K14 acetylation was analysed with quantitative real-time 
PCR  at  the  5’  regions  of  HLA-A,  HLA-C,  HLA-DRA  and  HLA-DRB1.  In  HT1080 
fibroblasts, the HLA-A and HLA-C genes are constitutively expressed while HLA-DRA 
and  HLA-DRB1  genes  are  transcriptionally  silenced  (Rohn  et  al.,  1996;  Singer  and 
Maguire, 1990). In agreement with previous reports, the PCR data show that HLA-A an 
HLA-C genes are significantly more H3-K9/K14 acetylated compared to HLA-DRA and 
HLA-DRB1  genes  confirming  that  H3-K9/K14  acetylation  is  associated  with  active 
transcription of human genes (Fig 3.6) (Agalioti et al., 2002; Liang et al., 2004). 
  
The DNA immunoprecipitates obtained using anti-acetyl H3-K9/K14 and mouse IgG 
antibodies were labelled with Cy5 and Cy3 fluorophores and co-hybridised to the MHC 
tiling path array. A dye swap experiment was carried out to reduce the bias introduced 
by the different fluorescent labelling of the DNA samples. The ratios of the fluorescent 
dyes of each locus were log2 transformed and the combined mean values calculated. An 
arbitrary cut-off of array enrichment was set at 3 standard deviations of the mean to 
identify H3-K9/K14 acetylated MHC regions which were subsequently plotted on the 
UCSC human genome database (Fig 3.7). The results show that 281 regions of the 
MHC, representing 17% of the array probes, are associated with K9/K14 acetylated H3. 
These enriched probes are unevenly distributed across the MHC locus. Over 47% of the 
H3-K9/K14 acetylated regions are contained in the MHC class I, 31% in the MHC class 
III, 8% in the MHC class II and 14% in the extended MHC class II regions. 
 
To determine if the H3-K9/K14 acetylation is biased towards any functional regions in 
the human genome, the MHC was divided into transcription initiation sites, gene body 
regions including introns and exons, and intergenic regions. Approximately 57% of the 
array probes covering the MHC locus contain entirely intergenic regions, 31% contain   91 
gene  body  regions  while  12%  contain  transcription  initiation  sites  (Fig  3.8a).  This 
distribution  is  significantly  different  from  that  of  the  array  probes  enriched  in  H3-
K9/K14 acetylation. Of such probes 23% contain intergenic regions, 43% contain gene 
body  regions  and  34%  contain  transcription  start  sites  (Fig  3.8b).  H3-K9/K14 
acetylation is thus biased towards the transcription sites and gene body regions of the 
genome.  The  distribution  of  the  50  array  probes  most  enriched  in  H3-K9/K14 
acetylation is even more shifted towards the transcription initiation sites (Fig 3.8c). This 
suggests that the 5’ ends of genes are the most highly acetylated regions, as previously 
shown by a genome-wide analysis of H3-K9/K14 acetylation in T cells (Roh et al., 
2005). 
 
In  agreement  with  the  real-time  PCR  results,  the  array  data  show  that  the  regions 
overlapping the 5’ region of HLA-A and HLA-C are enriched in H3-K9/K14 acetylated 
DNA while HLA-DRA and HLA-DRB1 are not H3-K9/K14 acetylated. This indicates 
that the arrays are suitable for the profiling of histone modifications across the MHC 
locus. The genes that are H3-K9/K14 acetylated include all the classical MHC class I 
genes  but  none  of  the  classical  MHC  class  II  genes  (Table  3.4).  While  fibroblasts 
constitutively express the classical MHC class I genes, they do not express the classical 
MHC class II genes unless induced with cytokines such as IFN-γ (David-Watine et al., 
1990; Rohn et al., 1996; Singer and Maguire, 1990). These experiments further validate 
the MHC tiling path arrays since they are consistent with previous reports associating 
transcriptionally active genes with H3-K9/K14 acetylation (Agalioti et al., 2002; Liang 
et al., 2004; Roh et al., 2005). 
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Figure 3.6 Quantitative real-time PCR analysis at the 5’ regions of HLA-A, HLA-C, 
HLA-DRA and HLA-DRB1 in HT1080 cells.  
Real-time PCR was carried out using two samples each of ChIP DNA from HT1080 
cells and primer pairs at the 5’ regions of HLA-A, HLA-C, HLA-DRA and HLA-DRB1. 
a) The data indicate that the 5’ regions of HLA-A and HLA-C are enriched in the ChIP 
samples obtained by using anti-acetyl H3-K9/K14 compared to the samples obtained by 
using mouse IgG. b) No significant differences are observed between the two ChIP 
samples relative to the enrichment of the 5’ region of HLA-DRA and HLA-DRB1. Bars 
represent the mean of two experiments and show the standard deviation. 
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Figure 3.7 H3-K9/K14 acetylation profile of the MHC.  
The plot was obtained by co-hybridising to the MHC tiling path array Cy3- and Cy5-
labelled ChIP DNA from HT1080 cells using anti acetyl-histone H3-K9/K14 and mouse 
IgG. The values above 0 represent enrichment in acetyl-H3-K9/K14 ChIP DNA.  The 
values below 0 represent enrichment in mouse IgG ChIP DNA. The experiment was 
carried out twice using ChIP DNA from two biologically independent experiments. The 
height of each bar shows the average log2 enrichment. 
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Figure 3.8 Distribution of H3-K9/K14 acetylated probes across the start sites of 
genes, within genes and intergenic regions of the MHC in HT1080 cells.  
Array probes were divided into three groups: overlapping transcription initiation sites, 
gene body regions including introns and exons and intergenic regions. The pie charts 
show the calculated percentages of each group in a) MHC array probes, b) H3-K9/K14 
acetylated probes and c) the 50 most acetylated H3-K9/K14 probes. 
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Number  Gene  Chr. co-ordinates  Number  Gene  Chr. co-ordinates 
1  MOG  29732788-29748126  48  BAT4  31737842-31741142 
2  HLA-F  29799096-29803052  49  CSNK2B  31741636-31745822 
3  HLA-G  29902735-29906878  50  LY6G5B  31746707-31748206 
4  HLA-A  30018310-30021632  51  LY6G5C  31794405-31797489 
5  HCG9  30050871-30054148  52  BAT5  31762715-31779067 
6  ZNRD1  30137015-30140665  53  DDAH2  31802797-31806018 
7  PPP1R11  30142911-30146085  54  CLIC1  31806339-31812320 
8  TRIM31  30178655-30188846  55  MSH5  31815753-31838429 
9  TRIM15  30238962-30248452  56  LSM2  31873155-31882722 
10  TRIM26  30260213-30289132  57  HSPA1L  31885375-31890814 
11  TRIM39  30403019-30419484  58  HSPA1A  31891316-31893696 
12  RPP21  30420916-30422611  59  HSPA1B  31903491-31906010 
13  HLA-E  30565250-30569064  60  C6ORF48  31910672-31915518 
14  GNL1  30621675-30632987  61  NEU1  31934932-31938662 
15  PRR3  30632735-30640159  62  SLC44A4  31938949-31954802 
16  ABCF1  30647149-30667286  63  ZBTB12  31975373-31977748 
17  PPP1R10  30676162-30692999  64  CFB  32021752-32027839 
18  MRPS18B  30693465-30702153  65  RDBP  32027844-32034843 
19  C6ORF134  30702592-30720427  66  SKIV2L  32034560-32045511 
20  C6ORF136  30722780-30728961  67  STK19  32047625-32057201 
21  DHX16  30728886-30748736  68  C4A  32090550-32111173 
22  NRM  30763806-30766748  69  TNXB  32116911-32185129 
23  MDC1  30775563-30793437  70  CREBL1  32191023-32203995 
24  TUBB  30796136-30801172  71  FKBPL  32204465-32206045 
25  FLOT1  30803492-30818432  72  PPT2  32229279-32239429 
26  IER3  30818955-30820306  73  AGPAT1  32243968-32253820 
27  DDR1  30959840-30975910  74  AGER  32256724-32260001 
28  GTF2H4  30983956-30989858  75  PBX2  32260488-32265941 
29  VARS2  30989961-31002212  76  GPSM3  32266522-32271278 
30  PSORS1C1  31190602-31215816  77  NOTCH4  32270599-32299822 
31  PSORS1C2  31213290-31215106  78  TAP2  32897588-32914525 
32  CCHCR1  31218195-31233545  79  PSMB8  32916477-32919794 
33  TCF19  31234282-31239970  80  TAP1  32920965-32929726 
34  HCG27  31273578-31279723  81  BRD2  33044415-33057260 
35  HLA-C  31344509-31347834  82  RXRB  33269344-33276410 
36  HLA-B  31429628-31432968  83  SLC39A7  33276581-33280191 
37  MICA  31479350-31491069  84  RING1  33284264-33288476 
38  HCP5  31538938-31541460  85  VPS52  33326028-33347640 
39  MICB  31573834-31586880  86  RPS18  33347830-33352259 
40  BAT1  31605977-31618204  87  PFDN6  33365356-33366689 
41  ATP6V1G2  31620221-31622606  88  RGL2  33367416-33374716 
42  NFKBIL1  31623351-31634584  89  TAPBP  33375452-33389967 
43  LTB  31656317-31658181  90  DAXX  33394379-33398682 
44  LST1  31661950-31664664  91  KIFC1  33467291-33485677 
45  BAT2  31696429-31713533  92  PHF1  33486772-33492191 
46  BAT3  31714784-31728456  93  CUTA  33492297-33494043 
47  C6ORF47  31734054-31736528  94  SYNGAP1  33495825-33529443 
 
Table 3.4 H3-K9/K14 acetylated genes across the MHC in HT1080 cells identified 
by ChIP assays coupled with MHC tiling path arrays. The H3-K9/K14 acetylated 
genes were identified setting an array enrichment cut-off of 3 standard deviations of the 
mean.   96 
3.3   Discussion 
 
The MHC tiling path arrays were validated using three strategies: 1) self-self DNA 
hybridisations  2)  hybridisations  of  CIITA-enriched  DNA  3)  hybridisations  of  DNA 
enriched  in  H3-K9/K14  acetylation.  Self-self  hybridisations  indicated  that  the  array 
probes  exhibited  a  high  degree  of  hybridisation  uniformity.  Hybridisations  of  DNA 
enriched  in  CIITA  and  H3-K9/K14  acetylation  showed  that  specific  DNA-protein 
interactions  at  previously  characterised  MHC  sites  could  be  detected  with  high 
reliability. For each set of experiments, findings compared well with quantitative real-
time PCR. Taken together, these results demonstrate the utility of the tiling path array in 
profiling DNA-protein interactions across the MHC locus.  
 
In contrast to most commercial arrays, these MHC array platforms include repetitive 
sequences,  which  were  blocked  in  each  experiment  using  Cot1  DNA.  Control 
hybridisations were performed with the MHC tiling path arrays, with and without Cot1 
DNA (Tomazou et al., 2008). These experiments showed that when using Cot1 DNA, 
the intensities of repeat-containing probes are similar to those detected for repeat free 
probes. This suggests that unwanted signals derived from repetitive elements can be 
efficiently  suppressed  and  that  the  unique  regions  of  repeat  containing  probes  are 
informative and can be used for further analysis (Tomazou et al., 2008). The array 
probes constituted entirely of repetitive sequences were removed from further analyses 
since hybridisation to those sequences would be non-specific.  
 
Control self-self hybridisations were carried out to identify any array probes that failed 
to  give  the  expected  ratios  of  fluorescent  dyes  and  to  determine  the  experimental 
variation. In these experiments, the log2 ratio for each probe was expected to be close to 
zero. The results did not reveal any probe with a ratio deviating significantly from the 
expected  values.  The  experimental  variation,  defined  as  the  technical  background 
signal, was determined by calculating the standard deviation of the array probes. This 
was extremely low in each hybridisation indicating that the results were consistent and 
reproducible.  The  results  of  the  self-self  experiments  were  then  validated  using  an 
independent method. Quantitative real-time PCR was carried out across six randomly 
selected regions, indicating that there were no significant enrichments of either DNA 
sample, thus further confirming the array data. 
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Array hybridisations with ChIP DNA samples obtained using antibodies against CIITA 
identified  27  CIITA-enriched  loci.  These  sequences  include  12  proximal-promoter 
regulatory modules, SXY, and 2 distal regulatory modules, S’-Y’, of the classical and 
non-classical MHC class II genes. The MHC class II contains a total of 12 proximal-
promoter regulatory modules, SXY, and 4 distal regulatory modules, S’-Y’, for a total 
of 16 characterised CIITA target sites (Krawczyk et al., 2004). The S’-Y’ module from 
HLA-DRA  was  not  represented  on  the  arrays  since  it  was  refractory  to  PCR 
amplification. Thus, out of the 15 CIITA target sites spotted onto the arrays, only one 
S’-Y’ module was not detected. This indicates that the MHC tiling path array is suitable 
for mapping DNA-protein interactions with high sensitivity. 
 
These  SXY  and  S’-Y’  modules  bind  to  RFX,  CREB  and  NF-Y  to  form  a  landing 
platform  that  recruits  CIITA  (Krawczyk  et  al.,  2004;  Louis-Plence  et  al.,  1997; 
Masternak  et  al.,  2000).  These  proximal-promoter  modules  have  been  shown  to  be 
essential for the expression of the classical and non-classical MHC class II molecules 
(Reith and Mach, 2001). The promoters of the genes coding for the classical and non-
classical MHC class I molecules are also characterised by the SXY module (Gobin and 
van den Elsen, 2000; Krawczyk et al., 2008; van den Elsen et al., 2004). Although 
CIITA is involved in the basal and induced transcriptional activation of these MHC 
class I genes, its binding to their regulatory sequences has not been yet shown (van den 
Elsen et al., 2004). The MHC tiling path arrays coupled with the ChIP assay indicated 
that the array probes overlapping the SXY modules of several genes of the MHC class I 
are associated with CIITA. This suggests that CIITA might play a role in the expression 
of  classical  and  non-classical  MHC  class  I  molecules  by  interacting  at  conserved 
binding sites. 
 
Six novel potential CIITA-binding sites were identified. These either overlap or are 
proximal to genes  which have been implicated  in a wide range of human diseases. 
TRIM14 encodes a member of the tripartite motif (TRIM) family of ubiquitin ligases 
(Meroni and Diez-Roux, 2005). By promoting the ubiquitination of substrate proteins, 
members of this family can alter their cellular location or function as well as regulating 
their degradation via the proteosome (Krawczyk et al., 2008). Krawczyk et al. (2008) 
suggested that an altered expression of TRIM proteins could potentially contribute to 
the development of tumours (Krawczyk et al., 2008). MICA encodes a transmembrane 
glycoprotein that functions as a ligand for NK cells (Zou et al., 2005). The expression of   98 
MICA has been associated with a risk of developing several autoimmune and immune-
mediated diseases (Gambelunghe et al., 2005). DPCR1 synthesises a multiple-domain 
transmembrane protein which has been linked with diffuse panbronchiolitis (Matsuzaka 
et al., 2002). HLA-G is an HLA class I heavy chain paralogue. Its expression is confined 
to extravillous cytotrophoblast cells and has been proposed to play a role in materno-
fetal tolerance (Gobin and van den Elsen, 1999). Previous studies suggest that HLA-G 
transcription is not responsive to CIITA mediated pathways, however, the implication 
of CIITA in the regulation of HLA-G cannot be conclusively excluded at present (Gobin 
and van den Elsen, 1999). TUBB synthesises β-tubulin, a GTPase. Mutations in the 
TUBB gene were shown to be a good predictor of chemotherapy responses in non-small 
cell lung cancer (Monzo et al., 1999). TAP1 encodes a membrane-associated protein 
that is involved in the processing of endogenous peptides that bind to MHC class I 
molecules (Alvarado-Guerri et al., 2005). This protein is associated with susceptibility 
to coeliac disease and insulin-dependent diabetes mellitus (Colonna et al., 1992).  
 
A recent microarray study by Krawczyk et al. (2008) did not identify these six potential 
CIITA  target  sites.  This  work  was  carried  out  with  a microarray  carrying  only  the 
promoter  regions  of  27434  human  genes  (Krawczyk  et  al.,  2008).  Thus  the  novel 
putative  CIITA-binding  sites  identified  in  TUBB  and  MICA  could  have  not  been 
identified as  they are located away from their promoter regions. The remaining four 
potential CIITA target sites could have been missed since Krawczyk et al. (2008) used a 
different  microarray  platform  (NimblGen)  and  analysed  the  data  using  a  software 
(SignalMap, NimblGen) which identified positive peaks using a 500 bp sliding window 
containing five consecutive peaks. It is also possible that these novel potential CIITA-
bindings sites are false positives generated during the amplification step that I used to 
generate sufficient quantities of DNA for microarray analysis. The DNA was amplified 
using ligation-mediated PCR, an approach which could introduce sequence-dependent 
and  length-dependent  biases  due  to  the  ligation  efficiency  and  kinetics  of  the  PCR 
reaction.  Furthermore,  the  amplification  of  low  abundance  species  can  be  highly 
variable. One way to validate the CIITA target sites identified with the microarrays 
would be to identify them with PCR using ChIP DNA products which have not been 
subjected to amplification. Due to the amplification step, the quantitative real-time PCR 
could not conclusively confirm the novel CIITA target sites, however, it was successful   99 
in validating the array results demonstrating that the MHC tiling path array can be used 
to screen DNA-protein interactions.  
 
To further validate the array platform we used ChIP in combination with the MHC 
tiling path arrays to profile histone H3-K9/K14 acetylation. This histone modification is 
a  hallmark  of  transcriptional  activation  and  has  been  previously  reported  to  be 
associated with the 5’ ends of active human genes (Kurdistani et al., 2004; Liang et al., 
2004; Pokholok et al., 2005; Roh et al., 2005). The array results have shown that the 5’ 
ends of the constitutively active classical MHC class I genes are highly acetylated while 
the 5’ ends of the transcriptionally silent classical MHC class II genes do not exhibit 
high levels of acetylation. This experiment did not require an amplification step since 
the DNA quantities obtained from ChIP using antibodies against acetylated H3-K9/K14 
were suitable to carry out array hybridisations. Quantitative real-time PCR confirmed 
the array results demonstrating that the MHC tiling path array is a powerful tool for the 
study of the histone modifications characterising the MHC locus. Major advances in our 
understanding of the role of histone acetylation in regulating gene expression comes 
from studies in yeast where the genome has high levels of acetylation, largely localised 
at the promoter as well as the coding regions of active genes (Bernstein et al., 2002; 
Kurdistani et al., 2004). Recent studies in human cells, however, have suggested that 
H3-K9/K14  acetylation  occurs  predominantly  at  the  beginning  of  transcriptionally 
active genes (Liang et al., 2004; Litt et al., 2001; Roh et al., 2005). This is in agreement 
with the MHC array data, which indicate that acetylation is highest at the 5’ ends of 
constitutively expressed MHC genes and decreases downstream of their start sites. 
 
A recent study has shown that the MHC tiling path array is suitable for the profiling of 
DNA methylation across the MHC of different cell types (Tomazou et al., 2008). This 
investigation, in combination with the study of H3-K9/K14 acetylation of the MHC, 
strongly  suggests  that  this  array  platform  can  facilitate  comprehensive  epigenetic 
analyses  of  this  region.  In  addition,  the  experiments  identifying  CIITA  target  sites 
indicate  that  these  arrays  can  be  also  used  to  map  MHC  regions  interacting  with 
proteins involved in the regulation of MHC genes. Based on the design of these arrays 
we  also  expect  them  to  be  compatible  with  additional  assays  including  array 
comparative genomic hybridisation (aCGH), expression profiling and the biochemical 
extraction of MARs. 
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4  Genomic anchors in MRC5 fibroblasts 
 
4.1  Introduction 
 
MARs have been implicated in numerous aspects of gene regulation (Berezney et al., 
1995; Singh et al., 1997). They can recruit chromatin remodelling enzymes, histone 
modifying enzymes, and transcription factors, including SATB1 and SAFB1, and can 
increase transgene expression by shielding the transgene from the silencing effects of 
neighbouring chromosomal regions (Cai et al., 2006; Girod et al., 2007; Oesterreich, 
2003). However, before this study was performed only a few MARs were identified, 
limiting our understanding of how they function (Linnemann et al., 2007).  
 
Individual MARs were identified previously by quantitative real-time PCR and in vitro 
binding affinity of genomic sequences to the nuclear matrix. The need to identify MARs 
on a genome-wide scale has led to the development of algorithms for their prediction 
based  on  the  sequence  patterns  associated  with  experimentally  defined  MARs. 
However, the predicted sequences are not always in agreement with experimental data 
(Linnemann et al., 2007).  Such inconsistencies could be due to our current incomplete 
understanding of MAR sequences and/or to the fact that a significant proportion bind to 
the nuclear matrix in a cell and stage-specific manner (Heng et al., 2004; Linnemann et 
al., 2007; Ostermeier et al., 2003). 
 
The development of high-throughput technologies presents the opportunity to construct 
detailed genome-wide maps of MARs. Ioudinkova et al. (2005), working on the 40 kb 
domain  at  the  α-globin  gene  domain,  were  the  first  to  show  that  MARs  could  be 
successfully identified by hybridising them onto oligonucleotide arrays of a specific 
genomic region (Ioudinkova et al., 2005). Taking a different approach, Linnemann et al. 
(2008) identified MARs on human chromosome 16 by competitively hybridising MAR 
and halo DNA onto genomic microarrays (Linnemann et al., 2008). The positions of 
MAR  and  halo  DNA  sequences,  which  were  previously  differentially  labelled  with 
fluorochromes,  were  then  determined  by  calculating  the  ratio  of  fluorochrome 
intensities at each microarray probe.  
 
Since the primary sequence and linear organisation of the MHC have been extensively   101 
characterised,  it  provides  an  ideal  model  region  to  investigate  the  structural  and 
functional  role  of  MARs.  In  this  chapter,  MARs  were  mapped  across  the  MHC  of 
human fibroblasts using the biochemical isolation of MAR and halo DNA fractions 
followed by their co-hybridisation to the tiling path array covering the MHC locus. 
 
MARs were found to be non-randomly distributed across the MHC, since most were 
located in the class I and II regions. Furthermore, they mainly had intergenic positions, 
closely flanking several class I and II genes as well as the MHC class boundaries. These 
data suggest that MARs define chromatin domains and contribute to the class-specific 
regulation of the locus. Sequence analysis of MARs did not reveal a unique consensus 
but established significant correlations between MARs and particular genomic features, 
reinforcing the view that the DNA binding ability to the nuclear matrix might depend on 
DNA sequence context rather than on a unique primary sequence. Finally, validation of 
the  microarray  data  by  real-time  PCR  indicates  that  the  array  platform  can reliably 
identify interactions of MHC sequences with the nuclear matrix and can thus be used to 
characterise  the  dynamics  of  MARs  in  cells  exhibiting  different  MHC  expression 
profiles. The findings in this Chapter and Chapter 5 are included in a paper in press 
(Ottaviani et al., 2008a). 
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4.2   Results 
 
4.2.1  Biochemical  isolation  of  matrix  attachment  regions  from  MRC5 
fibroblasts 
 
MARs were isolated by treating nuclei from MRC5 fibroblasts with 2 M NaCl followed 
by nuclease digestion. The hypertonic treatment removed the soluble proteins, including 
histones, causing the DNA to loop out of the nuclei (Cai and Kohwi-Shigematsu, 1999; 
Kramer and Krawetz, 1996). This resulted in the formation of histone-depleted halo 
structures consisting of extruded ‘loop’ DNA. Within the residual nucleus, the DNA is 
anchored  to  the  nuclear  matrix  through  MARs  (Gerdes  et  al.,  1994;  Kramer  and 
Krawetz, 1996). After digesting these structures with restriction enzymes, sedimentation 
was used to separate the MARs from the halo DNA (Ostermeier et al., 2003). 
 
To allow the full extraction of soluble proteins from nuclei and obtain reproducible 
results, the time of incubation with 2 M NaCl had to be optimised. The optimal time, 
defined as the minimum incubation time required to reach the maximum halo size, was 
previously  shown  to  vary  according  to  the  cell  type  (Martins  and  Krawetz,  2007; 
Ostermeier et al., 2003).  
 
Nuclear preparations were made from MRC5 cells, placed onto microscope slides and 
incubated in 2 M NaCl for varying times ranging from 0 to 15 min. The nuclei were 
then stained with DAPI and visualised under a Zeiss Axiophot microscope equipped for 
epifluorescence. The average size of the halo structures was determined by measuring 
the distance between the perimeter of the halo and the edge of the residual nuclear 
border of 30 cells in 3 biologically independent experiments. The optimal incubation 
time for MRC5 nuclei was found to be 12 min as this produced the largest circular halo 
structures (Fig 4.1, Fig 4.2). The nuclei not incubated with 2 M NaCl, which were used 
as negative controls, did not form halo structures. Incubation times shorter than the 
optimal  time  restricted  the  extraction  of  soluble  nuclear  proteins  and  led  to  the 
formation of small circular nuclear halo structures. Incubation times longer than optimal 
generated halo structures of highly variable shapes and sizes. 
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Figure 4.1 Relationship between halo size and incubation time of MRC5 nuclei 
with 2 M NaCl.  
The size of halo structures at each time point was determined by averaging the distance 
of the perimeter of the halo structure from the edge of the residual nuclear border in 30 
nuclei. An increase in halo size between 0 and 12 min of incubation time is followed by 
a  slight  decrease  at  15  min.  The  optimal  incubation  time,  defined  as  the  minimum 
incubation time producing the largest circular halo structures, was 12 min. Boxplots 
show the interquartile range of the data, with the horizontal black lines running through 
each  boxplot  representing  the  median  values  of  three  independent  biological 
experiments. The whiskers extend as far as 1.5 times the interquartile range. 
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Figure 4.2 Visualisation of nuclear halo structures in nuclei of MRC5 cells.  
DAPI-stained nuclei after different incubation times in 2 M NaCl (time shown for each 
panel). a) Halo structures were not seen in untreated nuclei. b) Incubation of nuclei with 
2 M NaCl for times shorter than optimal generated circular halo structures with a width 
ranging from 0 to 5 µm. c) The optimal incubation time formed circular halo structures 
with a width ranging from 2 to 7 µm. d) Incubations longer than the optimal time 
produced halo structures of highly variable shapes, with widths ranging from 0.5 to 6.5 
µm. The scale bar is 20 µm. 
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Following optimal extraction of nuclei with 2 M NaCl, EcoRI and HindIII restriction 
enzymes were added to the extracted nuclei to digest the DNA into short fragments of 
approximately  1.5-2.5  kb.  MARs  were  protected  from  digestion  by  their  strong 
interaction  with  nuclear  matrix  proteins  and  were  selectively  retained  in  nuclear 
matrices, enabling their separation from the dissociated halo DNA. After isolating these 
two fractions by high-speed centrifugation, their DNA was purified and quantified. The 
biochemical isolation of MARs was performed five times starting from different MRC5 
populations to obtain five independent biological replicates. In all samples, more than 
70% of the DNA was found to be in the halo fraction (Table 4.1). 
 
 
 
 
 
Table 4.1 Percentage of DNA in the MAR and halo fractions of MRC5 samples. 
Over 70% of the DNA was consistently found in the halo fraction, assuming 100% 
when the MAR and halo fractions were combined. 
 
 
 
To  confirm  that  the  isolation  procedure  was  performed  accurately  and  consistently, 
quantitative real-time PCR was performed using the purified MAR and halo fractions to 
interrogate previously characterised MARs and non-MARs sequences. Each amplicon 
was quantified using standard curves produced for each primer pair from real-time PCR 
reactions  with  known  amounts  of  genomic  DNA.  To  compare  the  quantity  of  each 
amplicon in the MAR and the halo fractions, PCR reactions were carried out with equal 
 6 min 
15 min 
 6 min 
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amounts  of  template  and  equal  amounts  of  master-mix.  For  each  amplicon,  PCR 
reactions were performed at the same time using the same cycling conditions. 
 
The amplicons PRM2 and F, which map to intragenic regions of the protamine 2 and 
the  δ-globin  gene  respectively,  were  used  as  non-MAR  controls  since  they  are 
sequences consistently enriched in the halo fraction of several somatic cells (Kramer 
and  Krawetz,  1996;  Kramer  and  Krawetz,  1997;  Ostermeier  et  al.,  2003).  The 
amplicons HS3 and rep30, which are located within the β-globin LCR and upstream of 
the γ-globin gene respectively, were used as controls for MARs since they are well 
characterised  in  human  fibroblasts  (Ostermeier  et  al.,  2003).  The  results  show 
significant enrichment of PRM2 and F in the halo fractions and of HS3 and rep30 in the 
MAR  fractions  (Fig  4.3).  The  proportion  of  each  amplicon  in  the  MAR  and  halo 
fractions was calculated by assuming 100% when the average of the MAR and halo 
fractions were combined. The MAR fractions contained 75% and 72% of the HS3 and 
rep30 amplicons, respectively, while the halo fractions contained 81% and 83% of the 
PRM2 and F amplicons, respectively. These findings indicate that the isolation of MAR 
and halo fractions was consistent, and therefore, these samples could be used for further 
analysis. 
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Figure  4.3  Enrichment  of  MAR  and  non-MAR  amplicons  in  MAR  and  halo 
fractions of MRC5 cells.  
Quantitative real-time PCR was performed using matrix and halo DNA samples from 
five biologically independent experiments and primer pairs spanning known MAR (HS3 
and rep30) and non-MAR (PRM2 and F) sequences. Bars represent the mean of five 
experiments, and show the standard deviation. 
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4.2.2  Hybridisation of matrix attachment regions and halo DNA onto MHC 
tiling path arrays 
 
A procedure combining the traditional biochemical isolation of matrix attached DNA 
with microarray technology was then used to identify MARs across the MHC of MRC5 
cells. Equal amounts of MAR and halo DNA from each sample were differentially 
labelled  by  random  priming  with  Cy-5  and  Cy-3  fluorophores  and  competitively 
hybridised  onto  the  genomic  MHC  tiling  path  array.  The  labelled  DNA  fragments 
identified the sequences corresponding to MAR and halo DNA in the MHC by binding 
to matching sequences on the array.  
 
Array hybridisations were carried out with MAR and halo DNA from samples 1 and 2. 
Both experiments included a dye swap to correct the bias introduced by the different 
properties of the fluorescent dyes. The relative intensity of the fluorescent dyes across 
each locus was calculated and log2 transformed. Each locus was represented four times 
in the MHC platform. Since two experiments were performed, a total of eight data 
points were obtained for each locus. Subsequently, the combined mean values for each 
locus  were  calculated  and  plotted  on  the  UCSC  human  genome  database 
(http://genome.ucsc.edu, May 2004 Assembly) (Fig 4.4). 
 
The graphical representation of the results indicates that MAR and halo DNA sequences 
are not evenly distributed across the MHC of MRC5 cells. The class I region contains 
approximately  equal  amounts  of  MAR  and  halo  DNA,  the  class  II  region  contains 
mainly MAR DNA, and the class III and the extended class II regions consist mainly of 
halo DNA. The overwhelming majority of MAR DNA is contained across the classical 
class I and II regions. Visual examination of the results suggests that the halo DNA has 
a high GC content and is enriched in gene-dense and conserved regions while MARs 
correlate positively with high AT content and gene-poor regions. 
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Figure 4.4 Competitive hybridisation of differentially labelled MAR and halo DNA 
fractions on MHC tiling path arrays.  
MAR  and  halo  DNA  fractions  were  differentially  labelled  with  Cy3  and  Cy5 
fluorophores  and  competitively  hybridised  onto  the  MHC  microarray  platform.  The 
log2  ratios  of  MAR/halo  DNA  were  calculated  and  plotted  on  the  UCSC  genome 
database  (http://genome.ucsc.edu/).  Positive  values  represent  MARs  while  negative 
values represent halo DNA (mean ratios of two independent experiments). The GC 
content, positions of RefSeq genes  and human  mRNAs from GeneBank, regions of 
conservation between 17 vertebrate species and the repetitive sequences LINE, SINE 
and LTR across the MHC are shown below the array data. The different regions of the 
MHC are highlighted in different colours: classical class I – red; classical class III – 
blue; classical class II – yellow; and extended class II – green.   110 
4.2.3  Quantitative  real-time  PCR  analysis  of  matrix  attachment  regions 
and halo DNA 
 
In order to validate the array results, twenty regions across the MHC were subjected to 
independent  quantitative  real-time  PCR  using  MAR  and  halo  DNA  fractions  from 
samples  3,  4  and  5.  Eight  regions  were  enriched  in  halo  DNA,  according  to  the 
microarray data, while the remaining twelve were MAR-enriched. These test regions 
were selected within or near genes critical for the functioning of the immune system, 
genes not directly involved in immunity, as well as boundaries separating the MHC 
classes.  
 
The eight regions enriched in the halo DNA according to the microarray data were 
situated within HLA-G, HLA-DRB5, HLA-C, TAP1, HLA-E, LY6G5C, HLA-DRA and 
upstream of TRIM15. Real-time PCR confirmed high enrichment in the halo fraction for 
the  regions  overlapping  HLA-G,  HLA-DRB5,  HLA-C,  TAP1,  HLA-E,  LY6G5C,  and 
upstream of TRIM39 and no significant enrichment in the halo fraction for the region 
overlapping HLA-DRA (Fig 4.5). These regions had array ratios equal to or lower than -
0.003 (log2). 
 
Of the twelve regions enriched in the MAR fraction according to the microarray data, 
eight  were  successfully  validated  with  quantitative  real-time  PCR  (Fig  4.6).  These 
regions,  which  were  located  upstream  of  NOTCH4,  HLA-C,  ZBTB2  and  HLA-A, 
downstream of HLA-DOB, PRRT1 and HLA-DPB1, and overlapping TRIM15, had array 
ratios  equal  to  or  higher  than  0.52 (log2).  The remaining  four  regions,  upstream  of 
C6orf10,  HLA-B,  MICA  and  HLA-F,  were  not validated  since  HLA-B,  C6orf10  and 
MICA were highly enriched in the halo fraction and HLA-F showed low enrichment in 
the halo fraction according to real-time PCR (Fig 4.7). These regions had array ratios 
equal to or lower than 0.32 (log2). 
 
Further  analysis  of  these  results  revealed  a  relationship  between  high  array  ratios 
indicating enrichment in the  MAR fraction and  successful real-time PCR validation 
(Table  4.2).  In  order  to  exclude  false  positive  MARs,  a  threshold  was  empirically 
determined using a series of real-time PCR as described in Chapter 2. MHC regions 
having array enrichments equal to or higher than 0.4 (log2) were defined as MARs since 
they  were  consistently  confirmed  with  real-time  PCR.  MHC  regions  having  array   111 
enrichments lower than 0.4 (log2) were defined as non-MARs as real-time PCR showed 
that they were either not significantly MAR-enriched or halo-enriched. 
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Figure  4.5  Quantitative  real-time  PCR  analysis  of  halo-enriched  loci  in  MRC5 
cells.  
Real-time  PCR  was  carried  out  with  primer  pairs  spanning  eight  loci,  which  were 
enriched in the halo fraction according to the results of array experiments. The loci 
HLA-G,  HLA-DRB5,  HLA-C,  TAP1,  HLA-E,  LY6G5C  and  the  upstream  region  of 
TRIM39 were confirmed to be highly enriched in the halo fraction while significant 
enrichment in the halo fraction was not confirmed for the amplicon overlapping HLA-
DRA. Bars represent the mean of three biologically independent experiments, and show 
the standard deviation.   113 
 
 
Figure  4.6  Quantitative  real-time  PCR  analysis  of  loci  showing  high  MAR 
enrichment in MRC5 cells. 
Real-time PCR was carried out with primers pair spanning eight loci, which were found 
to  be  highly  enriched  in  the  MAR  fraction  in  the  array  experiments.  The  regions 
upstream of NOTCH4, HLA-C, ZBTB12, HLA-A, downstream of HLA-DOB, PRRT1, 
HLA-DPB1 and overlapping TRIM15 were confirmed to be highly enriched in the MAR 
fraction. Bars represent the mean of three biologically independent experiments, and 
show the standard deviation.   114 
 
 
 
Figure  4.7  Quantitative  real-time  PCR  analysis  of  loci  showing  low  MAR 
enrichment in MRC5 cells.  
Real-time PCR was carried out with primer pairs spanning within regions of low MAR 
enrichment according to the array data. The regions upstream of HLA-B, MICA and 
C6orf10 were confirmed to be highly enriched in the halo fraction while significant 
enrichment in either the halo or MAR fraction was not observed for the region upstream 
of HLA-F. Bars represent the mean of three biologically independent experiments, and 
show the standard deviation. 
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Number  MHC region  Array 
enrichment  value 
(log2) 
Expected 
enrichment  based 
on array data 
Observed 
enrichment  by 
real-time PCR 
1  HLA-A  1.606  MAR  MAR 
2  TRIM15  1.104  MAR  MAR 
3  HLA-DPB1  1.008  MAR  MAR 
4  PRRT1  0.702  MAR  MAR 
5  NOTCH4  0.625  MAR  MAR 
6  ZBTB2  0.575  MAR  MAR 
7  HLA-C  0.522  MAR  MAR 
8  HLA-DOB  0.501  MAR  MAR 
9  MICA  0.326  MAR  Halo 
10  HLA-B  0.29  MAR  Halo 
11  C6orf10  0.118  MAR  Halo 
12  HLA-F  0.105  MAR  No enrichment 
13  HLA-DRB5  -0.003  Halo  Halo 
14  TRIM39  -0.1  Halo  Halo 
15  TAP1  -0.102  Halo  Halo 
16  HLA-E  -0.189  Halo  Halo 
17  HLA-DRA  -0.201  Halo  No enrichment 
18  HLA-C  -0.202  Halo  Halo 
19  HLA-G  -0.27  Halo  Halo 
20  LY6G5C  -0.301  Halo  Halo 
 
Table 4.2 Loci analysed by real-time PCR.  
(1-8) Regions enriched in the MAR fraction based on the array data and successfully 
validated with real-time PCR have array ratios ranging from 0.501 to 1.606 (log2). (9-
12) Regions enriched in the MAR fraction based on the array data but not able to be 
validated with real-time PCR have array ratios ranging from 0.326 to 0.105 (log2). (12-
20) Regions enriched in the halo fraction according to the array data and successfully 
validated with real-time PCR have array ratios ranging from -0.003 to -0.301 (log2). The 
HLA-DRA and HLA-F regions were not found to be enriched in either the MAR or 
halo fractions by real-time PCR.   116 
4.2.4  Position  of  matrix  attachment  regions  across  the  MHC  of  MRC5 
fibroblasts 
 
To  gain  a  better  insight  into  the  distribution  of  MARs  relative  to  structural  and 
functional characteristics of the MHC locus, a detailed map was constructed for MRC5 
cells using the array threshold of 0.4 (log2) (Fig 4.8).   
 
The graphical representation of the results confirms several trends observed earlier by 
plotting MAR and halo DNA. MARs are not evenly distributed across the MHC and are 
largely positioned within poorly conserved regions. The largest clusters of MARs are 
found within the class I and II regions, while the longest DNA regions lacking MARs 
are located in the class III and extended class II of the MHC suggesting that MAR 
position and gene density across the MHC are inversely correlated, as found in AoAF 
fibroblasts and the HeLa cell line (Linnemann, A. K., personal communication).  
 
Using  the  criteria  described  above,  MARs  were  identified  on  average  every  33  kb, 
consistent with a study on the 16q22 locus in HeLa cells (Shaposhnikov et al., 2007). A 
total of 117 MARs were identified across the MHC and subdivided as follows: 64 in the 
class I, 5 in the class III, 43 in the class II and 5 in the extended class II regions of the 
MHC. The class I, III, II and extended class II regions have, on average, one MAR per 
29, 144, 20 and 72 kb, respectively.  
 
Of the 117 MARs detected, 97 are intergenic whereas 19 are intragenic. Using a chi-
squared test, it was found that the bias of MARs to intergenic regions was statistically 
significant (p-value <0.0002; for all statistics a threshold p-value <0.01 was considered 
significant). Of these, 5 are within introns, 10 overlap introns and exons and 4 map to 
regions overlapping introns, exons and intergenic DNA (Table 4.3). Due to technical 
limitations including array resolution and the size of the DNA fragments generated by 
the  biochemical  isolation  procedure,  it  was  not  possible  to  map  these  MARs  more 
precisely. 
 
In this study, MARs are identified at the boundaries of the MHC class III and class II 
regions and the MHC class II and extended class II regions, and 30 kb away from the 
boundary of the MHC class I and class III regions (Fig 4.9). MARs have also been 
identified  in  regions  flanking  several  genes  that  have  critical  roles  in  the  adaptive   117 
immune  response  such  as  HLA-A,  HLA-C,  HLA-E,  HLA-G,  HLA-DRA,  HLA-DRB1, 
HLA-DRB5, HLA-DPA1, HLA-DPB1, HLA-DQA1 and HLA-DQB1 (Fig 4.10) (van den 
Elsen et al., 1998). These findings are consistent with previous studies showing that 
MARs can function as boundary elements (McKnight et al., 1992; Namciu et al., 1998). 
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Figure 4.8 MAR profile of MRC5 fibroblasts across the MHC.  
The  mean  value  for  two  array  hybridisations  was  calculated  for  each  fragment 
represented in the MHC tiling path array. Regions enriched in the MAR fraction with 
mean  ratios  equal  to  or  higher  than  0.4  (log2)  were  plotted  on  the  UCSC  genome 
browser  (http://genome.ucsc.edu/)  and  represented  on  the  top  row  by  black  vertical 
lines. Below the array data are shown the GC content, the positions of RefSeq genes 
and human mRNAs from GeneBank, regions of conservation between 17 vertebrate 
species and the repetitive sequences LINE, SINE and LTR. The different regions of the 
MHC are highlighted in different colours: classical class I – red; classical class III – 
blue; classical class II – yellow; and extended class II – green.   119 
MAR position (bp)  Gene  Organisation 
29802604-29804427  HLA-F  1 Exon/1 Intron/Intergenic region 
30146157-30148833  RNF39  1-2 Exons/1-2 Introns 
30231506-30234359  TRIM10  4 Exons/3 Introns 
30238940-30240972  TRIM15  1 Exon/1 Intron 
30698815-30701782  MRPS18B  2 Exons/2 Introns 
30731648-30734384  DHX16  4 Exons/5 Introns 
31865033-31867206  VARS  1 Intron 
31955316-31957399  EHMT2  3 Exons/3 Introns/Intergenic region 
32387922-32390488  C6ORF10  1 Intron 
32390209-32393140  C6ORF10  1 Intron 
32395956 32398655  C6ORF10  1 Exon/2 Introns 
32425489-32427795  C6ORF10  1 Exon/1 Intron 
32434975-32437634  C6ORF10  1 Intron 
32471036-32473567  BTNL2  1 Exon/2 Introns 
32904298-32906120  TAP2  3-4 Exons/3 Introns 
32931156-32933975  PMSB9  4 Exons/3 Introns 
33027231-33028946  HLA-DMA  1 Exon/1 Intron/Intergenic Region 
33283836-33286387  RING1  4 Exons/4 Introns/Intergenic Region 
33501985-33503886  SYNGAP1  1 Intron 
 
Table 4.3 Base pair (bp) position, gene name and DNA organisation of intragenic 
MARs across the MHC in MRC5 cells.  
Out of a total of 19 MARs, 5 are situated within individual introns, 10 are located 
within regions containing introns and exons and 4 MARs map to regions containing 
introns, exons and intergenic DNA.  
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Figure 4.9 Distribution of MARs at MHC class boundaries.  
The boundaries separating the MHC into different sub-regions are highlighted in grey. 
(A) The nearest MAR to the boundary separating class I from class III is approximately 
30 kb away from it. (B-C) The boundaries separating class III from class II and class II 
from extended class II contain 3 and 5 MARs, respectively.  
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Figure 4.10 Schematic representation of MARs flanking class I and II genes in 
MRC5 cells.  
MARs are represented by vertical black bars. (a-d) Class I genes HLA-A, HLA-C, HLA-
E and HLA-G. (e-i) Class II genes HLA-DRB5, HLA-DRA, HLA-DRB1, HLA-DQA1, 
HLA-DQB1, HLA-DPA1 and HLA-DPB1. 
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4.2.5  Sequence analysis of matrix attachment regions 
 
Several  genomic  features  including  conservation,  AT  content,  gene  and  repetitive 
sequences density of MAR and non-MARs within the MHC were analysed using public 
databases  and  the  sequence  analysis  tools  provided  by  the  UCSC  Genome  Project 
(http://genome.ucsc.edu/). 
 
The AT content of the MARs ranged from 39 to 67% with an average value of 58% 
while that of the non-MARs ranged from 32 to 72% with an average value of 53% 
confirming the previous reports that MARs are generally AT-rich DNA sequences (Fig 
4.11a) (Purbowasito et al., 2004; Shaposhnikov et al., 2007). Using a χ
2 test, we found 
that  the  difference  in  AT  content  between  MAR  and  non-MAR  sequences  was 
statistically significant (P-value of 0). Comparative analysis of AT-rich tracts in MARs 
failed to reveal a precise organisation of AT motifs. 
 
The proportion of intragenic sequences is under-represented by almost twofold among 
MARs relative to non-MARs (P-value < 0.0002) (Fig 4.11b). This is consistent with the 
graphical evaluation of the results showing that most MARs identified within the MHC 
are  intergenic  and  are  positioned  in  relatively  gene-poor  regions,  while  non-MARs 
extend intragenically and contain most gene-rich regions. 
 
According  to  multiple  whole-genome  alignments  of  17  vertebrates  including 
mammalian, amphibian, bird, and fish species,  non-MARs  are more conserved than 
MARs  (P-value  <  0.008). These  findings  agree with other studies showing that the 
primary sequence of MARs is not conserved across species despite the fact that their 
functions are evolutionary conserved (Fig 4.11c) (Glazko et al., 2003). 
 
The average content of repetitive sequences of MARs is 63%, while that of non-MARs 
is 45% (P-value of 0) (Fig 4.12a). A detailed analysis of different classes of repetitive 
sequences revealed that MAR and non-MAR DNA sequences do not differ significantly 
in relation to LTR content (P-value of 1) (Fig 4.12b), that non-MARs have a larger 
proportion of SINEs compared to MARs (P-value < 0.006) (Fig 4.12c), and that LINEs 
are  over-represented  by  almost  three-fold  among  MARs  relative  to  their  overall 
abundance in non-MARs (P-value < 0.002) (Fig 4.12d).   123 
 
Figure 4.11 Sequence analysis of MARs and non-MARs in relation to different 
genomic features.  
a) The AT content (P-value of 0) b) the proportion of coding region (P-value < 0.0002) 
c) and the degree of conservation were calculated for MARs and non-MARs sequences 
(P-value  <  0.008).  The  conservation  score  was  used  as  a  measure  of  evolutionary 
conservation and was calculated using the conservation track of the UCSC Genome 
Project  (http://genome.ucsc.edu/),  which  describes  the  multiple  alignment  of  17 
vertebrate species. The bars represent the mean values of two biologically independent 
experiments and show the standard deviation. 
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Figure 4.12 Sequence analysis of MARs and non-MARs in relation to different 
classes of repetitive sequences.  
a) The average repetitive content (P-value of 1), b) the LTR (P-value of 1), c) the SINE 
(P-value < 0.006) and d) the LINE abundance were calculated for MARs and non-
MARs  (P-value  <  0.002).  The  bars  represent  the  mean  values  of  two  biologically 
independent experiments and show the standard deviation.   
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4.2.6  Comparison  between  matrix  attachment  regions  identified 
experimentally and in silico 
 
Several computer programmes have been developed to predict the positions of MARs. 
Each of these recognises a unique set of motifs associated with MARs. SIDD identifies 
regions with a tendency for base-unpairing (Benham et al., 1997). MARScan identifies 
a bipartite sequence common to a large number of eukaryotic MARs (van Drunen et al., 
1999). ChrClass identifies sequences that associate with different components of the 
nuclear  matrix  including  lamins  A,  B  and  C  (Glazko  et  al.,  2001).  Here,  the 
performance of these, SIDD, MARScan and ChrClass, was assessed by comparing in 
silico predictions with the experimental data. 
 
The three programmes predicted different numbers of MARs for the MHC ranging from 
187  to  617.  The  total  number  of  predicted  MARs  matching  (true  positives)  or  not 
matching (false positives) the experimentally defined MARs in MRC5 fibroblasts is 
shown in Table 4.4. As expected for such heterogeneous sequences the number of false 
positives is high. ChrClass predicted most true  and false positives while  MARScan 
predicted the fewest.  
 
The  accuracy  of  each  computer  programme  is  also  expressed  using  specificity  and 
sensitivity scores (Table 4.4). The specificity is defined by the formula: (number of true 
positives)/(total number of predictions) while the sensitivity is defined by the formula: 
(number of true positives)/(total number of expected MARs). The highest sensitivity 
was shown by ChrClass and the lowest by MARScan. A low specificity was found for 
all three programmes. Overall the programme with the best performance in terms of 
sensitivity and specificity was ChrClass. 
 
Of the 117 predicted experimentally identified MARs, 18 were not predicted by any of 
the  three  programmes,  suggesting  that  additional  features  should  be  considered  to 
develop more accurate MAR prediction programmes.  
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  ChrClass  SIDD  MARScan 
Total Predicted  617  543  187 
True Positive  97  63  27 
False Positive  520  480  160 
False Negative  27  61  97 
Specificity  0.16  0.12  0.14 
Sensitivity  0.83  0.54  0.23 
 
Table 4.4 Comparison between different MAR predicting algorithms.  
True  positives  are  predictions  coinciding  with  the  experimentally  defined  MARs  in 
MRC5  fibroblasts.  False  positives  are  predictions  that  do  not  coincide  with 
experimentally  identified  MARs.  False  negatives  are  the  experimentally  identified 
MARs that are not predicted by each programme. The specificity is given by the total 
number  of  true  positives  divided  by  total  number  of  predictions.  The  sensitivity  is 
determined  by  the  number  of  true  positives  divided  by  the  total  number  of 
experimentally identified MARs. 
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4.3   Discussion 
 
In this chapter, MARs were identified across the MHC in human MRC5 fibroblasts 
using  MHC  tiling  path  arrays.  The  key  finding  is  that  MARs  are  non-randomly 
distributed across the MHC as they cluster at specific locations. Although a unique 
sequence consensus was not identified, the sequence context of MARs was defined. 
MARs reside within DNA regions of high AT and repetitive sequences content and low 
gene density. Most of the MARs identified are situated within intergenic domains of the 
MHC  class  I  and  II  regions,  closely  flanking  several  genes  that  are  critical  for 
immunity, as well as at the boundaries of the MHC sub-regions. This suggests that the 
folding of the MHC might contribute to transcriptional regulation by defining distinct 
chromatin domains. 
 
The 117 MARs identified in the MHC divide the locus into loop domains averaging 35 
kb in size. This is similar to the 36 kb loop size estimated for human chromosome band 
16q22.1, but smaller than the 50-200 kb predicted by the ‘multi-loop sub-compartment 
model’  which  appears  to  be  the  model  most  compatible  with  recent  experimental 
findings (Munkel et al., 1999; Ottaviani et al., 2008b; Shaposhnikov et al., 2007). It is 
important to note that the frequency of MARs has been shown to vary greatly across the 
human genome. For example, telomeres have one MAR per kb, while the 19q13.12 
band  has  one  MAR  every  88  kb  (Chernov  et  al.,  2002;  Luderus  et  al.,  1996).  A 
substantial variation in MAR density is present between the MHC sub-regions. More 
than 90% of the MARs identified are in the class I and II regions, which have loop sizes 
averaging  37  kb  and  18  kb  respectively.  The  MHC  class  III  and  extended  class  II 
regions contain less than 10% of the MARs and have larger loop sizes of 147 kb and 72 
kb, respectively.  
 
The  class  I  and  II  regions  are  characterised  by  a  higher  AT  content  and  repetitive 
sequences, lower gene density and lower overall conservation compared to the class III 
and  extended  class  II  regions.  Computer-assisted  analysis  was  used  to  define  the 
characteristics of MAR sequences. A positive correlation was found between MARs 
and  LINEs.  This  finding  is  in  agreement  with  a  study  of  experimentally  identified 
sequences  collected  in  the  MAR  transaction  database 
(http://transfac.gbf.de/SMARtDB/) (Jordan et al., 2003). The study revealed that LINEs 
are over-represented by more than twofold in human MARs relative to their overall   128 
density in the human genome (Jordan et al., 2003). Analysis of the 1 Mb imprinted 
domain  on  mouse  chromosome  7  also  showed  a  similar  LINE  enrichment  in  MAR 
sequences (Purbowasito et al., 2004). Another positive correlation was found between 
MARs and high AT content. The AT content of MAR sequences ranged from 39% to 
67% with an average of 58%, which is higher than that of surrounding regions, which is 
53%. This is compatible with studies in mice and humans, which showed that the AT 
content  of  MARs  is  often  only  slightly  higher  than  that  of  their  whole  genomes 
(Purbowasito et al., 2004; Shaposhnikov et al., 2007). One of the best-characterised 
MARs, located in the FRA1B fragile site of CEM leukaemic cells, is almost entirely 
constituted  of  AT-rich  minisatellites  that  appear  to  strengthen  its  attachment  to  the 
nuclear matrix (Jackson et al., 2003). Nevertheless, a large body of evidence suggests 
that high AT content alone is not sufficient to ensure binding to the nuclear matrix 
(Bickmore and Oghene, 1996; Das et al., 1993; von Kries, 1991). 
 
In this chapter, the relationship between MAR sequences and other genomic features 
including gene density, coding or non-coding DNA and evolutionary conservation were 
examined.  There  is  a  negative  correlation  between  MARs  and  gene  density.  This 
relationship is most clearly seen in the classical class III region, which has the highest 
gene density in the whole genome and the lowest MAR frequency among the MHC sub-
regions.  Similar  results  were  observed  by  a  recent  study  analysing  MARs  in 
chromosome  16  in  AoAf  and  HeLa  cells,  suggesting  that  gene-rich  regions  are 
generally  less  topologically  constrained  than  gene-poor  regions  (Linnemann  et  al., 
2008). My findings show that MARs are frequently located within intergenic sequences.  
 
Clusters of MARs were mapped near the boundaries separating the MHC sub-regions 
and flanking a significant number of classical class I and II genes including HLA-F, 
HLA-G, HLA-C and HLA-DRA. This indicates that the interaction between the nuclear 
matrix and MARs could define chromatin domains, in agreement with several reports 
suggesting  that  MARs  could  function  as  boundary  elements  by  topologically 
constraining  the  DNA  into  loops  or  by  forming  a  physical  barrier  that  blocks 
interactions  between  promoters  and  unrelated  enhancers  (Dunn  et  al.,  2003; 
Nabirochkin et al., 1998).  
 
Sequence analysis of MAR sequences did not identify a unique MAR consensus and 
showed a negative correlation between  MARs and evolutionary conserved domains.   129 
However,  studies  in  eukaryotic  organisms  ranging  from  plants  to  mammals,  clearly 
show  that  the  tethering  function  of  MARs  is  conserved  across  different  species 
(Eivazova et al., 2007; Ioudinkova et al., 2005; Michalowski et al., 1999; Ostermeier et 
al., 2003). These findings reinforce the view that the interactions of MARs with the 
nuclear  matrix  is  likely  to  depend  on  DNA  sequence  contexts  generating  distinct 
structures rather than on a primary sequence consensus. 
 
The positions of the experimentally identified MARs in the MHC were compared to 
those predicted by three different MAR prediction programs, namely ChrClass, SIDD 
and MARScan. The general conclusion is that while ChrClass showed high sensitivity, 
outperforming  SIDD  and  MARScan,  and  might  be  considered  as  valuable  tool  for 
genome-wide studies, each of these computer programs showed reduced specificity. 
Hence, the identification of an increasing number of MAR sequences will be essential 
to develop more accurate MAR prediction algorithms.  
 
The MHC tiling path array was used successfully to identify MARs across the entire 
MHC locus. However, a disadvantage is that MARs are 100-2000 bp and the 2 kb 
resolution of the arrays is not sufficient to define their sequence at the base pair level. A 
limitation of the data analysis strategy is that the stringent threshold used to define 
MARs might have led to an under-representation of the number of MARs across the 
MHC. The threshold of array enrichment to define MARs was set at approximately 4 
standard  deviations  of  the  mean  on  the  basis  of  real-time  PCR  reactions  that  were 
carried out to validate the array data. Values of enrichment below such a threshold 
could not be consistently validated with real-time PCR. One reasonable assumption 
might be that the low enrichment of several clones of the MHC tiling path arrays could 
represent  background  signal  due  to  hybridisation  of  non-specific  DNA  sequences. 
Using  the  relatively  stringent  threshold  of  4  standard  deviations,  the  rate  of  false 
positives was estimated from the real-time PCR results to approach 0% but the rate of 
false negatives was predicted to be approximately 2%. 
 
Not  all  previous  investigations  agree  with  our  findings.  For  example,  the  study  by 
Shaposhnikov et al. (2007) showed that 98% of the MARs identified in band 16q22.1 in 
HeLa S3 cells are localised within genes (Shaposhnikov et al., 2007). This contrasts 
with our findings indicating that more than 80% of the MARs in the MHC are situated 
outside genes. The same group mapped MARs within the 19q13.12 region and found   130 
that only approximately half of the MARs were situated within genes (Chernov et al., 
2002). Here, the differences in MAR distribution observed in several loci are probably 
not due to the different methodologies used to identify MARs but are likely to reflect 
the  distinct  spatial  organisation  of  different  regions  of  the  genome.  Given  the 
heterogeneity  of  the  human  genome  it  is  reasonable  to  expect  the  data  to  differ 
substantially.  
 
Inconsistencies between different studies could also due to the cell or tissue types used, 
or due to the replication and transcription status of a given genomic domain (Heng et 
al., 2004; Ostermeier et al., 2003). Several studies, including one characterising SATB1, 
have shown that MARs can bind to cell type specific matrix proteins suggesting that a 
proportion  of  MARs  are  cell  type  specific  (Cai  et  al.,  2006).  Other  studies  have 
indicated  that  the  binding  of  certain  MARs  to  the  nuclear  matrix  correlates  with 
transcription or replication of the loci with which they are associated (Anachkova et al., 
2005; Eivazova et al., 2007; Heng et al., 2004). The type of procedure used to isolate 
MARs might also be responsible for inconsistencies. A comparison of different matrix 
extraction procedures showed that 2 M NaCl led to the isolation of several MARs that 
differed from those isolated using 25 mM LIS and 0.65 M ammonium sulphate (Donev, 
2000). 
 
In  conclusion,  I  have  identified  MARs  across  the  MHC  region  of  human  MRC5 
fibroblasts. This is the first study to map MARs within a 4 Mb locus at a relatively high 
resolution.  The  frequency  and  distribution  of  the  MARs  as  well  as  their  sequence 
composition  were  determined.  Such  important  insights  will  help  to  elucidate  the 
relationship between DNA folding and genomic function. 
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5  Genomic anchors in PGF B lymphoblastoid cells and IFN-
γ induced MRC5 fibroblasts 
 
5.1   Introduction 
 
The  relationship  between  nuclear  organisation,  chromatin  architecture  and  gene 
expression is not well understood. Several studies indicate that transcription of certain 
loci can be modulated by their re-positioning within the nucleus and by interactions 
with loci on different chromosomes (Kioussis, 2005; Reddy et al., 2008; Spilianakis et 
al., 2005). In addition, certain gene clusters and gene-rich regions have been found to 
loop out of their CT upon transcriptional up-regulation (Chambeyron and Bickmore, 
2004; Volpi et al., 2000; Williams et al., 2002). These studies raise the hypothesis that 
the  movement  of  chromatin  toward  distinct  nuclear  microdomains  could  promote 
transcription and facilitate the co-regulation of functionally related genes (Kumaran et 
al., 2008). In order to test this hypothesis, it is critical to characterise the proteins and 
the DNA sequences that are involved in the re-organisation of chromatin. 
 
The identification of components of the nuclear matrix such as the SATB1 transcription 
factor, RNA and DNA polymerases suggests that transcription and replication occur at 
the nuclear matrix (Ottaviani et al., 2008b). Nuclear myosin, which is found in the 
nuclear  matrix,  has  been  found  to  mediate  long-range  chromosome  movements  at 
interphase (Chuang et al., 2006). Topoisomerase II, a major component of the nuclear 
matrix, is able to promote the re-structuring of chromatin (Adachi et al., 1989). The 
nuclear  matrix  thus  not  only  provides  the  structural  scaffold  where  key  nuclear 
processes are organised, but also may be a major player in chromatin movement. 
 
MARs organise the DNA into loops or folds by mediating the interaction of chromatin 
with the nuclear matrix. The constitutive association of MARs with the nuclear matrix 
has been proposed to maintain the integrity of higher-order chromosome architecture 
(Ottaviani et al., 2008b). The more dynamic transient associations are instead dependent 
on whether a genomic region is being transcribed or replicated (Heng et al., 2004). 
Since only a few MARs have been characterised, their role in genomic function and in 
the  context  of  large-scale  chromatin  organisation  gene  expression  has  yet  to  be   132 
established. Work on the murine Th2 cytokine locus has revealed that activation of gene 
expression is accompanied by a recruitment of MARs to the nuclear matrix (Cai et al., 
2006).  Another  investigation  showed  that  the  recruitment  of  MARs  to  the  nuclear 
matrix was required for gene repression (Alvarez et al., 2000). Additional small-scale 
studies have suggested that MARs can serve as landing platforms for a wide range of 
regulatory  proteins  including  chromatin  remodelling  enzymes,  splicing  factors, 
components of the transcriptional machinery and insulators (Cai et al., 2003; Donev et 
al., 2002; Dunn et al., 2003; Kim et al., 2007; Rajaiya et al., 2006). 
 
In order to gain a more comprehensive understanding of the DNA sequences regulating 
higher-order chromatin structure upon transcriptional regulation, MARs were mapped 
across  the  MHC  in  cells  exhibiting  different  levels  of  expression  and  large-scale 
chromatin organisation. The cell types used for this study were IFN-γ treated fibroblasts 
and B lymphoblastoid cells, as described previously (Christova et al., 2007; Volpi et al., 
2000), and the findings were compared to those in untreated fibroblasts (Chapter 4). 
Most genes in the MHC class I and III regions are expressed constitutively in all cell 
types (Boehm et al., 1997). In contrast, several MHC class II genes are constitutively 
expressed in IFN-γ induced fibroblasts and B lymphoblastoid cells while are repressed 
in untreated fibroblasts (Boehm et al., 1997; Rohn et al., 1996). 
 
In  this  chapter,  the  reconfiguration  of  MARs  upon  transcriptional  activation  is 
described. The mapping and comparison of MARs in the different cell types reveals that 
the uneven distribution of MARs across the MHC is generally maintained from cell to 
cell. MARs are predominantly located in intergenic regions and at or in close proximity 
to  the  MHC  class  boundaries,  thus  subdividing  the  locus  into  physical  domains. 
However, induction of transcription and extra-chromosomal looping are accompanied 
by  a  major recruitment  of  MARs  to  the  nuclear  matrix.  This recruitment  is  mainly 
adjacent to differentially expressed genes when they are activated, suggesting that the 
rearrangement of chromatin architecture is closely linked with the regulation of gene 
expression. 
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5.2   Results 
 
5.2.1  Biochemical  isolation  of  matrix  attachment  regions  from  PGF  and 
IFN-γ induced MRC5 cells 
 
The biochemical isolation of MARs in PGF and IFN-γ induced MRC5 cells was carried 
out as described in Chapter 4. The optimal incubation time with 2 M NaCl for IFN-γ 
induced MRC5 nuclei was found to be 12 min, as for uninduced MRC5 nuclei, while it 
was  9  min  for  PGF  nuclei  (Fig  5.1).  In  each  cell  type,  optimal  incubation  times 
produced the largest circular halo structures while incubation times longer than optimal 
produced halo structures of highly variable shapes. 
 
As for uninduced MRC5 cells, the biochemical isolation of MARs was performed 5 
times  for  each  cell  line  to  obtain  5  independent  biological  replicates.  Following 
separation of the MAR and halo fractions using restriction enzymes, more than 70% of 
the DNA was in the halo fraction of all samples (Table 5.1). 
 
The MAR controls, HS3 and rep30 and the non-MAR controls, PRM2 and F were 
interrogated by real-time PCR using the isolated MAR and halo fractions. In both cell 
types, HS3 and rep30 were found to be enriched in the MAR fraction while PRM2 and 
F were enriched in the halo fraction (Fig 5.2). In IFN-γ induced MRC5 cells, the MAR 
fractions contained 76% and 78% respectively of the HS3 and rep30 amplicons, while 
the halo fractions contained 82% and 84% respectively, of the PRM2 and F amplicons. 
In PGF cells, the MAR fractions contained 69% and 73% respectively of the HS3 and 
rep30 amplicons, while the halo fractions contained 69% and 84% respectively, of the 
PRM2 and F amplicons. These data show that the MAR and halo fractionations were 
carried out consistently in all the samples. 
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Figure 5.1 Optimisation of halo extraction time in IFN-γ induced MRC5 and PFG 
nuclei using 2 M NaCl.  
The size of halo structures at each time point was determined by averaging the distance 
of the perimeter of the halo from the edge of the nuclear matrix in 30 nuclei. The 
optimal incubation time, defined as the minimum incubation time producing the largest 
halo structures, was found to be 12 min for IFN-γ induced MRC5 nuclei and 9 min for 
PGF nuclei. Boxplots show the interquartile range of the data, with the horizontal black 
lines running through each boxplot representing the median values of three independent 
biological experiments. The whiskers extend as far as 1.5 times the interquartile range.   135 
 
 
Table 5.1 Proportion of DNA in the MAR and halo fractions of IFN-γ induced 
MRC5 and PFG cells.  
The majority of the DNA was consistently found in the halo fraction of IFN-γ induced 
MRC5 and PGF cells. These proportions were determined by quantifying the amount of 
DNA in the MAR and halo fractions of each sample and assuming 100% when both 
fractions were combined. 
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Figure  5.2  Enrichment  of  MAR  and  non-MAR  amplicons  in  MAR  and  halo 
fractions from IFN-γ induced MRC5 and PGF cells.  
Real-time  PCR  was  performed  using  matrix  and  halo  DNA  samples  from  five 
biologically independent experiments and primers spanning known  MARs (HS3 and 
rep30) and non-MARs (PRM2 and F). Bars represent the mean of five experiments with 
standard deviation. The MAR and non-MAR amplicons were enriched in the MAR and 
halo fractions respectively in samples from (a) IFN-γ induced MRC5 and (b) PGF cells. 
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5.2.2  Hybridisation of matrix attachment regions and halo DNA from  IFN-
γ induced MRC5 and PGF cells onto MHC tiling path arrays  
 
The MARs in the MHC of PGF and IFN-γ induced MRC5 cells were identified using 
the microarray approach described in the previous chapter. For each cell line two array 
hybridisations  were  carried  out  using  samples  1  and  2.  The  Pearson  Correlation 
Coefficient, which is common measure of correlation, was calculated between all arrays 
and found to be strongest between duplicates. 
 
The visual examination of the results shows that in PGF and IFN-γ induced MRC5 cells 
the MARs and halo DNA  are unevenly distributed across the  MHC (Fig 5.3). This 
distribution of MAR and halo DNA across the sub-regions of the MHC is remarkably 
similar to that observed in uninduced MRC5 cells (Chapter 4). In both cell lines the 
class II regions of the MHC is largely associated with the nuclear matrix, the class I 
region has long stretches of halo DNA but still contains a significant proportion of 
MARs while the class III and extended class II regions are mainly constituted of halo 
DNA.  
 
These  results  show  that,  although  the  overall  distribution  of  halo  DNA  and  MARs 
across the MHC of the different cell types appears to be conserved, there are important 
differences. Generally PGF and IFN-γ induced cells have higher enrichments of MARs 
compared to uninduced MRC5 cells. Furthermore, PGF cells have a higher number of 
MARs within the class III region of the MHC and a different distribution of MAR and 
halo DNA within the class I of the MHC compared to IFN-γ induced and uninduced 
MRC5 cells. 
 
Taken together, the graphical representation of the results from the different cell types 
indicate that the halo DNA correlates positively with high GC content, gene-dense and 
highly conserved regions while MARs have high AT content and are located mainly 
within regions of low conservation and gene-content. 
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Figure 5.3 Competitive hybridisation of differentially labelled MAR and halo DNA 
fractions on MHC microarrays using MRC5, IFN-γ induced MRC5 and PGF cells. 
Positive values represent MAR-enriched DNA while negative values represent halo-
enriched DNA (mean ratios of two independent experiments). GC content, RefSeq gene 
positions,  human  mRNAs  from  GeneBank,  regions  of  consevations  between  17 
vertebrate species and the repetitive sequences LINE, SINE and LTR across the MHC 
are also shown.   139 
5.2.3  Quantitative  Real-time  PCR  analysis  of  matrix  attachment  regions 
and halo DNA from IFN-γ induced MRC5 and PGF cells 
 
In order to validate the array results, thirteen regions across the MHC of IFN-γ induced 
and PGF cells were analysed by quantitative real-time PCR using MAR and halo DNA 
from samples 3,4 and 5.  
 
In  IFN-γ  induced  MRC5  cells,  six  regions  were  enriched  in  halo  DNA  while  the 
remaining  seven  were  MAR-enriched.  The  thirteen  amplicons  designed  to  span  the 
selected regions were interrogated using a similar approach to that described in Chapter 
4. According to the microarray data, the six regions situated within HLA-A, HLA-G, 
HLA-E, HLA-C, HLA-DRB5 and TAP1 were enriched in the halo DNA fraction. Real-
time PCR confirmed high enrichment in the halo DNA fraction for all these regions 
which  had  array  ratios  equal  to  or  lower  than  -0.128  (Fig  5.4).  The  seven  regions 
enriched in the MAR fraction based on the microarray data, were situated downstream 
of PRRT1, NOTCH4, ZBTB2, HLA-DPB1, upstream of C6orf10, HLA-B and HLA-C 
and were validated by real-time PCR (Fig 5.5). These regions had array ratios equal to 
or higher than 0.437. 
 
In PGF cells, five regions were enriched in halo DNA while the remaining eight were 
MAR-enriched.  The  five  regions  enriched  in  the  halo  DNA  fraction  based  on  the 
microarray data were situated in the regions overlapping HLA-C, HLA-E, HLA-DRB5, 
TAP1, and HLA-G. Real-time PCR confirmed high enrichment in the halo DNA fraction 
for all these regions, which had array ratios equal to or lower than –0.144 (Fig 5.6). Of 
the eight regions enriched in the MAR fraction based on microarray data, six were 
successfully validated with quantitative real-time PCR (Fig 5.7). These regions located 
downstream of PRRT1, NOTCH4, ZBTB2, upstream of C6orf10, HLA-B and HLA-C 
had array ratios equal to or higher than 0.6 (log2). The remaining two regions upstream 
of HLA-A and downstream of HLA-DPB1, which were enriched in the MAR fraction 
based on array data, could not be validated since they were enriched in the halo fraction 
by real-time PCR (Fig 5.8). The regions upstream of HLA-A and downstream of HLA-
DPB1 had array ratios of 0.319 and 0.127 respectively. This is in agreement with the 
results in uninduced MRC5 cells indicating that loci with low MAR enrichment using 
arrays are enriched in the halo fraction with real-time PCR. 
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Taken  together  these  data  confirm  that  values  equal  to  or  higher  than  0.4  can  be 
successfully validated with real-time PCR analysis. Thus 0.4 can be used as a threshold 
to identify MARs across the MHC of uninduced, IFN-γ induced MRC5 and PGF cells. 
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Figure  5.4  Quantitative  real-time  PCR  analysis  of  halo-enriched  loci  in  IFN-γ 
induced MRC5 cells.  
Real-time PCR was carried out with primer pairs spanning HLA-G, HLA-DRB5, HLA-
C, TAP1, HLA-E and HLA-A, which were enriched in the halo fraction in the array 
experiments. These loci were confirmed to be highly enriched in the halo fraction. Bars 
represent  the  mean  of  three  biologically  independent  experiments,  and  show  the 
standard deviation. 
   142 
 
 
Figure 5.5 Quantitative real-time PCR analysis of MAR-enriched loci in IFN-γ 
induced MRC5 cells.  
Real-time  PCR  was  carried  out  with  primer  pairs  spanning  downstream  of  PRRT1, 
NOTCH4, ZBTB2, HLA-DPB1, upstream of C6orf10, HLA-B and HLA-C, which were 
enriched in the MAR fraction in the array experiments. These loci were confirmed to be 
highly  enriched  in  the  MAR  fraction.  Bars  represent  the  mean  of  three  biologically 
independent experiments, and show the standard deviation. 
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Figure 5.6 Quantitative real-time PCR analysis of halo-enriched loci in PGF cells. 
Real-time PCR was carried out with primer pairs spanning HLA-C, HLA-E, HLA-DRB5, 
TAP1,  and  HLA-G,  which  were  enriched  in  the  halo  fraction  in  the  results  array 
experiments. These loci were confirmed to be highly enriched in the halo fraction. Bars 
represent  the  mean  of  three  biologically  independent  experiments,  and  show  the 
standard deviation. 
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Figure  5.7  Quantitative  real-time  PCR  analysis  of  loci  showing  high  MAR 
enrichment in PGF cells.  
Real-time  PCR  was  carried  out  with  primer  pairs  spanning  downstream  of  PRRT1, 
NOTCH4,  ZBTB2,  upstream  of  C6orf10,  HLA-B  and  HLA-C,  which  showed  high 
enrichment in the MAR fraction in the array experiments. These loci were confirmed to 
be highly enriched in the MAR fraction. Bars represent the mean of three biologically 
independent experiments, and show the standard deviation. 
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Figure  5.8  Quantitative  real-time  PCR  analysis  of  loci  showing  low  MAR 
enrichment in PGF cells.  
Real-time PCR was carried out with primer pairs spanning upstream of HLA-A and 
downstream of HLA-DPB1, which showed low enrichment in the MAR fraction in the 
array experiments. Real-time PCR indicated that these regions showed low enrichment 
in  the  halo  fraction.  Bars  represent  the  mean  of  three  experiments,  and  show  the 
standard deviation. 
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5.2.4  Position  of  matrix  attachment  regions  across  the  MHC  of  IFN-γ 
treated MRC5 and PGF cells 
 
Work by Volpi et al. (2000), showed that that giant chromatin loops containing the 
entire MHC extend outwards from the territory of chromosome 6 with higher frequency 
in B cells and IFN-γ induced fibroblasts induced than in uninduced fibroblasts. In that 
study AHB cells were used to represent B cells. Here we confirmed that large-scale 
looping of the MHC is also observed with high frequency in PGF B lymphoblastoid 
cells (Fig 5.9). 
 
To determine whether the change in large-scale chromatin organisation and expression 
of MHC genes are accompanied by a rearrangement of genomic anchors, we identified 
MARs across the MHC in IFN-γ treated fibroblast and in PGF B lymphoblastoid cells 
using the MHC tiling path array as previously described in (Fig 5.10). An interactive 
map of MARs can be obtained by uploading tables in Appendices II-IV into the UCSC 
Human  Genome  Browser  (http://genome.ucsc.edu/cgi-bin/hgGateway),  May  2004 
assembly and a detailed profile of MARs is shown in Fig 5.11. 
 
The overall distribution of MARs in the MHC is highly conserved in fibroblast and B 
lymphoblastoid cells. In all cells studied, over 90% of the MARs identified are located 
within the classical class I and class II regions while the remaining 10% of MARs are 
contained in the class III and extended class II regions of the MHC.  
 
There are, however, important differences between the MAR profiles of the different 
cell lines. A striking increase in the number of MARs was found in IFN-γ induced 
MRC5 and PGF cells compared to untreated fibroblasts. This increase in the number of 
MARs is mainly concentrated within the classical class I and class II regions.  
 
In  IFN-γ  treated  fibroblasts  and  B  lymphoblastoid  cells,  MARs  were  identified  on 
average every 17 and 15 kb respectively, which is approximately twice the frequency of 
that in untreated fibroblasts. In IFN-γ induced MRC5 cells, 221 MARs were identified 
and were subdivided as follows: 111 in the class I, 8 in the class III, 96 in the class II 
and 6 in the extended class II region of the MHC. The class I, III, II and extended class 
II regions have one MAR every 16, 120, 9, and 52 kb respectively. In PGF cells, 261 
MARs were identified and were subdivided as follows: 115 in the class I, 20 in the class   147 
III, 121 in the class II and 5 in the extended class II region of the MHC. The class I, III, 
II and extended class II regions have one MAR every 16, 40, 7 and 72 kb respectively. 
 
Of the 221 MARs detected in the MHC of IFN-γ treated fibroblasts, 192 are intergenic 
whereas 29 contain intragenic regions. In B lymphoblastoid cells of the 261 MARs 
identified, 205 are located intergenically while 56 contain intragenic DNA.  
 
As observed in uninduced MRC5 cells, in IFN-γ induced MRC5 and PGF cells MARs 
have been identified at the boundaries separating class I from class III , class III from 
the class II region and class II from the extended class II region (Fig 5.12) as well as in 
regions  flanking  genes  such  as  HLA-A,  HLA-C,  HLA-G,  HLA-F,  HLA-B  and  HLA-
DQB1. 
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Figure 5.9 Cytological visualisation of giant external chromatin loops carrying the 
MHC region in relation to the chromosome 6 territory. 
(a) FISH image showing the HLA-DRA gene (red) located within the chromosome 6 
territory (green). (b) Only a low basal level of external chromatin loops carrying the 
MHC of 10% (N = 313) was present in control MRC5 cells. IFN-γ induction of external 
chromatin loops in MRC5 cells, frequency of giant loop formation increased to 27% (N 
= 325). (c) PGF cells show a high basal level of external chromatin loops, 39% (N = 
344). N - number of CTs analysed. 
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Figure 5.10 MARs in the MHC of MRC5, IFN-γ induced MRC5 and PGF cells. 
The  mean  value  for  two  array  hybridisations  was  calculated  for  each  fragment 
represented in the MHC tiling path array. Regions enriched in the MAR fraction with 
mean  ratios  equal  to  or  higher  than  0.4  (log2)  were  plotted  on  the  UCSC  genome 
browser  (http://genome.ucsc.edu/)  and  represented  on  the  top  row  by  black  vertical 
lines. The number of MARs in each region is shown above the data plots. 
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Figure 5.11 (5 pages) Detailed profile of MARs across the MHC of MRC5, IFN-γ 
induced MRC5 and PGF cells.  
MARs  are  shown  relative  to  Refseq  genes  from  the  UCSC  web  browser 
(http://genome.ucsc.edu/) in MRC5, IFN-γ induced MRC5 and PGF cells.   151 
 
 
Figure 5.11 (continued).   152 
 
 
Figure 5.11 (continued). 
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Figure 5.11 (continued).   154 
 
 
Figure 5.11 (continued). 
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Figure 5.12 Distribution of MARs at MHC class boundaries in MRC5, IFN-γ 
induced MRC5 and PGF cells.  
The boundaries separating A) class I from class III, B) class III from class II, C) class II 
from the extended class II are highlighted in grey. MRC5, IFN-γ induced MRC5 and 
PGF cells are shown in the top, middle and bottom row respectively. 
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5.2.5  Sequence  analysis  of  matrix  attachment  regions  in  IFN-γ  induced 
MRC5 and PGF cells  
 
Different genomic properties including conservation, AT content, gene and repetitive 
sequences  density  of  MARs  and  non-MARs  across  the  MHC  of  IFN-γ  induced 
fibroblasts  and  B  lymphoblastoid  cells  were  analysed  as  described  for  uninduced 
fibroblasts. 
 
The average AT content of MARs in IFN-γ induced fibroblasts and B lymphoblastoid 
cells is 60% and 58% respectively while of halo DNA is 52% and 53% respectively. In 
general, the MARs identified in IFN-γ induced fibroblasts and B lymphoblastoid cells 
have  a  higher  AT  content  than  non-MARs  (P-value  of  0.003  for  IFN-γ  induced 
fibroblasts and 0.002 for and B lymphoblastoid cells). However there are a number of 
MARs that are GC-rich and non-MARs that are AT-rich. 
 
Intragenic sequences constitute more than 40% of non-MARs in both cell types and 
16% and 22% of MARs in IFN-γ induced MRC5 and PGF cells respectively (P-value of 
0.001 for IFN-γ induced fibroblasts and 0.004 for B lymphoblastoid cells). The Pearson 
Product Moment Correlation was determined to study the relatiosnhip between gene 
density and the positions of MARs. The correlation (r) values are consistently negative 
for all cell types (r-value of -0.23 for uninduced MRC5, -0.32 for IFN-γ induced MRC5 
and -0.37 for PGF cells) suggesting that MARs are mainly located in gene-poor regions. 
The relationship between gene density and the positions of MARs can be visualised in 
figure 5.13. 
 
The assessment of the conservation of MARs and non-MARs shows that non-MARs are 
generally more conserved than MARs. However the degree of conservation of these 
sequences varies substantially between the different cell types. The non-MARs in IFN-γ 
induced MRC5 cells are three times more conserved than MARs (P-value < 0.003) 
while the non-MARs in PGF cells are less than twice more conserved than MARs (P-
value < 0.005). 
 
In IFN-γ induced fibroblasts the average content of repetitive sequences of MARs and 
non-MARs  is  58%  and  38%  respectively  (P  value  of  0).  In  PGF  cells  the  average   157 
content of repetitive sequences of MARs and non-MARs is 48% and 43% respectively 
(P-value < 0.007). In both cell types, LINEs are over-represented by more than twofold 
among MARs relative to their overall abundance in non-MARs (P-value of 0) while the 
SINE content is approximately two times higher in MARs compared to non-MARs (P-
value  <  0.005).  MARs  and  non-MARs  of  PGF  cells  do  not  differ  significantly  in 
relation to the LTR content (P-value of 1). This contrasts to IFN-γ induced MRC5 cells, 
in which LTRs are over-represented by approximately three-fold in MARs relative to 
their overall abundance in non-MARs (P-value < 0.005). 
 
The sequence properties of MARs and non-MARs in IFN-γ induced MRC5 and PGF 
cells are similar to those in untreated MRC5 cells. In summary, compared with non-
MARs,  MARs  are  generally  AT-rich,  enriched  in  repetitive  sequences,  depleted  of 
intragenic sequences and show a lower degree of conservation. 
 
 
Figure  5.13  Correlation  of  MARs  and  gene  density  in  MRC5,  IFN-γ  induced 
MRC5 and PGF cells. 
Gene and MAR density were binned in 100 kb windows that were slid by 10 kb for 
each point. The trendlines were plotted based on two points moving average. In general, 
the different cell types show a negative correlation between MAR and gene density in 
all cell types. 
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5.2.6  Classification of matrix attachment regions 
 
To  gain  a  better  insight  into  the  roles  of  MARs  in  the  MHC,  we  compared  their 
positions in the three different cell types. This comparative analysis identified three 
main  categories  of  MARs:  structural,  cell  specific  and  transcription-dependent.  The 
positions of the MARs in each category are shown in tables in Appendices V-X.  
 
MARs constitutively attached to the nuclear matrix in all cell types account for 17% of 
all  MARs  (Fig  5.14a).  These  anchors  are  defined  as  structural  MARs  since  their 
tethering function is preserved regardless of the cell type and transcriptional status of 
the MHC locus. The majority of the structural MARs identified are situated within the 
class I region of the MHC. 
 
Approximately 45% of MARs are cell type specific. They are further classified into 
fibroblast  specific,  which  include  MARs  present  in  both  untreated  and  treated 
fibroblasts  (Fig  5.14b),  and  B  lymphoblastoid  specific  (Fig  5.14c).  Most  cell  type 
specific MARs are equally distributed within the class I and class II regions of the 
MHC. 
 
Transcription-dependent  MARs  are  DNA  sequences  that  transiently  associate  to  the 
nuclear matrix depending on the transcriptional status of the MHC. They include MARs 
in  untreated  fibroblasts  that  are  released  from  the  nuclear  matrix  in  IFN-γ  treated 
fibroblasts  (Fig  5.14d),  MARs  recruited  to  the nuclear  matrix  in  response  to  IFN-γ 
treatment  (Fig  5.14e)  and  MARs  recruited  to  the  nuclear  matrix  in  both  B 
lymphoblastoid cells and IFN-γ treated fibroblasts (Fig 5.14f). These groups of MARs 
together constitute 34% of all MARs identified and are predominantly located within 
the class I and II regions of the MHC.  
 
The remaining 4% of MARs were present in both B lymphoblastoid cells and untreated 
fibroblasts.  To  determine  whether  these  MARs  are  cell  specific  or  transcriptional 
dependent, it is necessary to characterise MARs across the MHC of other cell lines. 
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Figure  5.14  Distribution  of  structural,  cell  specific  and  transcription-dependent 
MARs across the MHC.  
Shown are (a) structural MARs, (b) MRC5-specific MARs, (c) PGF-specific MARs, 
(d) MARs of untreated MRC5 cells, (e) MARs of IFN-γ treated MRC5 cells and (f) 
MARs of both IFN-γ treated MRC5 and PGF cells. 
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5.2.7  Distribution  of  matrix  attachment  regions  relative  to  differentially 
and non-differentially expressed genes 
 
The  relationship  between  gene  expression  and  MARs  was  further  investigated  by 
examining  the  positions  of  MARs  in  relation  to  differentially  and  non-differentially 
expressed genes. 
 
Microarrays were used to compare expression of MHC genes of untreated fibroblasts 
with  IFN-γ  treated  fibroblasts  and  B  lymphoblastoid  cells  (Fig  5.15).  A  significant 
proportion of class II genes and a few class I genes are up-regulated genes in IFN-γ 
treated  fibroblasts  and  B  lymphoblastoid  cells.  The  expression  of  the  class  III  and 
extended class II genes in fibroblasts does not differ following IFN-γ treatment, while a 
proportion  of  class  III  genes  are  up-regulated  in  B  lymphoblastoid  cells  relative  to 
untreated fibroblasts. As expected, most of the differentially expressed genes code for 
classical class I and class II molecules (Table 5.2). 
 
The distances of MARs from differentially and non-differentially expressed genes in 
fibroblasts and B lymphoblastoid cells were calculated to determine how changes in 
gene expression affect MAR distribution (Fig 5.16). The results show that in both IFN-γ 
treated fibroblasts and B lymphoblastoid cells the average distance between MARs and 
differentially expressed genes was over two times shorter than the distance between 
MARs and non-differentially expressed genes (Fig 5.17). A Mann-Whitney test showed 
that the distribution was significant with p-values of 0.003 and 0.009, respectively. The 
average  distance  between  MARs  and  non-differentially  expressed  genes  in  IFN-γ 
induced fibroblasts is 26 kb, while between MARs and differentially expressed genes, 
the  average  distance  is  12  kb.  This  trend  is  observed  for  several  genes  of  critical 
immunological importance including HLA-C, HLA-DPA1, HLA-DPB1, and HLA-DRB1 
genes. 
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Figure 5.15 Comparison of gene expression levels in the MHC of MRC5, IFN-γ 
induced MRC5 and PGF cells.  
a) The red line represents the log2 expression ratios of IFN-γ induced MRC5/MRC5 
ratios and the blue line represents the ratios of PGF/MRC5. (b) Distribution of MARs in 
MRC5, IFN- γ treated MRC5 and PGF cells. 
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  IFN-γ treated MRC5    PGF 
Class I  HLA-F  Class I  HLA-F 
  HLA-E    VARS2 
  HLA-C    HLA-B 
  HLA-B    HCP5 
  MICB  Class III  LTA 
Class III  C4    TNF 
Class II  HLA-DRA    LTB 
  TAP2    AIF1 
  PSMB8    NEU1 
  TAP1    GPSM3 
  PSMB9  Class II  HLA-DRA 
  HLA-DMB    HLA-DRB1 
  HLA-DMA    HLA-DQA1 
  HLA-DPA1    HLA-DOB 
      PSMB8 
      TAP1 
      PSMB9 
      HLA-DMB 
      HLA-DMA 
      HLA-DPA1 
      HLA-DPB1 
    Ext. Class II  SLC39A7 
      HSD17B8 
 
Table 5.2 Differentially expressed genes in IFN-γ treated MRC5 and PGF cells.  
Genes  included  show  at  least  a  two-fold  change  in  up-regulation  of  expression 
compared to untreated MRC5 cells. 
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Figure 5.16 Distance of MARs from MHC genes in IFN-γ treated MRC5 and PGF 
cells.  
The  genomic  position  of  each  gene (x-axis)  is plotted  against  its  distance  from  the 
closest  MAR  (y-axis).  The  black  and  red  dots  represent  non-differentially  and 
differentially expressed genes respectively. 
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Figure 5.17 Distances of MARs to differentially and non-differentially expressed 
genes in IFN-γ MRC5 and PGF cells.  
Boxplots  show  the  interquartile  range  of  the  data,  with  the  horizontal  black  lines 
running through each boxplot represent the median values. The whiskers extend as far 
as 1.5 times the interquartile range. Any values that lie beyond the whiskers are plotted 
as dots. A Mann-Whitney test showed that the differences between the distributions of 
differentially  and  non-differentially  expressed  genes  were  statistically  significant  for 
both cell types (p-values of 0.003 and 0.009, respectively). 
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5.2.8  Comparison  between  matrix  attachment  regions  identified 
experimentally and in silico in IFN-γ induced MRC5 and PGF cells 
 
The performance of three MAR prediction programmes SIDD, ChrClass and MARScan 
was assessed as described for untreated MRC5 cells. 
 
The number of MARs predicted by all programmes is higher than that of experimentally 
identified MARs in IFN-γ induced MRC5 and PGF cells. It is important to note that 
SIDD, ChrClass and MARScan give extremely different distributions of MARs across 
the  MHC  locus.  This  is  to  be  expected  since  each  of  these  software  programmes 
recognises different sequence motifs associated with MARs (described in Chapter 4).  
 
Tables 5.3 and 5.4 show the number of predictions of experimentally defined MARs 
and  not  matching  experimentally  defined  MARs  in  the  two  cell  types.  As  seen  in 
untreated MRC5 cells the number of false positives is significantly high, in both IFN-γ 
induced  MRC5  and  PGF  cells.  The  number  of  true  positives  for  ChrClass  was 
approximately  more  than  2.5  times  greater  than  SIDD  and  3.5  times  higher  than 
MARScan. The number of false positive for ChrClass was slightly lower than SIDD and 
about 2.5 times higher than MARScan. 
 
In  agreement  with  the  results  from  uninduced  MRC5  cells,  ChrClass  outperformed 
SIDD and MARScan in both IFN-γ induced MRC5 and PGF cells. ChrClass had the 
highest sensitivity and specificity while SIDD and MARScan had the lowest specificity 
and sensitivity respectively.  
 
In IFN-γ induced MRC5 cells, 15 MARs detected with the MHC microarrays were not 
predicted by any of the selected programs while in PGF that number was 17. As seen in 
the  previous  chapter,  this  suggests  that  additional  sequence  motifs  associated  with 
MARs  should  be  incorporated  into  novel  software  programmes  to  improve  their 
predicting  power.  These  sequences  could  include  specific  classes  of  repetitive 
sequences such as LINEs since they are over-represented among MARs of the MHC 
relative to their abundance in non-MARs. 
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  ChrClass  SIDD  MARScan 
Total Predicted  617  543  187 
True Positive  191  75  55 
False Positive  426  468  132 
False Negative  18  71  69 
Specificity  0.31  0.14  0.29 
Sensitivity  0.86  0.34  0.25 
 
Table  5.3  Comparison  between  different  MAR  predicting  algorithms  in  IFN-γ 
treated cells. 
 
 
 
  ChrClass  SIDD  MARScan 
Total Predicted  617  543  187 
True Positive  236  77  47 
False Positive  381  476  140 
False Negative  41  33  90 
Specificity  0.38  0.14  0.25 
Sensitivity  0.90  0.30  0.18 
 
Table 5.4 Comparison between different MAR predicting algorithms in PGF cells.  
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5.3   Discussion 
 
In order to examine the relationship between chromatin folding and gene expression, 
MARs  were  mapped  in  cells  exhibiting  differential  expression  of  the  MHC.  By 
comparing the position of MARs in uninduced fibroblasts, IFN-γ induced fibroblasts 
and B lymphoblastoid cells, activation of the MHC was found to be accompanied by 
dynamic interactions between chromatin and the nuclear matrix. The vast recruitment of 
MARs to the nuclear matrix upon up-regulation of the MHC suggests that MARs play a 
role in transcriptional regulation of MHC genes.  
 
As  determined  in  uninduced  fibroblasts,  MARs  in  IFN-γ  induced  fibroblasts  and  B 
lymphoblastoid cells, MARs were found to be rich in AT and repetitive sequences, 
furthermore they correlate negatively with gene density. Despite the overall differences 
in MHC expression between uninduced, IFN-γ induced and B lymphoblastoid cells, 
MARs were mainly positioned within the MHC class I and class II regions. In all cell 
types  examined,  MARs  predominantly  occupy  intergenic  regions  closely  flanking 
several class I and class II genes and near MHC boundaries suggesting that MARs have 
an  insulator  function.  This  proposed  role  for  MARs  is  further  supported  by  recent 
findings showing that MARs shield transgenes from the effects of the neighbouring host 
chromatin  domains  (Girod  et  al.,  2007;  Halweg  et  al.,  2005).  It  remains  to  be 
established whether MARs act as boundary elements by topologically constraining the 
DNA  into  loops  or  by  forming  a  physical  barrier  that  blocks  interactions  between 
promoter and unrelated enhancers.  
 
Upon transcriptional up-regulation of MHC genes with IFN-γ, loop DNA adjacent to 
genes  is  recruited  to  the  nuclear  matrix.  The  number  of  MARs  in  IFN-γ  induced 
fibroblasts  is  approximately  two  times  greater  than  untreated  fibroblasts  and  their 
average  position  is  two  times  closer  to  differentially  expressed  MHC  genes.  The 
recruited  MARs,  mostly  situated  intergenically  within  the  classical  class  I  and  II 
regions,  reduce  the  average  loop  size  across  the  MHC  locus  of  IFN-γ  induced 
fibroblasts.  A  similar  pattern  of  anchoring  and  average  loop  size  is  seen  in  B 
lymphoblastoid cells, which constitutively express MHC genes that are up-regulated in 
IFN-γ  induced  fibroblasts.  This  association  between  transcriptional  activation  and 
recruitment of MARs has been previously reported at the murine Th2 cytokine locus   168 
containing the co-ordinately regulated Il4, Il3 and Il5 genes within a gene cluster of 120 
kb (Cai et al., 2006).  
 
To gain a better understanding of MAR function in the MHC, the MARs of the different 
cell  types  were  classified  into  three  groups:  structural,  cell  type  specific  and 
transcription-dependent  (Heng  et  al.,  2004;  Heng  et  al.,  2001;  Shaposhnikov  et  al., 
2007). Structural MARs are constitutively bound to the nuclear matrix in all cell types 
regardless of the transcriptional status of the MHC locus (Heng et al., 2004; Heng et al., 
2001).  MARs  that  bind  to  the  nuclear  matrix  in  all  cell  types  could  be  critical  in 
maintaining the higher-order chromatin structure of the MHC. Cell type specific MARs 
could  reflect  interactions  between  chromatin  and  cell  type  specific  nuclear  matrix 
proteins (Jackson et al., 1992). Studies on SATB1 have revealed that the binding of cell 
type specific nuclear matrix proteins at MARs is essential for tissue-specific regulation 
of gene expression (Cai et al., 2006; Galande et al., 2007). Therefore this group of 
MARs could interact with cell type specific matrix proteins, which are important for the 
distinct  MHC  expression  profiles  of  fibroblasts  and  B  lymphoblastoid  cells. 
Transcription-dependent  MARs  are  recruited  to or  released  from the  nuclear  matrix 
based on the transcriptional status of a given genomic region (Heng et al., 2004). Most 
MARs of this group are recruited to the nuclear matrix upon activation of the MHC and 
may associate with a sub-class of MAR-binding proteins functioning as transcriptional 
activators of MHC genes. 
 
These permanent and transient chromatin-matrix interactions should be examined in the 
context of previous findings showing that constitutively high gene expression or the 
induction of expression of certain genomic domains are accompanied by a higher-order 
re-structuring  of  chromatin  (Brown  et  al.,  2006;  Chambeyron  and  Bickmore,  2004; 
Mahy et al., 2002; Volpi et al., 2000; Williams et al., 2002). In IFN-γ treated fibroblasts, 
the  MHC  emanates  out  of  its  CT  forming  giant  chromatin  loops  with  an  increased 
frequency compared to untreated fibroblasts (Volpi et al., 2000). Here, FISH analysis 
revealed that the number of giant chromatin loops in B lymphoblastoid cells is largely 
equivalent to that seen in IFN-γ treated fibroblasts. Recent work by Christova et al. 
(2007) has shown that the formation of these giant loops is accompanied by chromatin 
decondensation,  which  probably  provides  a  more  ‘open’  chromatin  environment 
(Christova et al., 2007). Decondensed chromatin could thus facilitate chromatin-matrix 
interactions  by  increasing  accessibility  for  nuclear  matrix  proteins  and  transcription   169 
machinery (Hart and Laemmli, 1998; Kimura et al., 1999). Since several components of 
transcription factories associate with the nuclear matrix, it is tempting to speculate that 
dynamic  matrix-MAR  interactions  localise  genes  close  to  transcription  factories 
optimising their regulation (Ottaviani et al., 2008b). Furthermore, giant chromatin loops 
may place the MHC in distinct nuclear microenvironments containing specific matrix 
proteins as well as transcription factors required for the expression of MHC genes. 
Taken together these findings indicate that there is an intimate relationship between 
gene expression, higher-order chromatin structure and the association of MARs with the 
nuclear matrix (Fig 5.18).  
 
The role of MARs upon MHC induction could be explored in the future by interfering 
with their function and analysing the impact on regulation of gene expression. However, 
this approach cannot be used at present due to the lack of selective MAR-targeting 
agents to disrupt the binding of MARs with the nuclear matrix. A different strategy to 
analyse  the  structural  and  functional  role  of  MARs  includes  the  isolation  and 
characterisation  of  MAR-binding  proteins  (Donev  et  al.,  2002).  If  unknown,  the 
function of these proteins could be analysed using approaches such as gene silencing. A 
similar strategy has been successfully applied to characterise the matrix protein SATB1 
and  the  function  of  its  MAR  target  sequences  (Cai  et  al.,  2003;  Cai  et  al.,  2006). 
Additional studies would also be required to understand whether MAR recruitment is an 
important early step in transcriptional activation of the MHC. This question can be 
addressed by time-course experiments to determine the kinetics of MAR recruitment to 
the nuclear matrix during IFN-γ activation.  
  
The feasibility of large-scale MAR prediction was evaluated by comparing the positions 
of experimentally identified MARs in IFN-γ induced fibroblasts and B lymphoblastoid 
cells with those predicted by three MAR-prediction software programmes: ChrClass, 
SIDD and MARScan. As observed for uninduced fibroblasts in the previous chapter, 
ChrClass was found to have the best predicting power as measured by sensitivity and 
specificity. All the programmes used predicted a high number of false positives and 
therefore cannot yet substitute experimental verification. These findings show, however, 
that ChrClass could be a useful start where no experimental data is available. As seen, 
the binding of MARs to the nuclear matrix can be constitutive and transient, cell type 
specific  and  transcriptional  dependent.  The  description  of  the  sequence  of  these 
different MAR groups at the base pair level and the characterisation of target sites of   170 
MAR-binding  proteins  will  be  essential  for  the  development  of  improved  MAR-
predicting software. 
 
The  comparison  between  the  position  of  MARs  with  CIITA  binding  sites  and 
acetylated  regions  described  in  Chapter  3  did  not  reveal  significant  correlations. 
However, it  is  possible  that  such  correlations  were  not  detected  since  different  cell 
types were used in these experiments. 
 
In summary these results have shown that activation of MHC genes is accompanied by 
a massive re-organisation of chromatin architecture. The mapping of MARs in IFN-γ 
induced  fibroblasts  and  B  lymphoblastoid  cells,  and  the  comparison  with  those 
identified in uninduced fibroblasts has indicated that MARs are recruited to the nuclear 
matrix upon transcriptional up-regulation. MARs are formed adjacent to differentially 
expressed  genes  when  the  genes  are  activated  suggesting  that  there  is  an  intimate 
relationship  between  higher-order  genome  architecture  and  regulation  of  gene 
expression. This work thus provides a substantial framework for subsequent studies on 
DNA-protein  interactions  that  are  responsible  for  both  the  structural  integrity  of 
chromosomes and genomic function. 
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Figure  5.18  Model  showing  dynamic  changes  in  chromatin  organisation  of  the 
MHC locus upon transcriptional up-regulation.   
In cells that are not expressing MHC class II genes, such as uninduced fibroblasts, the 
4Mb MHC locus (red) is positioned within the chromosome 6 territory anchored by 
constitutive  MARs  (yellow)  to  nuclear  matrix  proteins  (dark  green),  forming  stable 
chromatin loops. Upon up-regulation of gene expression the entire MHC locus adopts a 
more  ‘open’,  decondensed  chromatin  structure,  represented  by  the  thinning  and 
lengthening of the chromatin line, and the entire MHC region is repositioned outside of 
the CT. IFN-γ-dependent MARs (light blue) are recruited to the nuclear matrix, folding 
chromatin  into  smaller  loops,  and  facilitating  the  interaction  of  chromatin  and 
transcription  factors  (light  green).  Many  IFN-γ-dependent  MARs  are  positioned 
immediately  adjacent  to  genes.  The  constitutive  MARs  remain  attached  to  nuclear 
matrix  proteins  following  transcriptional  up-regulation  and  some  may  have  an 
insulatory function.   172 
6  Summary and Discussion 
 
In this thesis, I have examined the relationship between genomic anchoring and gene 
expression  in  the  MHC,  a  large  human  locus  containing  clusters  of  co-ordinately 
regulated genes. Using a novel tiling path array of the MHC, I have shown that MARs 
are  unevenly  distributed  across  the  MHC  region.  They  are  mainly  situated  within 
intergenic domains and closely flank several genes, including those involved in antigen 
processing and presentation, as well as the boundaries defining the MHC sub-regions. 
Although a unique consensus was not identified, MARs have a high AT and repeat 
sequence content. Analysis of cell types with different expression profiles suggests that 
transcriptional up-regulation of the MHC is accompanied by a significant recruitment of 
MARs to the nuclear matrix.  Of particular interest, certain MARs are formed close to 
transcriptionally  up-regulated  genes  upon  MHC  activation,  while  others  are 
permanently  associated  with  the  nuclear  matrix in  all  cell  types.  Collectively,  these 
findings suggest that the rearrangement of chromatin architecture to form new loop 
domains may be an integral component of gene activation. 
 
6.1  Higher-order chromatin structure 
 
What  does  the  map  of  MARs  across  the  MHC  in  different  cell  types  tell  us  about 
chromatin architecture, and how compatible is it with the models described in Chapter 
1? To address these questions, one should consider the spatial arrangement of MARs in 
relation to the proposed chromatin loop domain. The common view is that MARs are 
located at the bases of the chromatin loop structures. However, each MAR may not 
identify the base of a separate loop, since consecutive, closely juxtaposed MARs may 
together be positioned at the base of a loop by their common attachment to a particular 
set of nuclear matrix proteins. Certain MARs may be located along a loop rather than 
exclusively  at  the  base,  and  furthermore,  one  cannot  exclude  a  role  for  MARs  in 
anchoring chromatin folds, rather than loops. 
 
With respect to the MHC, MARs identified within a 300 kb region of the class I region 
have been shown by a chromatin ligation assay, to be present at the bases of loops, with 
each pair of MARs that form a loop structure being in close spatial proximity in vivo   173 
(Kumar et al., 2007a).  In contrast, 3C analysis of the Ifng locus indicates that certain 
MARs  are  associated  with  a  linear,  rather  than  looped,  chromatin  conformation, 
indicating that not all MARs mediate the organisation of chromatin into loop structures 
(Eivazova  et  al.,  2007).  The  methodology  used  in  this  thesis  to  isolate  the  nuclear 
matrix is identical to that shown to extract proteins with both structural functions, such 
as  lamins,  and  no  known  structural  functions,  such  as  general  transcription  factors 
(Noma et al., 2006). Certain MARs in the MHC might thus only have a regulatory 
function and be located away from the bases of the loop structures. Analysis of the 
three-dimensional chromatin architecture using 3C analysis needs to be performed to 
determine which MARs mediate loop formation and which have a regulatory function. 
 
The findings from the present study should be examined in light of the different models 
of higher-order chromatin structure. The MLS model postulates that successive bases of 
chromatin  loops  are  held  together  by  ‘loop  base  springs’  (Munkel  et  al.,  1999). 
However, as the existence of a proteinaceous nuclear scaffold tethering the chromatin is 
not excluded, the MARs of the MHC could mediate the organisation of the MHC into 
rosette-like structures containing chromatin loops. If all the MARs are located at the 
bases of the loop structures, the MHC class I and II regions would be organised into 
smaller chromatin loops (~15 kb) compared to  those of the  MHC class III and the 
extended class II regions (~80 kb). In contrast, if certain MARs of the MHC class I and 
II regions were located away from the bases of the loop structures, the sizes of the 
chromatin loops could be similar across the MHC sub-regions.  
 
The RW/GL model predicts the formation of chromatin loops in the order of several Mb 
attached to a proteinaceous nuclear scaffold. According to this model, the MHC should 
only  contain  very  few  MARs  and  not  the  large  number  that  were  identified 
experimentally in all three cell types. Although this model might not be suitable to 
interpret our results, smaller chromatin loops might still be formed within the relatively 
large loops and allow for the existence of a higher number of MARs (Sachs et al., 
1995).  
 
The chromonema fibre model does not appear to agree with our findings since it favours 
the formation of chromatin folds maintained by chromatin interactions. However, this 
model can accommodate a nuclear matrix mediating the tethering of the chromatin folds 
(Belmont and Bruce, 1994). In this instance, MARs would organise the MHC class I   174 
and II regions into more tightly folded chromatin compared to the MHC class III and 
extended class II regions. 
 
6.2   Relationship to giant chromatin loops 
 
Within  the  nucleus,  chromatin  exists  in  open  and  closed  configurations.  Certain 
genomic regions are subject to dynamic changes in conformation, according to their 
transcriptional status and other parameters. None of the models described above provide 
information on how the different levels of chromatin condensation are established or 
how they are altered upon interaction with regulatory nuclear machineries.  
 
The  formation  of  giant  chromatin  loops  carrying  the  MHC  upon  transcriptional 
activation has been described earlier (Volpi et al., 2000). It might be expected that the 
release of a chromatin loop away from the chromosome territory would be achieved 
through release of MARs upon transcriptional activation. Rather, what is seen is the 
maintenance of virtually all existing MARs, together with the formation of additional 
MARs indicating new sites of anchoring to the nuclear matrix. This observation could 
reflect the biological and physical properties of the nuclear matrix. If nuclear matrix 
components  move  within  the  nucleus  they  might  facilitate  the  formation  of  giant 
chromatin loops through their interaction with MARs. This is in agreement with well-
established findings that many proteins in the nucleus are highly mobile and generate a 
dynamic,
  architectural  framework,  where  nuclear
  processes  take  place.  Immediately 
after  treatment  of  cells  with  IFN-γ  and  activation  of  the  JAK-STAT  pathway, 
phosphorylated STAT1 moves rapidly into the nucleus. As the giant chromatin loops 
appear within minutes, and only form if STAT1 is present (Christova et al., 2007), one 
could speculate that STAT1 may be involved in MAR-matrix interactions that generate 
large-scale reconfiguration of chromatin architecture. 
 
MARs are likely to mediate the tethering of the local chromatin loops across the MHC, 
however, whether these genomic sequences are also involved in the formation of the 
giant chromatin loops remains to be established. The average size of the giant chromatin 
loops is in the order of several Mb (Volpi et al., 2000), while the average distance 
between MARs in the MHC is approximately several kb. The formation of additional 
MARs upon activation of the MHC could indicate the formation of new chromatin   175 
loops, as observed in the mouse Th2 cytokine locus (Cai et al., 2006). However, this is 
difficult to reconcile with the observed decondensation of the MHC that accompanies 
its transcriptional up-regulation (Christova et al., 2007). It is more likely that the overall 
decondensation of the locus increases access of MARs, which are located a distance 
away from loop bases, to nuclear matrix proteins. Thus, the associations of these MARs 
with the nuclear matrix would not result in the formation of additional chromatin loops. 
Another possibility is that different MARs might be responsible for different levels of 
chromatin compaction so that the release of a few selected MARs might still lead to 
chromatin decondensation despite an overall recruitment of MARs. The data are thus 
consistent,  firstly,  with  a  complex  hierarchy  of  DNA  folding  to  achieve  effective 
packaging of the MHC, and secondly, with activation of MHC genes being associated 
with conformational changes occurring at multiple levels. 
 
6.3   Insights into the nature of the nuclear matrix 
 
As this thesis concerns the investigation of MARs, it is appropriate to evaluate whether 
the nuclear matrix is a true nuclear entity and analyse what the data reveal about the 
composition and properties of the nuclear matrix. 
 
The extraction of soluble histone and non-histone proteins with high-salt buffers can 
form  artifactual  protein  complexes  since  the  negatively  charged  polyanions  of  the 
buffers interact with the cationic sites of proteins (Pederson, 2000). This process may 
disrupt both pre-existing DNA-protein interactions and protein-protein interactions and 
lead to the formation of new aggregates. This limitation of the methodology has to be 
taken into account when considering recent findings proteins SATB1, topoisomerase II 
and  condensin,  which  are  found  in  the  matrix  fraction  of  the  nucleus  following 
treatment with 2 M NaCl buffer (Maeshima and Laemmli, 2003; Seo et al., 2005). All 
three proteins are important in chromatin architecture. SATB1 has a ‘cage-like’ network 
distribution  pattern  in  interphase  nuclei  (Cai  et  al.,  2003;  Cai  et  al.,  2006). 
Topoisomerase II and condensin form two juxtaposed or coiled chain structures along 
the longitudinal axis of metaphase chromosomes (Kireeva et al., 2004; Maeshima and 
Laemmli, 2003). These findings strongly suggest that components of the nuclear matrix 
form  complex  structures  in  nuclei  in  vivo.  However,  additional  components  might 
simply co-precipitate in the matrix fraction as a result of the high-salt treatment and thus   176 
might not actually participate in the maintenance of chromosomal structure. In order to 
distinguish  the  proteins  of  the  nuclear  matrix  from  the  artifactual  ones,  more 
components need to be characterised and studied using techniques such as ChIP and in 
vivo imaging. 
 
The presence of both constitutive and dynamic MARs in the MHC is likely to reflect 
the heterogeneous composition of the nuclear matrix, which is constituted not only of 
structural  proteins  but  also  of  factors  involved  in  transcription.  The  nuclear  matrix 
contains a few structural components including SATB1 and lamins, which can self-
assemble  to  form  complex  higher-order  nuclear  structures  extending  throughout  the 
nuclear interior (Cai et al., 2006; Dechat et al., 2008). Most nuclear matrix components, 
including  chromatin  remodelling  enzymes  and  general  transcription  factors,  have  a 
diffuse distribution in the nucleus of living cells (Bettinger et al., 2004; Noma et al., 
2006; Reyes et al., 1997). The nuclear matrix thus does not appear to be a continuous 
structural framework but rather is a collection of different proteins that mediate high-
order chromosome structure and regulate gene expression in response to transcriptional 
up-regulation. 
 
6.4   The architecture of the nucleus 
 
An understanding of chromatin architecture has to incorporate the surrounding nuclear 
environment.  The  Inter-Chromatin  Domain  (ICD)  model  describes  the  nucleus  as 
having compartmentalised chromatin domains separated by a network of chromatin-free 
space  (Cremer  and  Cremer,  2001).  This  view  of  the  nucleus  is  derived  from 
microscopic imaging of the CTs and ICD. Experiments showing that approximately 
90% of DNA, corresponding to about 50% of the nuclear mass, can be removed by 
extraction whilst preserving the structure of the ICD, suggest that the nuclear matrix 
could be situated within the channels of the ICD (Jackson, 2003). This hypothesis is 
further  supported  by  the  findings  that  both  the  ICD  and  the  nuclear  matrix  are 
implicated in transcription and replication and are associated with nuclear components 
such  as  PML  and  Cajal  bodies,  which  have  a  role  in  mRNA  maturation  and  RNP 
assembly (Cremer et al., 2004; Gribbon et al., 2002; Zhong et al., 2000). 
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The  definition  of  the  ICD  as  the  chromatin-free  compartment  separating  CTs  and 
chromatin domains is still controversial. Intermingling between CTs indicates that the 
ICD might not be preferentially distributed at the borders of CTs (Branco and Pombo, 
2006). In addition, experiments showing that large macromolecules are able to diffuse 
within  condensed  chromatin  suggest  that  the  ICD  might  ramify  in  between  fine 
chromatin  domains  (Cremer  and  Cremer,  2001; Verschure  et  al.,  2003).  These  data 
indicate that rather than simply being compartmentalised into chromatin and chromatin-
free  domains,  the  nucleus  is  divided  into  different  compartments  characterised  by 
variable volumes of chromatin-free space. Since it is highly condensed, heterochromatin 
contains less chromatin-free space than euchromatin, however, chromatin-free space is 
found throughout both domains. This network of chromatin-free space might be filled 
with different molecules including components of the nuclear matrix proteins, which are 
able to organise chromosomal architecture through their interactions with MARs. 
 
In order to understand the different elements responsible for the compartmentalisation 
of  the  nucleus  it  is  also  necessary  to  explore  the  forces  generated  by  molecular 
crowding, which are strong in the nucleus due to the high macromolecule concentration 
(in  the  range  of  100  mg/ml)  (Hancock,  2004b).  These  forces  vastly  increase  the 
association  constants  of  intermolecular  interactions  and  might  play  a  role  in  the 
assembly  and  function  of  distinct  nuclear  compartments  including  PML  bodies  and 
nucleoli  (Hancock,  2004b).  There  is  experimental  evidence  showing  that  these 
compartments disassembled with dispersion of their molecular components when nuclei 
expand in volume in hypotonic buffer and reassembled when the nuclear volume returns 
to normal in physiological buffers (Hancock, 2004a). 
 
6.5   Genomic features of matrix attachment regions 
 
The average AT content of MARs in all cell types analysed here is equal to or higher 
than 58% while that of non-MAR DNA is equal to or lower than 53%. MARs are 
therefore  relatively  AT-rich,  confirming  the  results  of  previous  small-scale 
investigations (Purbowasito et al., 2004; Shaposhnikov et al., 2007). These findings 
could  have  important  practical  implications  since  they  suggest  that  drugs  such  as 
bizelesin, which bind selectively to AT-rich regions, could exhibit their cytotoxicity by 
interfering with the function of MARs (as discussed in Chapter 1). However, MARs   178 
with low AT content have also been found indicating that high AT content alone is not 
sufficient for interaction of a genomic sequence with the nuclear matrix. 
 
MARs are relatively rich in repetitive elements since the average content of repetitive 
sequences of MARs is equal to or higher than 49% while that of non-MAR DNA is 
equal  to  or  lower  than  43%.  A  positive  correlation  between  MARs  and  repetitive 
elements was indicated previously in studies of several genomic regions including the 
human serpin gene cluster and  a 1 Mb imprinted domain on mouse chromosome 7 
(Purbowasito et al., 2004; Rollini et al., 1999). Further sequence analysis revealed that 
LINEs are the predominant class of repetitive sequences in the MARs in the MHC, and 
are consistently over-represented relative to their overall abundance in non-MAR DNA. 
This indicates that LINEs might contribute to the binding of DNA to the nuclear matrix 
and thus play a significant role in chromatin architecture. 
 
In all cell types studied here, intragenic sequences constitute approximately 40% of 
non-MAR DNA and 20% for MARs. In addition, MARs show a negative correlation 
with gene density. The preferential localisation of MARs within intergenic sequences as 
well as their proximity to MHC genes and class boundaries suggest that they might 
function  as  boundary  elements.  This  is  also  supported  by  previous  transgene 
experiments  revealing  that  MARs  are  able  to  shield  genes  from  positioning  effects 
(Girod et al., 2007; Halweg et al., 2005). Although the details need to be established, 
this insulatory function might arise from the ability of MARs of forming topologically 
constrained looped structures which protect the intervening DNA from the influence of 
chromatin outside the loop. 
 
Another feature of MARs observed consistently in all three cell types is that they are 
approximately  two  times  less  conserved  than  non-MAR  DNA.  No  unique  sequence 
consensus was identified for MARs, suggesting  that their conserved function across 
different species is not dictated by an evolutionary conserved primary sequence but 
rather by diverse DNA motifs generating distinct higher-order chromatin structures. A 
similar finding was shown for methylated sites on histones, which were found to be 
functionally conserved between the human and mouse genomes at orthologous sites 
even when their underlying sequence was not highly conserved (Bernstein et al., 2005).  
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The  absence  of  a  unique  consensus  characterising  MARs  has  led  to  difficulties  in 
predicting the position of MARs using in silico approaches. The performance of the 
computer programmes SIDD, ChrClass and MARScan was assessed in this thesis using 
experimental data from the three cell types. These programmes are based on different 
sets  of  DNA  motifs  associated  with  MARs,  thus,  it  is  not  surprising  that  their 
predictions across the MHC overlap only partially. Although the performance of each 
programme was found to vary in the three cell types, Chrclass outperformed SIDD and 
MARScan  since  it  had  the  highest  sensitivity  and  specificity.  In  each  cell  type,  a 
significant number of MARs were detected experimentally that were not predicted by 
any of the selected programmes. The positive and negative correlations between MARs 
and the genomic features analysed, which include AT content, repetitive sequences and 
gene density, should be incorporated into these programmes to improve their predicting 
power. 
 
6.6  The structural and functional relationship between matrix 
attachment regions and the MHC 
 
The  efficient  up-regulation  of  expression  of  MHC  genes  upon  specific  stimulatory 
signals  regulates  antigen  presentation  to  T  cells  and  ultimately  determines  the 
effectiveness  of  the  immune  response.  The  recruitment  of  genomic  anchors  near 
differentially  expressed  MHC  genes  accompanies  their  transcriptional  activation, 
indicating that they could be critical for the regulation of the MHC locus. 
 
The MHC class I and II regions contain a larger number of MARs and are therefore 
more topologically constrained than the class III and the extended class II regions. Since 
the class I and II regions have significantly higher AT and repetitive element content as 
well as higher gene density than the class III and extended class II regions, the uneven 
distribution of MARs might be due to the distinct genomic features of the MHC classes. 
The similar MAR distribution between the class I and class II regions might also reflect 
their similar evolution. The organisation and sequence of the genes contained in these 
classes suggest that they are derived from a common ancestor (Kasahara et al., 1995; 
Klein and Sato, 1998). In contrast, most of the class III genes and extended class II 
genes are not functionally or evolutionarily related to one another (Sultmann et al., 
2000).   180 
 
The organisation of chromatin into repeating local loops tethered to the nuclear scaffold 
might  define  distinct  chromatin  domains  and  constitute  the  basic  structural  unit  of 
chromatin for regulating DNA transcription and replication (Bode et al., 1995; Heng et 
al., 2001; Nickerson et al., 1995). Furthermore, if the MHC sub-regions are organised in 
a rosette-like conformation as proposed by the MLS model, several MARs could be 
tethered at the centre of each rosette and multiple loops could share the same nuclear 
microenvironment facilitating the co-ordinate regulation of the MHC genes contained 
within the class I and II regions (Munkel et al., 1999). 
 
One of the most striking features of the human genome is its subdivision into G- and R-
bands (as discussed in Chapter 1). In the MHC, the class II region replicates late and it 
is highly AT-rich (Tenzen et al., 1997). We would therefore expect the MHC class II 
region to correspond to a G-band. Does the MAR distribution provide insights into the 
banding phenomenon? According to Saitoh and Laemmli (1994), G- and R-bands arise 
from the differential compaction of MARs along metaphase chromosomes (Saitoh and 
Laemmli, 1994). They showed that G bands correspond to regions where MARs are 
more  tightly  coiled  than  R-bands.  A  similar  pattern  might  also  exist  in  interphase 
chromosomes  as  our  findings  suggest  that  the  MHC  class  II  contains  a  significant 
higher number of MARs than the adjacent sub-regions and might thus be subjected to 
higher structural constraints. 
 
Previous  small-scale  studies  on  different  organisms  have  indicated  that  dynamic 
recruitment of MARs to the nuclear matrix regulates the expression of genes involved 
in  cellular  differentiation  and  disease  development  as  well  as  additional  nuclear 
processes  including  DNA  replication  and  mitosis  (discussed  in  Chapter  1).  The 
expression  of  several  MHC  proteins,  including  HLA  class  I  molecules,  is  low  in 
pluripotent  human  embryonic  stem  cells  but  shows  a  significant  increase  during 
differentiation  (Drukker  and  Benvenisty,  2004;  Drukker  et  al.,  2002).  In  order  to 
improve  our  understanding  of  the  molecular  mechanisms  regulating  MHC  gene 
expression during cellular differentiation, the MHC tiling path arrays could be used to 
map the MARs in cells at different developmental stages. The identification of MARs in 
cells  exhibiting  abnormal  MHC  gene  expression  could  determine  whether  MARs 
contribute  to  the  diseases  associated  with  this  locus.  In  preparation  for  mitosis, 
chromatin  starts  undergoing  profound  conformational  changes  to  reach  the  extreme   181 
degree of compaction observed in metaphase chromosomes. The isolation of MARs 
from metaphase nuclei and their localisation across the MHC could reveal whether the 
rearrangement of MARs is also involved in the formation of metaphase chromosomes. 
In addition to consolidating the findings of the present study, these experiments will 
provide a broader view of the relationships between structure and function that underlie 
chromosome biology. 
 
6.7   Final Remarks 
 
Our  knowledge  of  how  the  MHC  functions  in  the  context  of  the  nucleus  has  been 
enhanced by the findings that distinct genomic sites of the MHC interact with proteins 
of the nuclear matrix. These MARs are likely to regulate the expression of the MHC 
locus  by  dynamically  organising  chromatin  in  three-dimensional  space.  The 
identification of CIITA-binding sites and histone acetylated regions across the MHC 
emphasises that this critical region of the genome is regulated at multiple levels. The 
characterisation  of  cis-regulatory  elements,  regulatory  proteins  and  epigenetic 
modifications  as  well  as  their  co-ordination  and  compartmentalisation  into  distinct 
nuclear  microenvironments  will  allow  us  to  gain  a  more  comprehensive  view  of 
genomic function and identify truly novel targets for therapy. 
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Appendix I - Position of clones constituted entirely of repetitive sequences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start position  End position 
29857045  29859021 
29859685  29861731 
29952327  29954750 
29954618  29957153 
30007795  30009507 
30071694  30074112 
30123120  30125633 
30157712  30159479 
30159325  30162190 
30254297  30256821 
30324946  30327580 
30326343  30328780 
30353431  30355824 
30355557  30357404 
30356186  30358959 
30358915  30361227 
30360627  30363086 
30373125  30373916 
30461074  30463679 
30505856  30508413 
30507610  30510119 
30548127  30550788 
30550719  30553560 
30553123  30554913 
30598279  30600699 
30624293  30626447 
31044408  31046885 
31102983  31105539 
31176621  31179067 
31258475  31261419 
31282010  31284107 
31309154  31310921 
31331246  31333604 
31333527  31335887 
31397092  31399917 
31399278  31403895 
31405420  31408180 
31407745  31410625 
31410312  31412594 
31481894  31483829 
31482771  31485215 
31505209  31507825 
31507238  31509555 
31509279  31511644 
31578226  31580534 
31929098  31930771 
32061007  32063565 
32063457  32066073 
32333324  32335035 
32334902  32337196 
32347172  32349492 
32357072  32359919 
32531595  32534000 
32552075  32554386 
32570284  32572093 
32637066  32640334 
32637942  32640486 
32750587  32752380 
32751956  32754798 
32803977  32805579 
32879848  32882714 
32946350  32948854 
33065138  33067726   205 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33099436  33102017 
33125489  33127433 
33128270  33130623 
33130078  33132394 
33171878  33174286 
33174199  33176819 
33196915  33199698 
33208179  33210083 
33211780  33213487 
33213814  33215866 
33423446  33426238 
33541330  33543791   206 
Appendix II - Position of MARs of uninduced MRC5 cells and their array  
                        enrichment 
 
Start position  End position  Matrix enrichment (log2) 
29802604  29804427  0.408556898 
29811013  29813380  0.560802711 
29840342  29842808  0.536847791 
29849827  29852415  0.454672441 
29872823  29875035  0.461270083 
29882039  29884543  0.608527194 
29884167  29886552  0.927214351 
29894385  29896949  0.415990851 
29933548  29935949  0.405509686 
29937894  29939594  0.89732932 
29960874  29962955  0.531348184 
29975451  29978299  0.454830111 
29982740  29984644  1.606179952 
29996470  29998921  0.475552781 
30036629  30039288  0.447158433 
30046908  30048715  0.691269293 
30062253  30064589  0.411414968 
30065589  30067967  0.534589265 
30101121  30103717  0.487064175 
30103986  30106521  0.484163181 
30129527  30132152  0.411419205 
30131866  30134499  0.524926594 
30134479  30136131  0.628146834 
30146157  30148833  0.413190429 
30168959  30171414  0.418168319 
30200798  30203110  0.429058999 
30223796  30226544  0.753265219 
30226106  30228443  0.813896405 
30231506  30234359  0.45203356 
30238940  30240972  1.103889025 
30249896  30252535  0.500941774 
30252097  30254580  0.719450528 
30304335  30306759  0.551212328 
30341155  30343559  0.540194347 
30343050  30345405  0.657699355 
30377836  30380380  0.81314185 
30389144  30392634  0.412102625 
30391810  30393924  0.568857432 
30421568  30424503  0.463906481 
30428243  30430343  0.614378646 
30442776  30445345  0.49071704 
30455483  30457800  0.998706823 
30459362  30461425  0.552074532 
30472435  30474725  0.434562973 
30482335  30484495  0.408831062 
30501127  30503780  0.596996587 
30507610  30510119  0.73442487 
30509530  30512280  0.860153585 
30516686  30519460  0.479511852 
30610759  30613495  0.421833521 
30698815  30701782  0.488345733 
30731648  30734384  0.753858118 
30767990  30770760  0.740066525 
30772906  30775852  0.49751423 
31056157  31059172  0.851972976 
31092038  31094660  0.551624383 
31321337  31323848  0.452281196 
31323764  31326217  0.621960824 
31365145  31367681  0.491564421 
31367358  31369739  0.43577134 
31389893  31392559  0.428661609 
31415829  31418487  0.419018763 
31425276  31427539  0.422257018 
31511491  31514354  0.540576928 
31865033  31867206  0.825494445 
31955316  31957399  0.802678454   207 
31975147  31977228  0.559284364 
31980740  31983206  0.575024791 
32220043  32222067  0.702016342 
32364646  32367027  0.411144569 
32387922  32390488  0.452297001 
32390209  32393140  0.663247501 
32395956  32398655  0.750176571 
32409735  32412419  0.689602651 
32425489  32427795  0.564261938 
32430334  32433086  0.453128227 
32434975  32437634  0.410066859 
32449154  32450929  0.432421388 
32471036  32473567  0.470043067 
32498517  32501144  0.524899088 
32505710  32507577  0.661459906 
32509557  32512401  0.429390024 
32511421  32513544  0.932602283 
32526778  32528509  0.503215151 
32539196  32541992  0.584627644 
32561821  32564747  0.431994573 
32566224  32568770  0.55458087 
32583051  32585482  0.478776537 
32619337  32622559  0.401899149 
32622631  32625110  0.513908404 
32651630  32653632  0.499003012 
32686431  32689080  0.767205538 
32691590  32694583  0.461439144 
32705613  32708110  0.735658383 
32761722  32764350  0.482341379 
32769075  32771517  0.565704136 
32780871  32783266  0.41115026 
32787740  32790461  0.412398176 
32794482  32797049  0.43454104 
32796793  32799124  0.617260724 
32857226  32859895  0.501158919 
32870242  32872810  0.548254335 
32875022  32877556  0.428879357 
32877232  32879913  0.455350541 
32904298  32906120  0.55790393 
32931156  32933975  0.417799295 
33025410  33027740  0.43507822 
33027231  33028946  0.558000713 
33067567  33070137  0.5299079 
33104021  33106350  0.445969608 
33117354  33120123  0.561697932 
33176769  33178915  0.404808889 
33217907  33219670  0.457952348 
33227950  33230409  0.460856046 
33283836  33286387  3.975215717 
33292021  33293767  0.426293697 
33501985  33503886  0.59069723 
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Appendix III - Position of MARs of IFN-γ induced MRC5 cells and their array   
                          enrichment 
 
Start position  End position  Matrix enrichment (log2) 
29772399  29775033  1.049801067 
29781700  29784102  0.591308658 
29792469  29798300  0.522471833 
29811013  29813380  0.420064147 
29840342  29842808  0.641989126 
29849827  29852415  0.704240122 
29854767  29857057  0.552058507 
29872823  29875035  0.54336622 
29882039  29884543  0.834133308 
29884167  29886552  1.133676991 
29896602  29899084  0.441221525 
29917144  29919923  0.50772475 
29931599  29934065  0.529999226 
29933548  29935949  0.910566307 
29935654  29938224  0.74470164 
29937894  29939594  0.441422054 
29949751  29952328  0.463249917 
29956443  29958865  0.617680963 
29960874  29962955  1.158341109 
29975451  29978299  0.50409617 
29977965  29979873  0.425804085 
29993954  29996553  0.644487391 
29996470  29998921  0.58506104 
30036629  30039288  0.442040222 
30062253  30064589  0.541396708 
30065589  30067967  0.844153915 
30096934  30100100  0.447535682 
30101121  30103717  0.639791775 
30103986  30106521  0.665963702 
30127345  30129803  0.493341502 
30168959  30171414  0.516361315 
30203030  30205314  0.50502874 
30207839  30210162  0.604713047 
30223796  30226544  0.762099579 
30226106  30228443  1.771074308 
30231506  30234359  0.722487581 
30238940  30240972  2.140226418 
30249896  30252535  0.641808161 
30252097  30254580  0.68684891 
30256578  30258948  0.418002505 
30269344  30271071  0.461621459 
30301929  30304620  1.081822769 
30306687  30309185  0.415578249 
30309105  30311651  0.574531723 
30322904  30325267  0.43606955 
30328752  30331413  0.550448473 
30331401  30333872  0.606252271 
30341155  30343559  0.655637831 
30345571  30347925  0.545263234 
30347804  30350169  0.46135727 
30389144  30392634  0.594588791 
30391810  30393924  0.754115027 
30406289  30409007  1.121396851 
30411277  30413752  0.542471092 
30424262  30426665  0.513809249 
30433512  30435982  0.469998703 
30435458  30437915  0.559598092 
30442776  30445345  0.458286542 
30450571  30453097  0.515079905 
30453257  30455963  1.092588766 
30455483  30457800  1.266178864 
30459362  30461425  0.757938884 
30463598  30466352  0.45280234 
30472435  30474725  0.590706527 
30474644  30477030  0.488176961 
30482335  30484495  0.522910204   209 
30484481  30486798  0.495980716 
30498694  30501279  0.582779522 
30501127  30503780  0.956521698 
30503512  30505932  0.52845754 
30509530  30512280  0.818405019 
30512150  30514491  0.595409879 
30516686  30519460  0.583966874 
30532105  30534885  0.433526001 
30546495  30548204  0.800496996 
30608279  30610773  0.426602843 
30687802  30690256  0.717735973 
30698815  30701782  0.441636431 
30767990  30770760  0.925658748 
30950261  30953164  0.403764536 
31054143  31056020  0.421592821 
31056157  31059172  0.554921445 
31147190  31149630  0.412134893 
31208146  31210054  0.587538815 
31256049  31258433  0.512333365 
31306864  31309399  0.449128931 
31321337  31323848  0.83287629 
31323764  31326217  0.769802675 
31349918  31352712  0.425241291 
31365145  31367681  1.001499443 
31367358  31369739  1.052325164 
31377505  31380155  0.549970869 
31387943  31390679  0.90454688 
31389893  31392559  1.020292464 
31392265  31394713  0.546338622 
31403562  31405377  0.446565181 
31413230  31416000  0.914900848 
31415829  31418487  0.668498238 
31421730  31424152  0.414236451 
31423462  31425292  0.493809738 
31425276  31427539  0.418474252 
31433998  31436656  0.545090692 
31435990  31438961  0.436673775 
31472505  31475307  0.455900346 
31498765  31501407  0.401680246 
31511491  31514354  0.77212005 
31517732  31520447  0.742048175 
31522428  31524251  0.589933091 
31555714  31557747  0.415611255 
31562288  31564901  0.407069889 
31567390  31569981  0.403397752 
31602298  31604502  0.617155371 
31784795  31786680  0.40183233 
31955316  31957399  0.494678105 
31980740  31983206  0.613123821 
31990195  31993322  0.531821297 
32220043  32222067  0.727509267 
32323976  32326426  0.638889147 
32330237  32333661  0.405145132 
32337055  32339933  0.65203743 
32352121  32354558  0.40422516 
32354408  32357209  0.432501891 
32359755  32362494  0.443665253 
32364646  32367027  0.611222219 
32379696  32381542  0.401916558 
32383418  32386054  0.406333698 
32387922  32390488  0.6774036 
32390209  32393140  0.428043767 
32395956  32398655  1.597834078 
32398586  32401154  0.891748454 
32402691  32405190  0.447497692 
32404753  32407328  0.458058934 
32409735  32412419  0.864437415 
32425489  32427795  0.772856453 
32434975  32437634  0.419542132 
32439560  32442112  0.523744186 
32449154  32450929  0.73579992   210 
32453538  32456020  0.519284458 
32471036  32473567  0.647072857 
32491122  32493607  0.447654425 
32501095  32503289  0.454018427 
32509557  32512401  0.587227372 
32511421  32513544  2.50762754 
32518443  32520782  0.544699667 
32526778  32528509  0.664975997 
32536608  32539324  0.616132169 
32539196  32541992  1.027431171 
32541661  32544149  0.401677674 
32543851  32546046  0.461342381 
32561821  32564747  0.793174255 
32566224  32568770  0.478428081 
32577343  32579881  0.430770385 
32583051  32585482  0.493821162 
32598134  32600400  0.412373568 
32613182  32615215  0.456789805 
32644074  32646662  1.030594313 
32646521  32649544  0.501180242 
32651630  32653632  0.448923754 
32663263  32666061  0.404139716 
32673701  32676631  0.414046656 
32686431  32689080  0.866036275 
32689045  32691474  1.184147147 
32691590  32694583  0.559257989 
32694444  32697209  0.46287668 
32696991  32699506  0.547303174 
32705613  32708110  0.738285211 
32710133  32712269  0.423524638 
32722734  32725314  0.495529479 
32724504  32727177  0.490469236 
32743165  32746083  0.404463712 
32745804  32748726  0.430081816 
32754319  32756817  0.580936359 
32761722  32764350  0.754099217 
32766998  32769591  0.615316648 
32769075  32771517  0.719787252 
32786130  32788393  0.686275865 
32787740  32790461  0.927442836 
32794482  32797049  0.50394299 
32796793  32799124  0.62237831 
32799001  32801669  1.4187691 
32808098  32810522  0.598241428 
32810462  32813136  0.420570067 
32825193  32827718  0.586511952 
32827724  32830188  0.515317133 
32829829  32831757  0.461188079 
32843585  32846054  0.418084091 
32847268  32850579  0.692887483 
32857226  32859895  0.778559184 
32868718  32871367  0.539393651 
32870242  32872810  0.479746347 
32872192  32874816  0.437635 
32875022  32877556  1.017812107 
32877232  32879913  0.717756672 
32931156  32933975  0.540953045 
32941867  32944276  0.499969951 
32962761  32965294  0.449659401 
32974464  32976746  0.460148697 
32975782  32978196  0.438711003 
32977812  32980308  0.676242898 
32980467  32982978  0.768576279 
32992393  32994837  0.557045226 
33022966  33025488  0.501840271 
33025410  33027740  0.914369565 
33067567  33070137  0.915400066 
33090674  33093215  0.613554929 
33104021  33106350  0.752821178 
33115900  33118153  0.658419785 
33117354  33120123  0.551879791   211 
33121204  33123602  0.51283286 
33123473  33125541  0.510379312 
33133928  33138288  0.720228682 
33138219  33141006  0.520126602 
33142984  33145436  0.408756126 
33176769  33178915  0.572146644 
33192620  33193912  0.486828122 
33210173  33212682  0.515207685 
33227950  33230409  0.545032793 
33320016  33322458  0.61226308 
33462560  33465285  0.559465849 
33501985  33503886  0.663283564 
33529999  33532371  0.559354425 
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Appendix IV - Position of MARs of PGF cells and their array enrichment 
 
Start position  End position  Matrix enrichment (log2) 
29739385  29741249  0.482147191 
29755213  29757127  0.432167475 
29849827  29852415  1.110277457 
29861411  29863644  0.405538158 
29894385  29896949  0.487401914 
29896602  29899084  0.502859211 
29929108  29931705  0.574111984 
29937894  29939594  2.526421952 
30023644  30025314  1.775267442 
30053351  30055956  0.693329948 
30065589  30067967  1.039362864 
30101121  30103717  0.581704641 
30103986  30106521  0.98209088 
30106463  30109071  0.519614908 
30108625  30111062  0.841034798 
30110866  30113454  1.729229932 
30113400  30115997  0.439612457 
30118308  30120829  0.801492862 
30123120  30125633  0.883641409 
30125000  30127465  0.805619325 
30127345  30129803  1.064832248 
30129527  30132152  1.99585852 
30131866  30134499  2.207236754 
30134479  30136131  2.387396226 
30152988  30155591  0.988586241 
30155515  30157551  0.529730025 
30200798  30203110  0.470841255 
30219223  30221767  0.533182358 
30231506  30234359  3.319040001 
30249896  30252535  0.464204585 
30252097  30254580  0.443791026 
30314787  30317588  0.501078915 
30341155  30343559  0.479846912 
30345571  30347925  1.205872764 
30347804  30350169  0.864868628 
30350008  30351777  0.799927299 
30363052  30365623  0.886622078 
30365212  30368158  0.652169791 
30368063  30370782  0.676448044 
30368214  30370831  0.622433822 
30377836  30380380  0.658218406 
30380190  30382789  0.542408668 
30391810  30393924  0.899687284 
30448175  30450582  0.476275354 
30463598  30466352  0.468579875 
30474644  30477030  0.732587325 
30482335  30484495  1.876325603 
30489386  30491682  0.416035621 
30498694  30501279  0.69955459 
30501127  30503780  0.758140163 
30503512  30505932  0.481793655 
30509530  30512280  0.74238899 
30555778  30557696  0.812807873 
30557295  30559029  0.670945263 
30562566  30564894  0.403426484 
30568353  30570872  0.903176347 
30583516  30586461  0.763093791 
30600787  30603165  0.711956124 
30610759  30613495  0.417564988 
30677499  30679491  0.993747688 
30689948  30692394  1.071166292 
30691343  30693991  1.058426869 
30698815  30701782  2.012782126 
30701596  30704062  0.744320899 
30711444  30713962  0.683121345 
30714444  30716453  0.405939453 
30756515  30758800  0.508400578 
30767990  30770760  0.54222195 
30772906  30775852  0.53441826   213 
30825368  30827875  0.533282644 
30827954  30830159  0.982094296 
30834737  30837454  0.488754857 
30901287  30903649  0.4370775 
30903401  30906093  0.850043797 
30923216  30925575  0.40814842 
30991536  30994461  0.653581056 
31018945  31021138  0.446628494 
31021804  31024362  1.027783576 
31023710  31026101  0.96905714 
31024896  31027536  0.915876174 
31026926  31029099  0.79052907 
31028955  31031073  0.741360261 
31030830  31033294  0.453431798 
31039751  31042033  1.470046109 
31049352  31051490  0.479301224 
31051409  31054038  1.143856913 
31054143  31056020  0.903290745 
31056157  31059172  2.389286257 
31061209  31064176  0.719780599 
31098259  31100652  0.770924003 
31100296  31102131  0.550215769 
31105233  31107465  0.62682859 
31110005  31112753  0.594295352 
31174122  31176523  0.431525983 
31256049  31258433  0.473060356 
31323764  31326217  0.587113883 
31352523  31355086  0.42361182 
31369850  31372247  0.794692668 
31373910  31376551  0.433074209 
31376096  31377899  0.992805918 
31403562  31405377  0.50653476 
31413230  31416000  0.524884214 
31435990  31438961  0.600006049 
31438478  31440903  0.488539995 
31442467  31444925  0.71193306 
31444860  31447238  1.130968695 
31451728  31454419  1.28228359 
31454436  31456982  0.403756867 
31485229  31487901  0.419517344 
31490983  31493112  1.13447987 
31511491  31514354  0.415125969 
31522428  31524251  0.510902871 
31558217  31560371  0.401852481 
31575231  31578232  0.417827056 
31588415  31591252  0.53639594 
31621456  31623166  0.756629863 
31662312  31665020  1.237122769 
31676093  31678464  0.690785896 
31678683  31681025  0.575932467 
31687714  31690387  0.490032589 
31689689  31692751  0.664720512 
31796596  31799113  0.439280284 
31838392  31840676  0.789680799 
31938977  31941560  0.407787394 
31945923  31948419  0.427803588 
31955316  31957399  0.714972748 
31963191  31965805  0.496633778 
31980740  31983206  0.638547938 
32193954  32196840  0.446889343 
32220043  32222067  1.041134424 
32246419  32248999  0.433639482 
32248564  32250364  0.488978232 
32249781  32252103  0.457409351 
32323976  32326426  0.62996533 
32327905  32330164  0.441934589 
32339897  32342653  0.402688603 
32359755  32362494  0.470886614 
32372351  32375042  0.479955291 
32376862  32379701  0.476129427 
32386043  32387227  1.506569425 
32393119  32395967  0.406674242   214 
 
 
32411660  32414241  1.849664636 
32414203  32416787  0.919980551 
32416697  32418805  0.423529254 
32418544  32420769  0.545012326 
32423326  32425860  1.26078944 
32432791  32435294  0.961228297 
32434975  32437634  0.730141176 
32439560  32442112  0.591598327 
32446941  32449572  0.489568258 
32453538  32456020  0.686435565 
32467000  32470237  0.423336688 
32483778  32485594  0.502526401 
32496153  32498835  0.562715912 
32498517  32501144  0.791099009 
32505710  32507577  2.094044123 
32524176  32526297  0.409230532 
32526778  32528509  0.682785027 
32536608  32539324  0.464144547 
32543851  32546046  0.616745224 
32566224  32568770  0.773844701 
32577343  32579881  0.491508336 
32577611  32579425  0.554686048 
32583051  32585482  0.688380975 
32585496  32588059  0.489706196 
32587814  32590389  0.433742848 
32613182  32615215  0.409983107 
32619337  32622559  1.002131183 
32626531  32628342  0.885650144 
32629755  32631649  0.471231818 
32649832  32652328  1.777332919 
32653939  32656323  0.483995856 
32657249  32658112  0.469473531 
32668459  32673858  0.540204285 
32678591  32681243  0.662968739 
32680961  32683760  0.553234079 
32710133  32712269  0.670335726 
32714274  32717018  1.377067649 
32716744  32719125  0.693679936 
32718336  32721027  0.463576216 
32720216  32722920  0.836576859 
32722734  32725314  0.622251611 
32724504  32727177  0.452963123 
32743165  32746083  0.524197086 
32759416  32762298  2.056098071 
32761722  32764350  0.431556292 
32766998  32769591  0.645115482 
32769075  32771517  1.12835019 
32771813  32774032  3.031142095 
32773440  32776301  0.499332172 
32776173  32778703  3.341811971 
32778597  32781168  1.112091941 
32786130  32788393  1.279673698 
32787740  32790461  1.534303387 
32794482  32797049  1.04283508 
32796793  32799124  0.505040719 
32801443  32804134  0.597150639 
32805771  32808229  1.192730415 
32808098  32810522  0.793411988 
32810462  32813136  0.52587137 
32812745  32815129  0.531638095 
32827724  32830188  0.640426903 
32843585  32846054  0.409749519 
32847268  32850579  0.608774574 
32850451  32852327  1.587074053 
32857226  32859895  0.609320612 
32859507  32861730  2.525040351 
32861678  32864080  1.060303875 
32877232  32879913  0.540065293 
32890054  32892994  0.556003338   215 
Appendix V - Position of MARs common to all cell types 
 
Start position  End position 
29849827  29852415 
29937894  29939594 
30065589  30067967 
30101121  30103717 
30103986  30106521 
30231506  30234359 
30249896  30252535 
30341155  30343559 
30391810  30393924 
30482335  30484495 
30501127  30503780 
30509530  30512280 
30698815  30701782 
30767990  30770760 
31056157  31059172 
31323764  31326217 
31511491  31514354 
31955316  31957399 
31980740  31983206 
32220043  32222067 
32434975  32437634 
32526778  32528509 
32566224  32568770 
32583051  32585482 
32761722  32764350 
32769075  32771517 
32787740  32790461 
32794482  32797049 
32796793  32799124 
32857226  32859895 
32877232  32879913 
33117354  33120123 
33501985  33503886 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   216 
Appendix VI - Position of MARs in the MHC of both IFN-γ induced and   
                          uninduced MRC5 cells 
 
Start position  End position 
29811013  29813380 
29840342  29842808 
29872823  29875035 
29882039  29884543 
29884167  29886552 
29933548  29935949 
29960874  29962955 
29975451  29978299 
29996470  29998921 
30036629  30039288 
30062253  30064589 
30168959  30171414 
30223796  30226544 
30226106  30228443 
30238940  30240972 
30389144  30392634 
30442776  30445345 
30455483  30457800 
30459362  30461425 
30472435  30474725 
30516686  30519460 
31321337  31323848 
31365145  31367681 
31367358  31369739 
31389893  31392559 
31415829  31418487 
31425276  31427539 
32364646  32367027 
32387922  32390488 
32390209  32393140 
32395956  32398655 
32409735  32412419 
32425489  32427795 
32449154  32450929 
32471036  32473567 
32509557  32512401 
32511421  32513544 
32539196  32541992 
32561821  32564747 
32651630  32653632 
32395956  32398655 
32686431  32689080 
32691590  32694583 
32705613  32708110 
32875022  32877556 
32931156  32933975 
33025410  33027740 
33067567  33070137 
33104021  33106350 
33176769  33178915 
33227950  33230409 
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Appendix VII - Position of MARs of PGF cells only 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start position  End position 
29739385  29741249 
29755213  29757127 
29861411  29863644 
29929108  29931705 
30023644  30025314 
30053351  30055956 
30106463  30109071 
30108625  30111062 
30110866  30113454 
30113400  30115997 
30118308  30120829 
30125000  30127465 
30152988  30155591 
30155515  30157551 
30219223  30221767 
30314787  30317588 
30350008  30351777 
30363052  30365623 
30365212  30368158 
30368063  30370782 
30368214  30370831 
30380190  30382789 
30448175  30450582 
30489386  30491682 
30555778  30557696 
30557295  30559029 
30562566  30564894 
30583516  30586461 
30600787  30603165 
30677499  30679491 
30689948  30692394 
30691343  30693991 
30701596  30704062 
30711444  30713962 
30714444  30716453 
30756515  30758800 
30825368  30827875 
30827954  30830159 
30834737  30837454 
30901287  30903649 
30903401  30906093 
30923216  30925575 
30991536  30994461 
31018945  31021138 
31021804  31024362 
31023710  31026101 
31024896  31027536 
31026926  31029099 
31028955  31031073 
31030830  31033294 
31039751  31042033 
31049352  31051490 
31051409  31054038 
31054143  31056020 
31061209  31064176 
31098259  31100652 
31100296  31102131 
31105233  31107465 
31110005  31112753 
31174122  31176523 
31352523  31355086 
31369850  31372247 
31373910  31376551 
31376096  31377899 
31438478  31440903   218 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31442467  31444925 
31444860  31447238 
31451728  31454419 
31454436  31456982 
31485229  31487901 
31490983  31493112 
31558217  31560371 
31575231  31578232 
31588415  31591252 
31621456  31623166 
31662312  31665020 
31676093  31678464 
31678683  31681025 
31687714  31690387 
31689689  31692751 
31796596  31799113 
31838392  31840676 
31938977  31941560 
31945923  31948419 
31963191  31965805 
32193954  32196840 
32246419  32248999 
32248564  32250364 
32249781  32252103 
32327905  32330164 
32339897  32342653 
32372351  32375042 
32376862  32379701 
32386043  32387227 
32393119  32395967 
32411660  32414241 
32414203  32416787 
32416697  32418805 
32418544  32420769 
32423326  32425860 
32432791  32435294 
32446941  32449572 
32467000  32470237 
32483778  32485594 
32496153  32498835 
32524176  32526297 
32577611  32579425 
32585496  32588059 
32587814  32590389 
32626531  32628342 
32629755  32631649 
32653939  32656323 
32657249  32658112 
32668459  32673858 
32678591  32681243 
32680961  32683760 
32714274  32717018 
32716744  32719125 
32718336  32721027 
32720216  32722920 
32759416  32762298 
32771813  32774032 
32773440  32776301 
32776173  32778703 
32778597  32781168 
32801443  32804134 
32805771  32808229 
32812745  32815129 
32850451  32852327 
32859507  32861730 
32861678  32864080 
32890054  32892994 
32892523  32894937   219 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32894483  32897025 
32896974  32899399 
32906204  32908888 
32944237  32946032 
32948866  32951226 
32951208  32953571 
32964422  32967273 
32967276  32969811 
32968550  32971099 
32970390  32972719 
32972559  32975260 
32987255  32990019 
32989946  32992530 
32997141  32999893 
32999284  33001846 
33003704  33006056 
33006053  33008988 
33008444  33010878 
33010869  33013520 
33034370  33036962 
33037346  33039646 
33039760  33042545 
33049800  33052268 
33086287  33088714 
33092818  33095473 
33097613  33099941 
33106390  33108236 
33109482  33111869 
33112049  33114719 
33113667  33116173 
33144119  33146299 
33146226  33148958 
33148418  33151260 
33150708  33153101 
33162178  33164006 
33219995  33222707 
33538830  33541653   220 
Appendix VIII - Position of MARs of uninduced MRC5 cells 
 
Start position  End position 
29802604  29804427 
29894385  29896949 
29982740  29984644 
30046908  30048715 
30129527  30132152 
30131866  30134499 
30134479  30136131 
30146157  30148833 
30200798  30203110 
30304335  30306759 
30343050  30345405 
30377836  30380380 
30421568  30424503 
30428243  30430343 
30610759  30613495 
30731648  30734384 
30772906  30775852 
31092038  31094660 
31865033  31867206 
31975147  31977228 
32430334  32433086 
32498517  32501144 
32505710  32507577 
32619337  32622559 
32622631  32625110 
32780871  32783266 
32904298  32906120 
33027231  33028946 
33217907  33219670 
33283836  33286387 
33292021  33293767 
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Appendix IX - Position of MARs of IFN-γ induced MRC5 only 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start position  End position 
29772399  29775033 
29781700  29784102 
29792469  29798300 
29854767  29857057 
29917144  29919923 
29931599  29934065 
29935654  29938224 
29949751  29952328 
29956443  29958865 
29977965  29979873 
29993954  29996553 
30096934  30100100 
30203030  30205314 
30207839  30210162 
30256578  30258948 
30269344  30271071 
30306687  30309185 
30309105  30311651 
30322904  30325267 
30328752  30331413 
30331401  30333872 
30406289  30409007 
30411277  30413752 
30424262  30426665 
30433512  30435982 
30435458  30437915 
30450571  30453097 
30453257  30455963 
30484481  30486798 
30512150  30514491 
30532105  30534885 
30546495  30548204 
30608279  30610773 
30687802  30690256 
30950261  30953164 
31147190  31149630 
31208146  31210054 
31306864  31309399 
31349918  31352712 
31377505  31380155 
31387943  31390679 
31392265  31394713 
31421730  31424152 
31423462  31425292 
31433998  31436656 
31472505  31475307 
31498765  31501407 
31517732  31520447 
31562288  31564901 
31567390  31569981 
31602298  31604502 
31784795  31786680 
31990195  31993322 
32330237  32333661 
32337055  32339933 
32352121  32354558 
32354408  32357209 
32379696  32381542 
32383418  32386054 
32398586  32401154 
32402691  32405190 
32404753  32407328   222 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32491122  32493607 
32501095  32503289 
32518443  32520782 
32541661  32544149 
32598134  32600400 
32644074  32646662 
32646521  32649544 
32663263  32666061 
32673701  32676631 
32689045  32691474 
32694444  32697209 
32696991  32699506 
32745804  32748726 
32754319  32756817 
32799001  32801669 
32825193  32827718 
32829829  32831757 
32868718  32871367 
32872192  32874816 
32962761  32965294 
32974464  32976746 
32975782  32978196 
32980467  32982978 
33022966  33025488 
33090674  33093215 
33115900  33118153 
33121204  33123602 
33123473  33125541 
33142984  33145436 
33192620  33193912 
33210173  33212682 
33320016  33322458 
33462560  33465285 
33529999  33532371   223 
Appendix X - Position of MARs of both IFN-γ induced MRC5 and PGF cells 
 
Start position  End position 
29896602  29899084 
30127345  30129803 
30345571  30347925 
30347804  30350169 
30463598  30466352 
30474644  30477030 
30498694  30501279 
30503512  30505932 
31054143  31056020 
31256049  31258433 
31403562  31405377 
31413230  31416000 
31435990  31438961 
31522428  31524251 
32323976  32326426 
32359755  32362494 
32439560  32442112 
32453538  32456020 
32536608  32539324 
32543851  32546046 
32577343  32579881 
32613182  32615215 
32710133  32712269 
32722734  32725314 
32724504  32727177 
32743165  32746083 
32766998  32769591 
32786130  32788393 
32808098  32810522 
32810462  32813136 
32827724  32830188 
32843585  32846054 
32847268  32850579 
32941867  32944276 
32977812  32980308 
32992393  32994837 
33133928  33138288 
33138219  33141006 
 